16.11.2014 Views

programma & abstracts - Nederlandse Vereniging voor Radiologie

programma & abstracts - Nederlandse Vereniging voor Radiologie

programma & abstracts - Nederlandse Vereniging voor Radiologie

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

16<br />

29 en 30 september 2011<br />

radio<br />

logen<br />

dagen<br />

m e c c , m a a s t r i c h t<br />

<strong>Nederlandse</strong> <strong>Vereniging</strong> <strong>voor</strong> <strong>Radiologie</strong><br />

Radiological Society of the Netherlands<br />

<strong>programma</strong> & <strong>abstracts</strong>


<strong>programma</strong> <strong>voor</strong>woord & <strong>abstracts</strong><br />

Kwaliteit<br />

Dames en heren, geachte leden van de <strong>Nederlandse</strong> <strong>Vereniging</strong> <strong>voor</strong> <strong>Radiologie</strong>,<br />

Welkom in Maastricht op de Radiologendagen 2011! Het thema dit lustrumjaar is Kwaliteit.<br />

Kwaliteitseisen in de gezondheidszorg worden steeds meer opgelegd en zijn belangrijk <strong>voor</strong> een goede praktijkvoering. Dit<br />

geldt uiteraard ook <strong>voor</strong> de radiologie, dan bij <strong>voor</strong>keur door ons als vereniging zelf de eisen opgesteld en in goede samenwerking<br />

met onze klinische collega’s.<br />

Voor de hand liggend is het om kwalitatief beter te worden door te leren van eigen fouten. Het <strong>programma</strong> begint donderdagochtend<br />

daarom met ‘Deze misser maak je maar 1 keer’.<br />

In de tweede plenaire sessie op donderdag ‘Setting standards in healthcare – many ways, no return’ zal het onderwerp<br />

kwaliteit belicht worden door gastsprekers Dr. M-J Vrancken Peeters (chirurg, NKI-AvL) en Prof. Dr. D. Rubin (radioloog,<br />

Stanford University, USA).<br />

Op vrijdag zal er door een drietal pro-con koppels worden gedebatteerd over het hanteren van kwaliteitsnormen: ‘Pro-con:<br />

setting standards in healthcare – which way to go?’.<br />

Nieuw onderwerp bij de parallelsessies is de Educatieve Voordracht. Dit is bedoeld om onderwerpen welke direct toepasbaar<br />

zijn in uw praktijk, maar (nog) niet zijn verworden tot een wetenschappelijk artikel.<br />

Bij alle wetenschappelijke abstract sessies zijn hierbij passende keynote lectures gezocht.<br />

De ‘Research Corner’ uit 2009 is gestoken in een nieuw jasje. Acht UMC’s presenteren niet alleen hun spraakmakende<br />

wetenschappelijke onderzoeken, maar steken ook de hand naar elkaar uit, om samen beter te worden.<br />

De Refresher Courses op beide dagen worden deels verzorgd door toonaangevende gastsprekers uit het buitenland. Aan de<br />

hand van de verstrekte leerdoelen kunt u beter schatten of een onderwerp uw belangstelling heeft.<br />

Wij zijn buitengewoon verheugd een aantal van u ook een workshop te kunnen aanbieden. De geluksvogels onder u gaan<br />

statistisch gezien herboren naar huis en met bouwstenen <strong>voor</strong> een robuuste teachingfile (millennium proof). Lees <strong>voor</strong> details<br />

het volledige <strong>programma</strong>.<br />

Dit jaar is er een andere formule gekozen <strong>voor</strong> de verschillende prijzen. Naast de bekende Philipsprijs en Radiologendagen<br />

prijs zal er een toelichting op en uitreiking van de NVvR Travel Grant plaatsvinden.<br />

Bent u dit jaar niet in de prijzen gevallen dan bent u niet minder welkom in feestelijke kleding op het Diner & Galafeest met<br />

als thema ‘Dress to impress’. Op een prachtige locatie in Maastricht wordt u op zuidelijke wijze verwend.<br />

De radiologendagen kunnen mede mogelijk worden gemaakt door sponsoring van de industrie, u wordt dan ook van harte<br />

uitgenodigd om met de industrie in contact te komen op de expositie.<br />

Onze dank gaat uit naar de inzet van velen, zichtbaar in het <strong>programma</strong> boekje. Namen noemen is ontoereikend, enthousiaste<br />

deelnemers is uw verdienste.<br />

Veel plezier op de radiologendagen 2011!<br />

Bert-Jan de Bondt, <strong>voor</strong>zitter<br />

Vincent Cappendijk<br />

Marion Smits<br />

Bart Wiarda<br />

Henk-Jan van der Woude


16 E RADIOLOGENDAGEN 2011<br />

Organisatie<br />

Organisatie Comité<br />

Bert-Jan de Bondt, <strong>voor</strong>zitter<br />

Vincent Cappendijk<br />

Marion Smits<br />

Bart Wiarda<br />

Henk-Jan van der Woude<br />

WETENSCHAPPELIJK COMITÉ<br />

Henk Jan Baarslag<br />

Ludo Beenen<br />

Marc Engelbrecht<br />

Nanko de Graaf<br />

Jan-Cees de Groot<br />

Ieneke Hartmann<br />

Mechli Imhof-Tas<br />

Simone Jap-a-Joe<br />

Viola Koen<br />

Martin Kraai<br />

Krijn van Lienden<br />

Ruud Pijnappel<br />

Stefan Steens<br />

Joachim Wilberger<br />

CONGRESSECRETARIAAT<br />

Postbus 2428<br />

5202 CK ‘s-Hertogenbosch<br />

Tel 073 700 3500<br />

Fax 073 700 3505<br />

info@congresscompany.com<br />

www.congresscompany.com<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 1


<strong>programma</strong> & <strong>abstracts</strong><br />

<strong>programma</strong><br />

Donderdag 29 september 2011<br />

Tijdstip<br />

Onderwerp<br />

TRAJECTUM<br />

10.00 - 10.40 Ontvangst & registratie<br />

AUDITORIUM 2<br />

10.40 - 10.45 Opening door <strong>voor</strong>zitter<br />

Dr. R.B.J. de Bondt, Isala klinieken, Zwolle<br />

AUDITORIUM 2<br />

10.45 - 12.00 Plenaire sessie: Deze misser maak je maar één keer<br />

Voorzitter: Mw. Drs. V.H. Koen, Kennemer Gasthuis, Haarlem<br />

Dr. K.P. van Lienden, AMC, Amsterdam<br />

Mw. Dr. C.S.P. van Rijswijk, LUMC, Leiden<br />

Dr. M.W. de Haan, MUMC, Maastricht<br />

EXPOFOYER<br />

12.00 - 13.00 Lunch<br />

EXPOFOYER<br />

12.15 - 12.45 Postersessie<br />

AUDITORIUM 2<br />

13.00 - 14.00 Plenaire sessie: Setting standards in healthcare - many ways, no return<br />

Kwaliteitseisen opgelegd door de zorgverzekeraar, maar ook die van de heelkundige beroepsvereniging<br />

zijn opmerkelijk in het nieuws geweest. Onvermijdelijk dat de radiologie hiermee te maken krijgt. Van<br />

buitenaf opgelegd dan wel zelf opgesteld. In deze sessie schetst dr. M-J. Vrancken Peeters, chirurg en<br />

woordvoerster van de NVvH, de aanloop tot -en achtergrond van de recent gepubliceerde kwaliteitseisen<br />

<strong>voor</strong> oncologische chirurgie. Vervolgens stelt dr. D. Rubin een ambitieuze maar praktische manier<br />

<strong>voor</strong> om de kwaliteit van het radiologisch werk te verbeteren.<br />

Inleiding door: Prof. dr. J.S. Laméris, AMC, Amsterdam<br />

Gastsprekers:<br />

Dr. M-J. Vrancken Peeters, chirurg, NKI-AvL, Amsterdam<br />

Prof. D. Rubin, Stanford University, USA<br />

14.05 - 15.35 Parallelsessies vrije <strong>voor</strong>drachten<br />

Voorafgaand aan de wetenschappelijke <strong>voor</strong>drachten zal iedere sessie aanvangen met een keynote lecture.<br />

ZAAL 2.1 COLORADO<br />

Sessie 1: Abdominale radiologie 1<br />

Voorzitters: Dr. R.F.A. Vliegen, Atrium MC, Heerlen & Drs. J.E. van den Bergh, AMC, Amsterdam<br />

PET-MRI: tool or toy<br />

Dr. J. Buscombe, Addenbrooke’s Hospital, Cambridge, UK<br />

Learning objectives:<br />

Understand technical issues of PET/MR<br />

Look at possible indications for PET/MR<br />

Understand some of the issues for nuclear medicine staff<br />

The first PET/MR machines are now on the market for €2 million. However there are significant<br />

technical issues including just trying to acquire images. What compromises are made in terms of image<br />

quality for both PET and MR. How can attenuation correction be applied? Once these technical issues<br />

have been resolved is PET/MR just a technique looking for an indication?<br />

ZAAL 0.8 ROME<br />

Sessie 2: Abdominale radiologie / Acute radiologie / Diversen<br />

Voorzitters: Mw. M.A. Stam, Medisch Centrum Alkmaar & L.F.M. Beenen, AMC, Amsterdam<br />

Alternatieve diagnoses bij MRI appendicitis<br />

Mw. M.A. Stam, Medisch Centrum Alkmaar, Alkmaar<br />

ZAAL 0.5 PARIS<br />

Sessie 3: Cardiovasculaire radiologie<br />

Voorzitters: Dr. H.J. Lamb, LUMC, Leiden & H.C.M. van den Bosch, Catharina Ziekenhuis, Eindhoven<br />

MRI bij diabetes en metabool syndroom<br />

Dr. H.J. Lamb, LUMC, Leiden<br />

ZAAL 0.9 ATHENS<br />

Sessie 4: Mammadiagnostiek 1<br />

Voorzitters: Dr. M.J.C.M. Rutten, Jeroen Bosch Ziekenhuis & Mw. K.M. Duvivier, UMC Utrecht, Utrecht<br />

3D echografie van de mamma; een poor mans MRI?<br />

Dr. M.J.C.M. Rutten, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

ZAAL 0.4 BRUSSELS<br />

Sessie 5: Interventieradiologie / Cardiovasculaire radiologie<br />

Voorzitters: Dr. M.W. de Haan, MUMC, Maastricht & L.W. Kaufmann, Spaarne Ziekenhuis, Hoofddorp<br />

Update abdominale endoprothesen<br />

Dr. M.W. de Haan, MUMC, Maastricht<br />

AUDITORIUM 2<br />

Research Corner<br />

Voorzitters: Mw. Prof. dr. R.G.H. Beets-Tan, MUMC, Maastricht & Prof. dr. J.S. Laméris, AMC, Amsterdam<br />

Tijdens deze parallelsessie zullen de 8 UMC’s de gelegenheid hebben een presentatie te geven van een<br />

hoogstaand en origineel onderzoeksproject. Van het project wordt een kort overzicht gegeven. Duidelijk<br />

zal worden wat de positie van het onderzoek is ten opzichte van andere groepen in Nederland en daarbuiten,<br />

en wat het perspectief van het onderzoek is in 5 a 10 jaar van nu. Tot slot wordt aangegeven<br />

met welke additionele (externe?) kennis, men dit perspectief verwacht eerder te kunnen halen.<br />

2<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Tijdstip<br />

Onderwerp<br />

16 E RADIOLOGENDAGEN 2011<br />

EXPOFOYER<br />

15.35 - 16.00 Theepauze<br />

LUMC: Toepassingen van ultrahoogveld MRI bij patientenpopulaties<br />

Prof. dr. M.A. van Buchem<br />

Erasmus MC: Population Imaging<br />

Prof. dr. A. van der Lugt<br />

UMC Groningen: Screening for Coronary Artery Disease by Non-invasive Imaging in Patients with<br />

known Extra-cardiac Atherosclerotic Disease: the GROUND-2 study<br />

Mw. Dr. R. Vliegenthart<br />

VUMC: Pseudo-continuous arterial spin-labeling at 3T in Alzheimer’s disease<br />

Drs. M.A.A. Binnewijzend<br />

UMC St Radboud: MR gestuurde prostaat interventies; klaar <strong>voor</strong> de praktijk?<br />

Dr. J.J. Fütterer<br />

MUMC: Wait and See in rectal cancer patients: selection by imaging and outcome<br />

Mw. Drs. M. Maas & Mw. Prof. dr. R.G.H. Beets-Tan<br />

AMC: Neurotransmitters in de MRI<br />

Mw. Dr. L. Reneman, neuroradioloog<br />

UMC Utrecht: MRI-guided High Intensity Focused Ultrasound: The future of tumor ablation?<br />

Dr. M.A.A.J. van den Bosch<br />

16.00 - 17.15 Refresher courses<br />

ZAAL 0.4 BRUSSELS<br />

Chronische thrombo-embolische pulmonale hypertensie<br />

Voorzitter: Dr. H.W. van Es, St. Antonius Ziekenhuis, Nieuwegein<br />

Het klinisch gezichtspunt<br />

L. van den Toorn, Erasmus MC, Rotterdam<br />

Leerdoelen:<br />

* De patient met pulmonale hypertensie bestaat (niet)?<br />

* Work-up van patiënten met (vermoeden) pulmonale hypertensie<br />

* Wat zijn de verschillende behandelingen (medicamenteus en chirurgisch).<br />

CT beeldvorming<br />

Mw. Dr. W. van Lankeren, Erasmus MC, Rotterdam<br />

Leerdoelen:<br />

* Welk protocol bij analyse pulmonale hypertensie?<br />

* Wat zijn de direct en indirecte kenmerken CTEPH op CT?<br />

* Wat zijn de pitfalls?<br />

MRI beeldvorming<br />

Prof. dr. A. Vonk-Noordegraaf, VUMC, Amsterdam<br />

Leerdoelen:<br />

* Welk protocol bij analyse pulmonale hypertensie?<br />

* Wat zijn de direct en indirecte kenmerken CTEPH op CT?<br />

* Toegevoegde waarde van functionele informatie?<br />

Chirurgie<br />

Dr. W.J. Morshuis, St. Antonius Ziekenhuis, Nieuwegein<br />

Leerdoelen:<br />

* Wat zijn de operatie-indicaties<br />

* Wat houdt CTEPH chirurgie in?<br />

* Post-operatief beloop: succes gegarandeerd?<br />

Paneldiscussie<br />

Leerdoel:<br />

Kunnen MRI en CT angiografie vervangen?<br />

ZAAL 0.8 ROME<br />

Beeldvorming bij groei- en puberteitsstoornissen<br />

Voorzitter: Drs. N. de Graaf, Erasmus MC, Rotterdam<br />

Beeldvorming<br />

Mw. A.M.J.B. Smets, AMC, Amsterdam<br />

What the clinician wants to know!<br />

Drs. N. Zwaveling-Soonawala, kinderarts-endocrinoloog, EKZ-AMC, Amsterdam<br />

Leerdoelen:<br />

Beeldvorming bij groei- en puberteitsstoornissen<br />

Beeldvorming is een essentieel onderdeel in de work-up van een slecht of juist te snel groeiend kind,<br />

van een puberteit die te lang op zich laat wachten of juist te vroeg begint.<br />

Beeldvormers beschikken over een palet aan technieken om de kinderarts te ondersteunen in<br />

de diagnostiek van deze problemen. Na deze refresher course, weet u meer over de achtergrond van<br />

groei- en puberteitsstoornissen, beheerst u welke radiologische onderzoeken sleutels kunnen zijn in<br />

het oplossen van een endocrinologisch probleem bij kinderen en hoe u deze modaliteiten optimaal kunt<br />

inzetten.<br />

ZAAL 2.1 COLORADO<br />

What is the best imaging modality for ‘aseptic/low grade infection/infectious<br />

loosening of joint prostheses?’<br />

Chairman: Dr. A. Ginai, AMC, Amsterdam & Erasmus MC, Rotterdam<br />

Imaging of Total Hip Replacement and Complications<br />

Dr. A. Ginai, AMC, Amsterdam & Erasmus MC, Rotterdam<br />

Learning objectives:<br />

* Various types of hip prostheses and their radiological appearances.<br />

* Recognition of postoperative complications.<br />

* Role of imaging in diagnosis of prosthetic loosening.<br />

* Recommendations and an algorithm for imaging in ‘a patient with painful total hip arthroplasty or THP’<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 3


<strong>programma</strong> & <strong>abstracts</strong><br />

Tijdstip<br />

Onderwerp<br />

Radionuclide imaging of the problematical prosthetic hip<br />

Dr. J. Buscombe, Addenbrooke’s Hospital, Cambridge, UK<br />

Learning objectives:<br />

Understand the role of multiphase scintigraphy in the painful hip prosthesis<br />

Understand advantages and problems of labelled leucocyte imaging in the painful hip prosthesis<br />

Understand the interaction of nuclear medicine and other investigations.<br />

Whilst many areas of clinical practice has been lost to nuclear medicine the assessment of the painful<br />

hip prosthesis remains a common indication. The incidence of infected hip prosthesis is less than that<br />

for the knee (1% vs4%) but hip replacements remain more common. In many cases pain in a hip<br />

prosthesis is not due to infection or loosening but the advantage of nuclear medicine techniques is their<br />

high negative predictive value. However care must be taken when using various scintigraphic<br />

techniques to ensure an accurate final diagnosis is established.<br />

AUDITORIUM 2<br />

Respons monitoring made sexy<br />

Chairman: Dr. B. Brans, nucleair geneeskundige, MUMC, Maastricht<br />

Accurate respons monitoring is crucial for the patient<br />

Prof. dr. H.C. Schouten, hemato-oncologist, MUMC, Maastricht<br />

Learning objectives:<br />

Refresh knowledge about respons workhorses RECIST and HOVON<br />

Advantages and disadvantages of these workhorses<br />

What does the oncologist do with the (standardized) radiology report?<br />

Learn about the impact of respons monitoring on survival, management, and complications<br />

Respons monitoring, State of the art<br />

Prof. Dr. V. Vandecaveye, UZ Leuven, Belgium<br />

Learning objectives:<br />

Overview of methods of respons monitoring of the near future (automatic volume measurements, DWI,<br />

dynamic postcontrast imaging, PETCT/PETMRI, other?)<br />

Work out of 1 or 2 of these techniques; how do I, interpretation, reporting (with emphasize on daily<br />

practice)<br />

Information technology solutions for practical implementation of these new techniques<br />

Prof. D. Rubin, Stanford University, USA<br />

Learning objectives:<br />

* Learn about IT developments which can accelerate introduction of new techniques in daily practice<br />

* Learn about IT developments which can accelerate introduction of quantitative imaging in daily practice<br />

* Learn about basic IT concepts to achieve your optimal workflow -learn about who can do this for you<br />

ZAAL 0.5 PARIS<br />

Neuroanatomie <strong>voor</strong> dummies<br />

Voorzitter: Prof. dr. F.A. Barkhof, VUMC, Amsterdam<br />

Oppervlakte en diepte anatomie - chirurgische landmarks<br />

Prof. dr. F.A. Barkhof, VUMC, Amsterdam<br />

Functionele anatomie - toepassingen fMRI en tractografie<br />

Prof. dr. S. Sunaert, UZ Leuven, België<br />

Vasculaire anatomie - arteriële en veneuze territoirs<br />

Dr. G.J. Lycklama à Nijeholt, MCH Westeinde, Den Haag<br />

Leerdoelen:<br />

Kennis van anatomie vormt de basis van elke radiologische interpretatie. Gezien de complexiteit van de<br />

hersenanatomie geldt dat zeker ook <strong>voor</strong> de Neuroradiologie. Toenemende scankwaliteit en geavanceerde<br />

beeldvormingstechnieken zoals fMRI en DTI maken het mogelijk steeds meer descriptieve en<br />

functionele anatomie af te beelden van zowel cortex als subcorticale structuren. Kennis hiervan is van<br />

belang <strong>voor</strong> goede diagnostiek en planning van therapie. Deze ‘refresher course’ behandelt aan de hand<br />

van state-of-the-art MRI beelden de descriptieve en functionele anatomie van de cortex, diepe kernen,<br />

vezelbanen en vasculaire territoria en reikt praktische tips aan <strong>voor</strong> een klinisch relevante beschrijving<br />

van afwijkingen van deze structuren. Het volgen van deze cursus zal hopelijk leiden tot een verbetering<br />

van uw neuroradiologische verslagen. Verder kan de verworven kennis uw inzicht in ziekteprocessen<br />

vergroten, en zullen uw diagnostisch arsenaal en didactische vaardigheden toenemen.<br />

ZAAL 0.2 BERLIN<br />

Workshop “Interpretatie van radiologisch wetenschappelijk onderzoek”<br />

Mw. Dr. S. Spronk, klinisch epidemioloog, Erasmus MC, Rotterdam<br />

Leerdoelen:<br />

* Het toepassen van risicomaten zoals incidentiecijfer en cumulatieve incidentie, en de effectmaten<br />

zoals relatief risico, (populatie-)attributief risico<br />

* Het beoordelen van een studie op validiteit en precisie en daarbij de volgende begrippen leren<br />

gebruiken: selectiebias, informatiebias, confounding bias, effectmodificatie, verification bias,<br />

regressie naar het gemiddelde<br />

* Berekenen van sensitiviteit en specificiteit op basis van onderzoeksgegevens en werken met de regel<br />

van Bayes<br />

* Onderzoeksdesign kunnen herkennen: follow-up onderzoek (retrospectief, prospectief); patientcontrole<br />

onderzoek; experimenteel onderzoek; non-expirimentele evaluatie van therapie; meta-analyse.<br />

ZAAL 0.3 COPENHAGEN<br />

Emeritus <strong>programma</strong> (parallel aan het algemene <strong>programma</strong>)<br />

Voorzitters: Prof. dr. G. Rosenbusch en J.F.M. Panhuysen<br />

11.20 - 12.00 Een bijzondere tentoonstelling in 1929: Invloed van de Russische kunst op de kinderboek<br />

illustratie in het westen vóór de 2e wereldoorlog<br />

Dr. A. Lemmens<br />

4<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


16 E RADIOLOGENDAGEN 2011<br />

Tijdstip<br />

Onderwerp<br />

14.05 - 14.35 Opwekking van röntgenstraling m.b.v. het teruggevonden toestel van Hoffmans uit januari<br />

1896 te Maastricht<br />

Prof. dr. J. van Engelshoven en Dr. G. Kemerink<br />

14.35 - 15.15 De eerste Wereldoorlog in België, <strong>Radiologie</strong> in ‘Trench Coat’<br />

Dr. R. van Tiggelen<br />

16.00 - 16.35 “Koorts en Honger” ofwel geneeskunde op het platteland in de afgelopen eeuwen<br />

J.A.C. van den Broek<br />

16.35 - 17.15 De gang van J.S. Bach naar Nederland<br />

Prof. dr. M. Oudkerk, UMC Groningen, Groningen<br />

AUDITORIUM 2<br />

17.15 - 18.45 Uitreiking prestigieuze WSS penning aan Prof. dr. J.O. Barentsz met aansluitend de ALV NVvR<br />

& Juniorsectie<br />

EXPOFOYER<br />

18.15 Industrieborrel: exclusief aangeboden door<br />

Vrijdag 30 september 2011<br />

Tijdstip<br />

Onderwerp<br />

8.30 - 9.00 Ontvangst & registratie<br />

9.00 - 10.15 Refresher courses<br />

ZAAL 0.4 BRUSSELS<br />

Buiktrauma, waar gaat het nou eigenlijk om<br />

Voorzitter: L.F.M. Beenen, AMC, Amsterdam<br />

Classificaties van orgaanletsels, lever en milt<br />

L.F.M. Beenen, AMC, Amsterdam<br />

Classificaties van orgaanletsels, overige organen<br />

Mw. D.R. Kool, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

Interventieradiologie bij buiktrauma<br />

Dr. O.M. van Delden, AMC, Amsterdam<br />

Leerdoelen:<br />

* Inzicht in wat wel en wat niet van belang is bij buiktrauma’s<br />

* Inzicht achter de ratio van de verschillende chirurgische en radiologische classificaties<br />

* Rol van de interventieradiologie in de behandeling van buiktrauma’s<br />

ZAAL 0.5 PARIS<br />

Acute pijn op de borst: Stand van zaken<br />

Voorzitter: Prof. dr. M. Oudkerk, UMC Groningen, Groningen<br />

Acute Chest Pain: The clinical perspective<br />

Dr. S.C.A.M. Bekkers, MUMC, Maastricht<br />

* To understand the challenges for the clinical assessment of pulmonary embolism, acute aortic<br />

pathologies and coronary artery disease<br />

* To define the in- and exclusion criteria for imaging in patients with acute chest pain<br />

Acute Chest Pain: The imaging perspective<br />

Prof. dr. J.E. Wildberger, MUMC, Maastricht<br />

* To summarize the technical prerequisites for advanced cross-sectional imaging<br />

* To define the role of CT and MR in the assessment of pulmonary embolism, acute aortic pathologies<br />

and coronary artery disease<br />

* To understand the potential clinical impact of imaging in the emergency setting, also in the<br />

perspective of logistics and cost-effectiveness<br />

Acute Chest Pain: Statement of the European Society of Cardiac Radiology<br />

Prof. dr. M. Oudkerk, UMC Groningen, Groningen<br />

* To summarize current clinical concepts and guidelines for acute chest pain<br />

* To learn about the specific role of different imaging modalities (CT, MR, Ultrasound, QCA) in this context<br />

Differentiated examination protocols even for the emergency setting have become technically feasible<br />

due to ongoing advances especially in non-invasive imaging techniques. The aim of this refresher<br />

course is to provide an overview on the rationale, the opportunities and current concepts for the<br />

work-up in patients with acute chest pain.<br />

ZAAL 0.8 ROME<br />

De knie: Niet standaard MRI bevindingen en de postoperatieve knie<br />

Voorzitter: Mw. Dr. M.P. Terra, AMC, Amsterdam<br />

De postoperatieve knie (MRI)<br />

Dr. P. Van Dyck, UZ Antwerpen, België<br />

De postoperatieve knie<br />

Mw. Dr. G.A. Meins, orthopedisch chirurg, ZGT, Almelo-Hengelo / clubarts FC Twente<br />

Niet standaard MRI bevindingen in en rond de knie<br />

Dr. P. Van Dyck, UZ Antwerpen, België<br />

ZAAL 0.9 ATHENS<br />

Opleiden anno 2011<br />

Voorzitter: Dr. H.J. Baarslag, Meander MC, Amersfoort<br />

AIOS als “active learner”<br />

Mw. Drs. J.A. Baane, AMC, Amsterdam<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 5


<strong>programma</strong> & <strong>abstracts</strong><br />

Tijdstip<br />

Onderwerp<br />

EXPOFOYER<br />

10.15 - 10.45 Koffiepauze<br />

Intervisie <strong>voor</strong> opleiders<br />

Prof. dr. O.R.C. Busch, chirurg, AMC, Amsterdam<br />

Optimalisatie radiologie bespreking<br />

Dr. M. Maas, AMC, Amsterdam & Drs. B.M. Wiarda, MCA, Alkmaar<br />

Leerdoelen:<br />

De HORA heeft veel veranderd en verbeterd in opleidingsland. Maar daarmee zijn we er nog niet. Met<br />

betrekking tot het opleiden anno 2011 is een nog actievere instelling mogelijk, die zowel de AIOS, de<br />

opleider als ook de gehele opleidingsstaf stimuleert. Alle 3 genoemde groepen komen zowel individueel<br />

als interactief aan bod bij deze refreshercourse onderwijs.<br />

ZAAL 2.1 COLORADO<br />

Veneuze interventies<br />

Voorzitters: Dr. K.P. van Lienden, AMC, Amsterdam & Mw. Dr. C.S.P. van Rijswijk, LUMC, Leiden<br />

Pelvic congestion syndroom<br />

Dr. J.H.B. Boomsma<br />

Behandeling veneuze trombose<br />

Dr. J.A. Vos, St. Antonius Ziekenhuis, Nieuwegein<br />

Rol van cava filters<br />

Prof. dr. J.A. Reekers, AMC, Amsterdam<br />

Veneuze toegang; PICCs, Dialyse catheters en andere CVCs<br />

Dr. H. van Overhagen, HagaZiekenhuis, Den Haag<br />

ZAAL 0.1 LONDON<br />

Workshop / hands-on: To make Radlex more familiar.<br />

Using IHE TCE for export of PACS data to an MIRC teaching file<br />

E. Sanders, Amphia Ziekenhuis, Breda<br />

P. van Ooijen, UMC Groningen, Groningen<br />

10.45 - 12.15 Parallelsessies vrije <strong>voor</strong>drachten<br />

Voorafgaand aan de wetenschappelijke <strong>voor</strong>drachten zal iedere sessie aanvangen met een keynote lecture.<br />

ZAAL 0.4 BRUSSELS<br />

Sessie 6: Abdominale radiologie 2<br />

Voorzitters: Prof. dr. A.A.M. Masclee, MUMC, Maastricht & Dr. R.E. van Gelder, AMC, Amsterdam<br />

Endoscopie vs CTC<br />

Prof. dr. A.A.M. Masclee, MUMC, Maastricht<br />

ZAAL 0.8 ROME<br />

Sessie 7: Kinderradiologie / Diversen<br />

Voorzitters: Dr. R.A.J. Nievelstein, UMC Utrecht, Utrecht & N. de Graaf, Erasmus MC, Rotterdam<br />

Huidige status en toekomstperspectief<br />

Dr. R.A.J. Nievelstein, UMC Utrecht, Utrecht<br />

ZAAL 0.5 PARIS<br />

Sessie 8: Mammadiagnostiek 2 & Uitreiking Jan Hendriksprijs<br />

Voorzitters: Drs. R.D.M. Mus, UMC St Radboud, Nijmegen & Mw. M.W. Imhof-Tas, UMC St Radboud, Nijmegen<br />

MRI van de mamma in 2 minuten?<br />

Drs. R.D.M. Mus, UMC St Radboud, Nijmegen<br />

ZAAL 2.1 COLORADO<br />

Sessie 9: Neuro-Hoofdhals radiologie<br />

Voorzitters: Dr. J.C. de Groot, UMC Groningen, Groningen & Dr. S.C.A. Steens, UMC St Radboud,<br />

Nijmegen<br />

Vasculaire evaluatie van het brein in stroomversnelling<br />

Dr. J.C. de Groot, UMC Groningen, Groningen<br />

ZAAL 0.9 ATHENS<br />

Sessie 10: MSK / Thorax / Diversen<br />

Voorzitters: Mw. Dr. M. Reijnierse, LUMC, Leiden & Dr. P.J.W. Wensing, ZGT Almelo/Hengelo<br />

Postop infection around metals: CT/Mri techniques<br />

Mw. Dr. M. Reijnierse, LUMC, Leiden<br />

AUDITORIUM 2<br />

De educatieve <strong>voor</strong>dracht<br />

Voorzitters: Dr. C.J. van Rooden, HagaZiekenhuis & Dr. R. Ouwendijk, Erasmus MC, Rotterdam<br />

In deze gloednieuwe sessie tijdens de Radiologendagen komt een groot scala aan klinisch georiënteerde<br />

onderwerpen <strong>voor</strong>bij, van echogeleide bijnierpunctie tot beeldvorming van atherosclerose. Voor het<br />

eerst konden dit jaar, naast wetenschappelijke, ook educatieve <strong>abstracts</strong> ingestuurd worden.<br />

De kwaliteit van de inzendingen was hoog, dus deze primeur belooft een erg interessante, gevarieerde<br />

en <strong>voor</strong>al ook leuke sessie te worden, <strong>voor</strong>gezeten door twee top-radiologen!<br />

Future clinical applications of high resolution anatomical imaging of the brain at 7.0 Tesla MRI<br />

A.G. van der Kolk, UMC Utrecht, Utrecht<br />

Is beeldvorming van atherosclerose klaar <strong>voor</strong> de dagelijkse praktijk?<br />

Mw. S. Gerretsen, MUMC, Maastricht<br />

Lung perfusion defects on dual-energy Computed Tomography (DECT): review of morphology<br />

and differential diagnosis<br />

Mw. Dr. A.E. Odink, Erasmus MC, Rotterdam<br />

Value of computed tomography coronary angiography in failed conventional coronary angiography<br />

A.S. Thijssen, Erasmus MC, Rotterdam<br />

Pseudotumoren bij metaal op metaal totale heup artroplastiek<br />

M.F. Boomsma, Isala klinieken, Zwolle<br />

6<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Tijdstip<br />

Onderwerp<br />

16 E RADIOLOGENDAGEN 2011<br />

EXPOFOYER<br />

12.15 - 13.15 Lunch<br />

EXPOFOYER<br />

12.30 - 13.00 Postersessie<br />

De vergrote bijnier: Endosonografische FNA van de linker-bijnier<br />

R. de Ridder, MDL-arts, MUMC, Maastricht<br />

Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical<br />

complete response in rectal cancer patients treated with chemoradiotherapy<br />

D.M.J. Lambregts, MUMC, Maastricht<br />

Implementatie van virtuele colonoscopie in de dagelijkse radiologische praktijk<br />

M.T. de Witte, VieCuri Medisch Centrum, Venlo / UMC St Radboud, Nijmegen<br />

Mw. Dr. P.C.G. Simons, VieCuri Medisch Centrum, Venlo<br />

ZAAL 0.2 BERLIN<br />

Workshop “Interpretatie van radiologisch wetenschappelijk onderzoek”<br />

Mw. Dr. S. Spronk, klinisch epidemioloog, Erasmus MC, Rotterdam<br />

Leerdoelen:<br />

* Het toepassen van risicomaten zoals incidentiecijfer en cumulatieve incidentie, en de effectmaten<br />

zoals relatief risico, (populatie-)attributief risico<br />

* Het beoordelen van een studie op validiteit en precisie en daarbij de volgende begrippen leren<br />

gebruiken: selectiebias, informatiebias, confounding bias, effectmodificatie, verification bias,<br />

regressie naar het gemiddelde<br />

* Berekenen van sensitiviteit en specificiteit op basis van onderzoeksgegevens en werken met de regel<br />

van Bayes<br />

* Onderzoeksdesign kunnen herkennen: follow-up onderzoek (retrospectief, prospectief); patient-controle<br />

onderzoek; experimenteel onderzoek; non-expirimentele evaluatie van therapie; meta-analyse.<br />

AUDITORIUM 2<br />

13.15 - 13.30 Wetenschappelijk beleid NvvR <strong>voor</strong> academische -en niet academische centra<br />

Mw. Prof. dr. R.G.H. Beets-Tan, MUMC, Maastricht<br />

AUDITORIUM 2<br />

Plenaire sessie<br />

13.30 - 14.30 Pro-con: Setting standards in healthcare - Which way to go?<br />

Ook <strong>voor</strong> de radiologie zullen kwaliteitsnormen steeds belangrijker worden. Wat vinden de debaters,<br />

maar ook: Wat vindt U! Drie onderwerpen zullen U raken. Drie pro-con koppels testen uw dekking.<br />

Fair play is de regel, maar neem uw bokshandschoenen mee.<br />

Voorzitter: Dr. J.A. Vos, St. Antonius Ziekenhuis, Nieuwegein<br />

De kwaliteitseisen <strong>voor</strong> de radiologie zijn autonoom op te stellen<br />

Pro: Dr. C. Holt, Isala klinieken, Zwolle<br />

Con: J.W.A.P. van Hoogstraten, Deventer Ziekenhuis, Deventer<br />

Hoog complex, (laag volume) diagnostiek moet alleen door experts worden uitgevoerd<br />

Pro: Prof. dr. J. Stoker, AMC, Amsterdam<br />

Con: Mw. L.F.I.J. Oudenhoven, ZGT Almelo, Almelo<br />

Information technology in radiology - Yes, it helps!<br />

Pro: Prof. D. Rubin, Stanford University, USA<br />

Con: R.H.M. Smithuis, Rijnland Ziekenhuis, Leiderdorp<br />

14.30 - 15.15 Richtlijnen sessie<br />

Voorzitter: Drs. B.M. Wiarda, Medisch Centrum Alkmaar, Alkmaar<br />

Licht traumatisch hoofd/hersenletsel<br />

Mw. D.R. Kool, Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

Distale Radius Fracturen<br />

Mw. S. Kolkman, AMC, Amsterdam<br />

Acuut lateraal enkelletsel en Interne indicatoren Acuut lateraal enkelbandletsel<br />

J.W.A.P. van Hoogstraten, Deventer Ziekenhuis, Deventer<br />

Oesofaguscarcinoom<br />

Prof. dr. E.J. van der Jagt, UMC Groningen, Groningen<br />

EXPOFOYER<br />

15.15 - 15.45 Theepauze<br />

AUDITORIUM 2<br />

15.45 - 16.25 Uitreiking Philipsprijs, gevolgd door bekendmaking en presentatie van achtereenvolgens de<br />

Posterprijs, Radiologendagen prijs, NVvR Travel Grant en Fellowshipdiploma’s<br />

AUDITORIUM 2<br />

16.25 - 17.15 Quiz<br />

Door de maatschap radiologie van het Albert Schweitzer ziekenhuis<br />

AUDITORIUM 2<br />

17.15 - 17.20 Afsluiting door <strong>voor</strong>zitter<br />

Dr. R.B.J. de Bondt, Isala klinieken, Zwolle<br />

Vanaf 20.00<br />

Diner & Galafeest<br />

Amrâth Grand Hotel De L’Empereur Maastricht<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 7


<strong>programma</strong> genomineerden & <strong>abstracts</strong><br />

Genomineerde <strong>abstracts</strong> <strong>voor</strong><br />

de Radiologendagenprijs 2011<br />

O1.7 ASSESSMENT OF A COMPLETE RESPONSE OF RECTAL CANCER TO<br />

PREOPERATIVE CHEMORADIATION THERAPY: A COMPARISON<br />

BETWEEN MR VOLUMETRY AND DIFFUSION-WEIGHTED MRI<br />

D.M.J. Lambregts 1 , L. Curvo-Semedo 2 , M. Maas 1 , T. Thywissen 1 , G. Lammering 1 , G.L. Beets 1 ,<br />

F. Caseiro-Alves 2 , R.G.H. Beets-Tan 1<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Radiology University Clinic, Coimbra University Hospital, Coimbra, Portugal<br />

O4.3 LESION DETECTION AND BI-RADS CLASSIFICATION IN 3D-US AUTO-<br />

MATED BREAST VOLUME SCANS (ABVS): CORRELATION WITH BREAST MRI<br />

T.A. Fassaert, I.J.M. Dubelaar, M.D.F. de Jong, M.C.J.M. Rutten<br />

Jeroen Bosch Ziekenhuis, Den Bosch<br />

O5.8 1 JAAR NA EVAR BESTAAT NOG ONGEVEER EENDERDE DEEL VAn de<br />

ANEURYSMAZAK UIT ONGEORGANISEERDE THROMBUS BIJ PATIENTEN<br />

MET EN ZONDER AANTOONBAAR ENDOLEAK<br />

S.A.P. Cornelissen 1 , E.P.A. Vonken 1 , H.J. Verhagen 2 , F.L. Moll 1 , L.W. Bartels 3<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Erasmus Medisch Centrum, Rotterdam<br />

3<br />

Image Sciences Institute, Universitair Medisch Centrum Utrecht, Utrecht<br />

O9.1 ARTERIAL CALCIFICATION IN RELATION TO COGNITION AND<br />

STRUCTURAL BRAIN CHANGES<br />

D. Bos, M.W. Vernooij, S.E. Elias-Smale, G.P. Krestin, A. Hofman, W.J. Niessen, J.C.M. Witteman,<br />

A. van der Lugt, M.A. Ikram<br />

Erasmus Medisch Centrum, Rotterdam<br />

O10.5 IMPACT ON DIAGNOSTIC PERFORMANCE AND READING TIME OF A<br />

COMPUTER AIDED DETECTION ALGORITHM FOR THE DETECTION OF<br />

ACUTE PE: SECOND READING VERSUS CONCURRENT READING<br />

R. Wittenberg 1 , J.F. Peters 2 , I.A.H. Van den Berk 3 , N.J.M. Freling 3 , R.J. Lely 4 , B. de Hoop 5 , K. Horsthuis 3 ,<br />

C.J. Ravesloot 5 , M. Prokop 6 , C.M. Schaefer-Prokop 7<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Philips Healthcare, Best<br />

3<br />

Academisch Medisch Centrum, Amsterdam<br />

4<br />

VU Medisch Centrum, Amsterdam<br />

5<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

6<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

7<br />

Meander Medisch Centrum, Amersfoort<br />

8<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


16 E RADIOLOGENDAGEN 2011<br />

Genomineerde <strong>abstracts</strong> <strong>voor</strong><br />

de NVvR Travel Grant 2011<br />

O2.3 MRI FEATURES ASSOCIATED WITH ACUTE APPENDICITIS<br />

M.M.N. Leeuwenburgh 1 , B.M. Wiarda 2 , A. Spilt 3 , P.M.M. Bossuyt 1 , M.A. Boermeester 1 ,<br />

J. Stoker 1 , OPTIMAP Studiegroep<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Medisch Centrum Alkmaar, Alkmaar<br />

3<br />

Kennemer Gasthuis, Haarlem<br />

O2.4 OPTIMAL STRATEGY IN PATIENTS WITH SUSPECTED ACUTE APPENDICITIS,<br />

CAN MRI REPLACE CT?<br />

M.M.N. Leeuwenburgh 1 , H.W. van Es 2 , J.W.C. Gratama 3 , P.M.M. Bossuyt 1 , M.A. Boermeester 1 ,<br />

J. Stoker 1 , OPTIMAP Studiegroep<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

St. Antonius Ziekenhuis, Nieuwegein<br />

3<br />

Gelre ziekenhuizen, Apeldoorn<br />

O2.7 MR EVALUATION OF URETHRAL DIVERTICULA AND DIFFERENTIAL<br />

DIAGNOSIS IN SYMPTOMATIC FEMALE PATIENTS<br />

S.I. Verschuuren, R.S. Dwarkasing, W. Dinkelaar, W.C.J. Hop, G.R. Dohle, G.P. Krestin<br />

Erasmus Medisch Centrum, Rotterdam<br />

O5.7 CAROTID ATHEROSCLEROTIC PLAQUE PROGRESSION AND CHANGE<br />

IN PLAQUE COMPOSITION OVER TIME; A PROSPECTIVE IN VIVO SERIAL CT<br />

ANGIOGRAPHY STUDY<br />

M.J. van Gils, D. Vukadinovic, D.W.J. Dippel, W.J. Niessen, A. van der Lugt<br />

Erasmus Medisch Centrum, Rotterdam<br />

O6.4 PERCEIVED BURDEN OF SCREENING BY COLONOSCOPY OR<br />

CT-COLONOGRAPHY IN THE DETECTION OF ADVANCED NEOPLASIA:<br />

A RANDOMIZED CONTROLLED TRIAL<br />

M.C. de Haan 1 , T.R. de Wijkerslooth 1 , E. Stoop 2 , P.M. Bossuyt 1 , M. Thomeer 2 ,<br />

M.L. Essink-Bot 1 , M.E. van Leerdam 2 , P. Fockens 1 , E.J. Kuipers 2 , E. Dekker 1 , J. Stoker 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Erasmus Medisch Centrum, Rotterdam<br />

O7.2 MINIMALLY INVASIVE MRI BY OMITTING INTRAVENOUS CONTRAST<br />

INJECTION; DOES IT CHANGE THE RADIOLOGIC ASSESSMENT OF KNEE<br />

JOINT PATHOLOGIES IN JIA?<br />

R. Hemke, M.A.J. van Rossum, M. van Veenendaal, T.W. Kuijpers, M. Maas<br />

Academisch Medisch Centrum, Amsterdam<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 9


<strong>programma</strong> genomineerden & <strong>abstracts</strong><br />

Vervolg<br />

O7.3 ULTRASOUND TO PREDICT SIGNIFICANT HEPATIC STEATOSIS IN OBESE<br />

ADOLESCENTS: POOR POST-TEST PROBABILITY DESPITE ACCEPTABLE<br />

SENSITIVITY AND SPECIFICITY<br />

A.E. Bohte 1 , B.G. Koot 1 , A.J. Nederveen 1 , O.H. van der Baan-Slootweg 2 , S. Bipat 1 , T.H. Pels Rijcken 3 ,<br />

P.L.M. Jansen 1 , M.A. Benninga 1 , J. Stoker 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Heideheuvel Kliniek, Hilversum<br />

3<br />

Tergooiziekenhuizen, Hilversum<br />

O9.1 ARTERIAL CALCIFICATION IN RELATION TO COGNITION AND STRUCTURAL<br />

BRAIN CHANGES<br />

D. Bos, M.W. Vernooij, S.E. Elias-Smale, G.P. Krestin, A. Hofman, W.J. Niessen,<br />

J.C.M. Witteman, A. van der Lugt, M.A. Ikram<br />

Erasmus Medisch Centrum, Rotterdam<br />

O9.2 TIA AND STROKE PATIENTS WITH CAROTID STENOSIS: PRESENCE<br />

OF COMPLICATED PLAQUE FEATURES AT MRI IS ASSOCIATED WITH<br />

RECURRENT EVENTS<br />

R.M. Kwee 1 , R.J. van Oostenbrugge 1 , W.H. Mess 1 , M.H. Prins 1 , R.J. van der Geest 2 , J.W.M. ter Berg 3 ,<br />

C.L. Franke 4 , A.G.G.C. Korten 5 , B.J. Meems 6 , J.M.A. van Engelshoven 1 , J.E. Wildberger 1 , M.E. Kooi 1<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Leids Universitair Medisch Centrum, Leiden<br />

3<br />

Orbis Medisch Centrum, Sittard<br />

4<br />

Atrium Medisch Centrum Parkstad, Heerlen<br />

5<br />

Laurentius Ziekenhuis, Roermond<br />

6<br />

VieCuri Medisch Centrum, Venlo<br />

O10.6 DEVELOPMENT AND VALIDATION OF A DIAGNOSTIC MODEL FOR<br />

AIRFLOW LIMITATION IN HEAVY SMOKERS BY USING QUANTITATIVE<br />

COMPUTED TOMOGRAPHY<br />

O.M. Mets 1 , C.M.F. Buckens 1 , P. Zanen 1 , I. Isgum 1 , M. Prokop 2 , P.A. de Jong 1<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

P02<br />

AUTOMATED BREAST VOLUME SCANNER: 3D-ULTRASOUND<br />

OF BREAST LESIONS<br />

T.A. Fassaert, M.D.F. de Jong, I.J.M. Dubelaar, M.C.J.M. Rutten<br />

Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

10<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Auteursindex<br />

16 E RADIOLOGENDAGEN 2011<br />

AUTEUR<br />

abstract<br />

Aalten, S.M. van O6.7<br />

Adam, J. O1.8<br />

Adams, A. O8.7<br />

Adriaanse, S.M. O9.6<br />

Akkerman, E.M. O1.8<br />

Amstel, J.D. van O8.10<br />

Aquarius, R. O5.2<br />

Baan-Slootweg, O.H. van der O7.3<br />

Backes, W.H. O1.3<br />

Backx, F.J.G. O3.7<br />

Bakers, F.C.H. E02, O1.3<br />

Bakker, C.J. O5.4<br />

Ballegooijen, M. van O6.3<br />

Barkhof, F.A. O9.5, O9.6<br />

Bartels, L.W. O3.2, O5.8<br />

Bechan, M.A.H.<br />

P03<br />

Beek, F.J.A. O1.8, O7.4<br />

Beek, H. van O10.8<br />

Beenen, L.F.M. O2.5<br />

Beerman, H. O10.8<br />

Beets, G.L. E02, O1.1, O1.2, O1.3,<br />

O1.6, O1.7, P14<br />

Beets-Tan, R.G.H. E02, O1.1, O1.2,<br />

O1.3, O1.6, O1.7, O2.2,<br />

O4.1, O6.8, P14<br />

Benedictus, M.R. O9.5<br />

Benninga, M.A. O7.3<br />

Bentohami, A. O7.5<br />

Berckel, B.N.M. van O9.6<br />

Berg, A.S. van den O5.1<br />

Berg, R. van den O9.5, P09, P12, P13<br />

Berk, I.A.H. van den O10.5<br />

Berkhof, M. O1.1<br />

Bernsen, M.R. O7.7, O7.8<br />

Beumer, D. O9.5<br />

Beute, G.N. O9.8<br />

Bierings, M.B. O1.8<br />

Biermann, K. O6.3<br />

Biessels, G.J. O3.8<br />

Bijlsma, T.S. O7.5<br />

Binnewijzend, M.A.A. O9.6<br />

Bipat, S. O2.1, O5.3, O5.5, O6.1,<br />

O6.5, O7.1, O7.3<br />

Bisschops, R.H.C. O8.6<br />

Bluekens, A.M.J. O8.4<br />

Boelens, J.J. O7.4<br />

Boellaard, T.N. O6.2, O6.5<br />

Boer, E. de O6.6<br />

Boer, R. de O9.4<br />

Boermeester, M.A. O2.3, O2.4<br />

Boersma, E.H. O3.1<br />

Boetes, C. † O4.1<br />

Bohté, A.E. O7.3<br />

Boiten, J. O5.6, O9.5<br />

Bokkers, R.P.H.<br />

P05, P06<br />

Bonenkamp, J.<br />

P04<br />

Booij, R.<br />

E06<br />

Boomsma, M.F.<br />

E08<br />

Borst, G.J. de<br />

P05<br />

Bos, D. O9.1<br />

Bosch, M.A.A.J. van den O4.4,<br />

O5.4, O8.5, O8.10<br />

Bosker, B.H.<br />

E08<br />

Bosker, R.J.I. O1.4<br />

Bosscha, K.<br />

P10<br />

Bossuyt, P.M.M. O2.3, O2.4, O6.1,<br />

O6.2, O6.3, O6.4<br />

Bot, J. O9.5<br />

Bouwhuijsen, Q.J.A. van den O9.3<br />

Breest Smallenburg, V. van O4.3<br />

Brink, R.B.A. van den O3.6<br />

Broeder, A.A. den O10.4<br />

Broeders, M.J.M. O8.4<br />

Bron, E. O10.1<br />

Bruijnes, V. O4.5<br />

Brundel, M. O3.8<br />

Buckens, C.M.F. O10.6<br />

Budde, R.P.J. O3.2, O3.4, O3.5, O3.6<br />

Buijsen, J. O1.2<br />

Caan, M.W.A. O2.1, O7.1<br />

Cappendijk, V.C. E01, E02, E05,<br />

O1.3, O2.2<br />

Carli, D.F.M. O9.8<br />

Caseiro-Alves, F. O1.7<br />

Chamuleau, S.A.J. O3.6<br />

Cleutjens, J. O4.1<br />

Cornelissen, S.A.P. O5.8<br />

Cramer, M.J.M. O3.7<br />

Cremers, P.T.J. O1.5<br />

Cremers, S.E.H. O1.5<br />

Curvo-Semedo, L. O1.7<br />

Dalen, T. van O4.4<br />

Damoiseaux, J.S. O9.6<br />

Das, M.<br />

E05<br />

Dekker, E. O6.3, O6.4<br />

Dekker, H.M. O2.6<br />

Dharampal, A.S. O3.1, O3.3<br />

Diepstraten, S.C.E. O4.4<br />

Diest, P.J. van O4.4, O8.10<br />

Dijk, R.A.J.M. van O1.4, O4.6, O8.3<br />

Dijkman, B.A. van O7.5<br />

Dinkelaar, W. O2.7<br />

Dippel, D.W.J. O5.7, O9.5, P08<br />

Doeswijk, G. O7.7, O7.8<br />

Dohle, G.R. O2.7<br />

Doorn, M.M.A.C. van O2.5, O9.5<br />

Douwes, D.C.E. O2.2<br />

Dubelaar, I.J.M. O4.2, O8.1, P02<br />

P04, P07<br />

Duijm, L.E.M. O4.3, O8.2, 08.9<br />

Duvivier, K.M. O4.4<br />

Dwarkasing, R.S. O2.7, O6.1, O6.7<br />

Eddes, E.H. O1.4<br />

Eeftinck Schattenkerk, M. O1.4<br />

Elias, S.G. O8.7<br />

Elias-Smale, S.E. O9.1<br />

Elschot, M. O5.4<br />

Engelen, S.M.E. O1.2<br />

Engelshoven, J.M.A. van E05, O9.2<br />

Ernst, M.<br />

P10<br />

Es, H.W. van O2.4<br />

Essink-Bot, M.L. O6.4<br />

Ettema, H.B.<br />

E08<br />

Fassaert, T.A. O4.2, O8.1, P02<br />

Fernandez-Gallardo, M.A. O4.4<br />

Feyter, P.J. de O3.1, O3.3<br />

Fijnheer, R. O1.8<br />

Flier, W.M. van der O9.5, O9.6<br />

Flucke, U.<br />

P04<br />

Fockens, P. O6.3, O6.4<br />

Folbert, E.C. O10.3<br />

Franke, C.L. O9.2<br />

Frans, F.A. O5.3, O5.5<br />

Fransen, P.S. O9.5<br />

Freling, N.J.M. O10.5<br />

Frotscher, C. O4.1<br />

Geelen, L.M.H. O9.7<br />

Geerdes, M. O5.2<br />

Geest, R.J. van der O9.2<br />

Gerretsen, S.C.<br />

E05<br />

Gilhuijs, K.G.A. O4.5<br />

Gillissen, F. O1.2<br />

Gils, M.J. van<br />

O5.7, P08<br />

Gorp, T. van O6.8<br />

Goslings, J.C. O7.5<br />

Gratama, J.W.C. O2.4<br />

Gryspeerdt, S. O1.5<br />

Guenoun, J. O7.7, O7.8<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 11


<strong>programma</strong> index & <strong>abstracts</strong><br />

Haan, M.C. de O6.1, O6.3, O6.4<br />

Habets, J. O3.4, O3.5, O3.6<br />

Hartkamp, N.S.<br />

P05, P06<br />

Hartmann, I.J.C. E06, O10.7<br />

Hauptmann, M. O7.6<br />

Havinga, M.E. O5.2<br />

Heer, L.M. de O3.2<br />

Heeten, G.J. den O8.4<br />

Hegeman, J.H. O10.3<br />

Heijde, D.M.F.M. van der O10.4,<br />

P12, P13<br />

Helle, M.<br />

P06<br />

Hellemondt, F.J. van O3.7<br />

Hemke, R. O7.2<br />

Hendrikse, J.<br />

E04, O3.8,<br />

P05, P06<br />

Hendriks-Roelofs, F. O10.4<br />

Hensen, J.J. O8.8, O10.8<br />

Herk, M. van O7.6<br />

Herwerden, L.A. van O3.2<br />

Hobbelink, M. O8.10<br />

Hoeberigs, M.C. O9.7<br />

Hofman, A. O9.1<br />

Hofman, P.A.M. O9.7<br />

Holland, R. O8.4<br />

Homburg, P.J.<br />

P08<br />

Hoop, B. de O10.5<br />

Hop, W.C.J. O2.7<br />

Horsthuis, K. O10.5<br />

Houterman, S. O1.5<br />

Huizinga, T.W.J.<br />

P12, P13<br />

Hummel, T.Z. O7.1<br />

IJzermans, J.N.M. O6.7<br />

Ikram, M.A. O9.1, O9.3, O9.4<br />

Imholz, A.L.T. O4.6, O8.3<br />

Isgum, I. O10.6<br />

Jager, G.J.<br />

O8.1, P10<br />

Jansen, F.H. O4.3, 08.9<br />

Jansen, P.L.M. O7.3<br />

Jansen, R.J. O6.1<br />

Jasperse, B. O9.4<br />

Jens, S. O5.5<br />

Jeukens, C.R.L.P.N O1.6<br />

Jong, H.W. de O5.4<br />

Jong, M.D.F. de O4.3, O8.1,<br />

P02, P10<br />

Jong, P.A. de O7.4, O10.6<br />

Kallen, B.F.W. van der O5.6, O9.5<br />

Karssemeijer, N. O8.4<br />

Kate, F.J.W. ten O6.6<br />

Kauffman, D. O6.1<br />

Kersten, M.J. O1.8<br />

Kessel, C.S. van O6.6<br />

Keymeulen, K. O4.1<br />

Kindermann, A. O7.1<br />

Klein, S. O10.1<br />

Klein, W.M.<br />

P01<br />

Klerk, J.M.H. de O1.8<br />

Klieverik, S.J.<br />

P14<br />

Klomp, D.W. O8.5<br />

Kluin, J. O3.2<br />

Kluza, E.<br />

O1.6, P14<br />

Koek, M. O9.4<br />

Koelemay, M.J.W. O5.3, O5.5<br />

Kolk, A.G. van der E04, O3.8<br />

Kollen, B.J.<br />

E08<br />

Koning, G.A. O7.7, O7.8<br />

Kooi, M.E. E05, O9.2<br />

Koot, B.G. O7.3<br />

Korten, A.G.G.C. O9.2<br />

Korteweg, M.A. O8.5, O8.10<br />

Koster, K. O1.4<br />

Kotek, G. O10.1<br />

Kraai, M. O10.3<br />

Kraal, K.J. O8.8<br />

Kreb, D.<br />

P10<br />

Krestin, G.P. E07, O2.7, O3.1, O3.3<br />

O7.7, O7.8, O9.1, O9.3<br />

O10.1, O10.2<br />

Kruitwagen, R. O6.8<br />

Kruse, A. O6.8<br />

Kuijer, J.P.A. O9.5<br />

Kuijpers, T.W. O7.2<br />

Kuipers, E.J. O6.3, O6.4<br />

Kwee, R.M. E05, O9.2<br />

Kwee, T.C. O1.8<br />

Lahaye, J. O1.2, O4.1<br />

Lalisang, R. O6.8<br />

Lalji, U.C. O2.8<br />

Lam, M.G.E.H. O5.4<br />

Lambregts, D.<br />

E02, O1.1,<br />

O1.2, O1.3, O1.6,<br />

O1.7, O6.8, P14<br />

Laméris, J.S. O7.6<br />

Lammering, G. E02, O1.7<br />

Lavini, C. O2.1, O7.1<br />

Ledeboer, M. O1.4<br />

Leerdam, M.E. van O6.3, O6.4<br />

Leeuwen, M.S. van O1.8, O6.6<br />

Leeuwenburgh, M.M.N. O2.3, O2.4<br />

Lefere, P. O1.5<br />

Legemate, D.A. O5.3<br />

Leij, C. van der O6.1<br />

Leiner, T. E05, O3.4<br />

Lely, R.J. O10.5<br />

Liedenbaum, M.H. O6.1<br />

Lijn, F. van der O9.4<br />

Lijster, M.S. de O6.1<br />

Lima Passos, V. O4.1<br />

Linden, H. van der<br />

P10<br />

Linden, E. van der O5.6<br />

Lobbes, M.B.I. E05, O4.1<br />

Loeffen, D.V. O2.2<br />

Loo, C. O4.5<br />

Looij, B.G.<br />

P10<br />

Ludwig, I. O1.8<br />

Lugt, A. van der O5.7, O9.1, O9.3,<br />

O9.4, O9.5, P08<br />

Luijkx, T. O3.7<br />

Luijten, P.R. E04, O3.8, O8.5<br />

Lute, C.C. O6.1<br />

Lutgens, L. O6.8<br />

Lycklama à Nijeholt, G.J. O5.6, O9.5<br />

Maas, M.<br />

E02, O1.1, O1.2,<br />

O1.3, O1.6, O1.7, P14<br />

Maas, M. E08, O7.2, O7.5<br />

Maat, G.H. van de O5.4<br />

Majoie, C.B.L.M. O9.5, P09<br />

Mali, W.P.Th.M. O3.2, O3.4, O3.6,<br />

O3.7, O4.4,<br />

O8.5, O8.7, O8.10<br />

Man, R.A. de O6.7<br />

Marcelis, C.<br />

P01<br />

Meems, B.J. O9.2<br />

Meijer, F.A.<br />

P07<br />

Mendez, C.P.<br />

P03<br />

Mess, W.H. O9.2<br />

Met, R. O5.3<br />

Mets, O.M. O10.6<br />

Mol, B.A.J.M. de O3.4, O3.5<br />

Moll, F.L. O5.8<br />

Mollet, N.R.A. E07, O3.1, O3.3<br />

Mongula, J.E. O6.8<br />

Mourik, J.E.M. O8.7<br />

Nederend, J. O8.9<br />

Nederkoorn, P.J. O9.5<br />

Nederveen, A.J. O2.1, O6.5, O7.1, O7.3<br />

Neefjes, L. O3.1, O3.3<br />

Nieman, K. O3.1, O3.3<br />

Niessen, W.J. O5.7, O9.1, O9.3, O9.4<br />

Nievelstein, R.A.J. O1.8, O7.6<br />

Niezen, R.A. O8.8, O10.8<br />

Nijman, J. O8.8<br />

12<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


16 E RADIOLOGENDAGEN 2011<br />

Nijsen, J.F.W. O5.4<br />

Nio, C.Y. O6.2, O6.3<br />

Nunspeet, L. van O1.4<br />

Odink, A.E. E06, O10.7<br />

Odink, H. O5.1<br />

Oei, E.H.G. O10.1, O10.2<br />

Oostenbrugge, R.J. van O9.2, O9.5<br />

Osch, M.J.P. van<br />

P06<br />

Paardt, M.P. van der O6.1, O6.5<br />

Pels Rijcken, T.H. O7.3<br />

Pengel, K. O4.5<br />

Pennings, J.P. O8.6<br />

Peters, J.F. O10.5<br />

Plas, G.J.J.<br />

P08<br />

Ponsioen, C.Y. O2.1<br />

Prakken, N.H.J. O3.7<br />

Prehn, J. van O3.2<br />

Prins, M.H. O9.2<br />

Prokop, M. O3.5, O10.5, O10.6, P04<br />

Quarles van Ufford, H.M.E. O1.8<br />

Ravesloot, C.J. O10.5<br />

Reekers, J.A. O5.3, O5.5<br />

Reijnierse, M. O10.4, P12, P13<br />

Riedl, R.G. O1.3<br />

Ridder, R. de<br />

E01<br />

Ronckers, C.M. O7.6<br />

Rooij, W.J.J. van O9.8<br />

Roos, Y.B. O9.5<br />

Rooy, J.W.J. de<br />

P04<br />

Rooy, T.D. de O5.6<br />

Rossi, A. O3.1, O3.3<br />

Rossius, M. E06, O10.7<br />

Rossum, M.A.J. van O7.2<br />

Rozendaal, R. O8.6<br />

Ruggiero, A.R. O7.8<br />

Rutten, I.J.G. O1.3<br />

Rutten, M.J.C.M. O4.2, O8.1<br />

P02, P10<br />

Sandt-Koenderman, W.M.E. van de<br />

P03<br />

Sanz-Arigita, E. O9.6<br />

Schaefer-Prokop, C.M. E06, O10.5,<br />

O10.7<br />

Scheltens, P. O9.5, O9.6<br />

Schep, N.W.L O7.5<br />

Schepers-Bok, R. O5.2<br />

Schip, A.D. van het O5.4<br />

Schoonheim, M.M. O9.6<br />

Seevinck, P.R. O5.4<br />

Senden, P.J. O3.7<br />

Setz-Pels, W. O4.3, O8.2<br />

Siebelt, M. O10.2<br />

Sijbrandij, L.<br />

E08<br />

Sikkenk, A.C. O8.8<br />

Simons, P.C.G.<br />

E03<br />

Slaar, A. O7.5<br />

Slangen, B.F. O6.8<br />

Slooter, G. O1.5<br />

Sluzewski, M.S. O9.8<br />

Smets, A.M. O7.1, O7.6<br />

Smit, H. O10.1<br />

Smit, R.S. O10.3<br />

Smits, M.<br />

O9.4, P03<br />

Smits, M.L.J. O5.4<br />

Spijkerboer, A.M. O2.1, O3.6<br />

Spilt, A. O2.3<br />

Sprengers, M.E. O9.5<br />

Stehouwer, B.L. O8.5, O8.10<br />

Stoker, J. O1.8, O2.1, O2.3, O2.4<br />

O6.1, O6.2, O6.3, O6.4<br />

O6.5, O7.1, O7.3<br />

Stokkers, P. O2.1<br />

Stoop, E. O6.3, O6.4<br />

Storm, R. O8.6<br />

Straten, M. van O10.2<br />

Symersky, P. O3.4, O3.5<br />

Tanghe, H.L.J.<br />

P08<br />

Ter Berg, J.W.M. O9.2<br />

Terkivatan, T. O6.7<br />

Thijssen, A.S.<br />

E07<br />

Thomeer, M.G.J. O6.1, O6.3,<br />

O6.4, O6.7<br />

Thywissen, T. O1.7<br />

Tiel, J. van O10.1, O10.2<br />

Tilborg, G.F.A.J.B. van<br />

E07<br />

Tolboom, N. O9.6<br />

Tran, V.H.P. O8.3<br />

Uijlings, R. O3.6<br />

Uiterwaal, C.S.P. O1.8<br />

Vandenbussche, F.<br />

P01<br />

Veenendaal, M. van O7.2<br />

Velde, D. van der O10.3<br />

Veldhuis, W.B. O8.5, O8.10<br />

Velthuis, B.K. O3.7<br />

Vente, M.A.D. O5.4<br />

Verhagen, H.J. O5.8<br />

Verheij, J. O6.7<br />

Verhulst, M.L. O1.5<br />

Verkooijen, H.M. O4.4<br />

Vermeule, W. O10.7<br />

Vermoolen, M.A. O1.8<br />

Vernooij, M.W. O9.1, O9.3, O9.4<br />

Verreyen, C.C.C.M.<br />

E08<br />

Verschuuren, S.I. O2.7<br />

Versluys, A.B. O7.4<br />

Vijver, M.J. van de O6.3<br />

Vincken, K.L. O3.2<br />

Visch-Brink, E.G.<br />

P03<br />

Visser, R.N. de<br />

E07<br />

Visser, F. E04, O3.8<br />

Visser, P.J. O9.5<br />

Vliegen, R. O6.8<br />

Vlies, M. van der<br />

P09<br />

Volmerink, M.H.M. O4.6, O8.3<br />

Vonken, E.P.A. O5.8<br />

Voogd, A.C. O8.2<br />

Voort, M. van der O8.7<br />

Vossen, M.H.E. O10.4, P12, P13<br />

Vroegindeweij, D. O8.8, O10.8<br />

Vrooman, H.A. O9.4<br />

Vukadinovic, D. O5.7<br />

Waarsing, J.H. O10.2<br />

Walenkamp, M.W. O7.5<br />

Wattjes, M.P. O9.5<br />

Weerink, L.B.M. O10.3<br />

Weinans, H. O10.1, O10.2<br />

Wensing, P.J.W. dr. O5.2<br />

Weustink, A.C. E07, O3.1, O3.3<br />

Wiarda, B.M. O2.3<br />

Wielopolski, P.A. O7.7<br />

Wiersma, H.W. O1.4<br />

Wijkerslooth, T.R. de O6.3, O6.4<br />

Wildberger, J.E. E05, O4.1, O9.2<br />

Wilde, J.C.H. O7.5<br />

Wink, A.M. O9.6<br />

Winkens, B. O5.1<br />

Witkamp, A.J. O4.4, O8.10<br />

Witte, M.T. de<br />

E03<br />

Witteman, J.C.M. O9.1, O9.3<br />

Wittenberg, R. O10.5<br />

Worp, H.B. van der<br />

P05<br />

Ypma, Y.F.R. O10.8<br />

Zagers, M.B. O5.5<br />

Zanen, P. O10.6<br />

Ziech, M.L.W. O2.1, O7.1<br />

Zijlstra, I.J.A. O6.1<br />

Zijta, F.M. O6.5<br />

Zonnenberg, B.A. O5.4<br />

Zsiros, J. O1.8<br />

Zwam, W. van O9.5<br />

Zwanenburg, J.J.M. E04, O3.8<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 13


RC<strong>programma</strong> <strong>abstracts</strong><br />

& <strong>abstracts</strong><br />

Samenvattingen<br />

‘Research Corner’<br />

Donderdag 29 september, 14.05 - 15.35 uur<br />

LUMC<br />

TOEPASSINGEN VAN ULTRAHOOGVELD<br />

MRI BIJ PATIENTENPOPULATIES<br />

M.A. van Buchem<br />

Enkele jaren geleden zijn MRI-systemen ontwikkeld met een<br />

zeer hoge veldsterkte die geschikt zijn <strong>voor</strong> onderzoek bij<br />

mensen. Recent zijn twee van zulke systemen, functionerend<br />

bij een veldsterkte van het magnetisch veld van 7Tesla, in<br />

Nederland geplaatst, respectievelijk in het LUMC en het<br />

UMCU. Inmiddels zijn een groot aantal patiënten op deze<br />

systemen onderzocht. In deze presentatie zal een indruk<br />

geschetst worden van de eerste ervaringen die daarbij<br />

opgedaan zijn.<br />

Erasmus MC<br />

POPULATION IMAGING<br />

A. van der Lugt, M. Vernooij, M. Smits, W. Niessen,<br />

G.P. Krestin<br />

Introductie: Beeldvormende technieken worden in toenemende<br />

mate gebruikt in epidemiologische studies.<br />

Het gaat hier niet meer alleen om de relatief goedkopere<br />

technieken zoals conventionele Röntgenonderzoeken of<br />

echografie, maar ook om state-of-the-art CT en MRI. In<br />

grote populatiestudies met langdurige follow-up wordt<br />

onderzoek gedaan naar 1) determinanten van ziekten,<br />

gericht op 1a) inzicht in de pathofysiologie van ziekte en 1b)<br />

de mogelijkheid tot preventie door middel van interventie;<br />

2) vroegtijdige detectie van ziekte; 3) vaststellen van hoog<br />

risico groepen.<br />

Gezien het jarenlange subklinische beloop van ziekten<br />

zoals aderverkalking en neurodegeneratieve afwijkingen<br />

(dementie) waarvan de afwijkingen (mogelijk) al vroeg in<br />

het ziekte proces zichtbaar te maken zijn, kan beeldvorming<br />

een belangrijke rol spelen in deze onderzoeks<strong>programma</strong>’s.<br />

Beeldvorming en met name seriële beeldvorming kan surrogaat<br />

eindpunten leveren <strong>voor</strong> ziekte waardoor het onderzoek<br />

naar determinanten kan verbeteren en meer inzicht<br />

kan worden verkregen in de pathofysiologie van ziekte.<br />

Beeldvorming kan bijdrage aan vroege detectie van ziekte<br />

waardoor een tijdige interventie ook binnen handbereik<br />

komt.<br />

Project: De afdeling <strong>Radiologie</strong> van het Erasmus MC<br />

is partner in twee grote lopende populatie studies: de<br />

Rotterdam Studie en Generation R. In beide studies wordt<br />

(seriële) MRI verricht bij alle deelnemers in de studie<br />

(>1000). Het onderzoek richt zich op hersenen, bloedvaten,<br />

hart en skelet. In de presentatie wordt aangegeven wat<br />

de meerwaarde is van de radiologische bijdrage in het<br />

beantwoorden van de studie vraagstellingen. Tevens wordt<br />

ingegaan op de specifieke radiologische problemen zoals<br />

kwaliteitscontrole, dataopslag, data analyse en toevalsbevindingen.<br />

Bijzonder: Beeldvorming in populatie studies heeft een<br />

andere oogpunt dan de klinische radiologie waarbij men<br />

gericht is op het oplossen van een specifiek klinisch probleem<br />

en de radioloog met een differentiaal diagnose een<br />

bijdrage levert aan de zorg van de individuele patiënt. In<br />

populaties studies gaat het om grote aantallen deelnemers<br />

waarbij <strong>voor</strong>namelijk wordt gekeken naar “normale afwijkingen”<br />

die geleidelijk optreden bij veroudering en waarbij<br />

afwijking van de norm relevant is. Grote datasets zijn<br />

nodig <strong>voor</strong> het vaststellen van determinanten (waaronder<br />

genetische variaties) en het <strong>voor</strong>spellen van ziekte. (Semi)-<br />

automatische kwantitatieve evaluatie van afwijkingen is<br />

noodzakelijk gezien de omvang van de datasets en de subtiliteit<br />

van de afwijkingen.<br />

Perspectief: Door de inbreng van de radiologie worden de<br />

nieuwste technieken direct toegepast in wetenschappelijk<br />

onderzoek. Andersom kan de klinische radiologie leren van<br />

de manier waarop consistente data acquisitie plaats vindt,<br />

wat het belang is van standaardisatie en kwantificatie<br />

van data. Ontwikkelde kwantificatiesoftware kan gebruikt<br />

worden in de kliniek. Tot slot verschaffen deze studies normaal<br />

waarden waartegen klinische pathologie kan worden<br />

uitgezet.<br />

14<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


RC<br />

research naam corner sessie 1<br />

UMC Groningen<br />

SCREENING FOR CORONARY ARTERY<br />

DISEASE BY NON-INVASIVE IMAGING<br />

IN PATIENTS WITH KNOWN EXTRA-<br />

CARDIAC ATHEROSCLEROTIC DISEASE: THE<br />

GROUND-2 STUDY<br />

R. Vliegenthart 1 , M. Oudkerk 1 , M.A.M. Dekker 1 ,<br />

J.J.A.M. van den Dungen 2 , R.A. Tio 3 , W.P.Th.M. Mali 4 ,<br />

M.M.J.J.R. Jaspers 5<br />

1<br />

Center for Medical Imaging – North East Netherlands<br />

(CMINEN), Dept of Radiology, University Medical Center<br />

Groningen/University of Groningen, Groningen<br />

2<br />

Dept of Surgery, University Medical Center Groningen/<br />

University of Groningen, Groningen<br />

3<br />

Dept of Cardiology, University Medical Center Groningen/<br />

University of Groningen, Groningen<br />

4<br />

Dept of Radiology, University Medical Center Utrecht,<br />

Utrecht<br />

5<br />

Dept of Radiology, Deventer Hospital, Deventer<br />

Patients with extra-cardiac atherosclerosis, like claudication,<br />

carotid stenosis or aortic aneurysm, have an increased risk<br />

of coronary heart disease. The purpose of the GROUND-2<br />

study is to non-invasively evaluate the presence of asymptomatic<br />

coronary artery disease (CAD) by CT calcium scoring,<br />

coronary CT angiography (CTA) and adenosine perfusion cardiac<br />

magnetic resonance imaging (APMR) in case of known<br />

extra-cardiac atherosclerosis.<br />

This study is designed as a prospective multicenter study.<br />

Patients aged 50 and over, diagnosed with extra-coronary<br />

atherosclerosis, either stenotic or aneurysmatic, are eligible<br />

to participate. Exclusion criteria are a history of symptomatic<br />

cardiac disease, severe arterial hypertension and contraindications<br />

to the used imaging modalities. All patients will<br />

non-contrast CT scanning to evaluate the coronary calcium<br />

score. In case of a zero calcium score, patients will be followed.<br />

In all other cases, CTA will be performed to evaluate<br />

the coronary arteries for significant stenoses. In case of a<br />

calcium score above 1000, the CTA is bypassed.<br />

Next, APMR will be used to assess perfusion defects of the<br />

myocardium. If there is a left main stenosis or equivalent on<br />

CTA or a perfusion defect on APMR, the patient will be referred<br />

to a cardiologist for further evaluation and treatment.<br />

All patients will be followed for 5 years for the occurrence<br />

of events.<br />

In this multicenter study, at least 1030 patients will be<br />

included. Inclusion has started in December 2009. This study<br />

will provide insight into the prevalence of silent severe<br />

CAD, detected by non-invasive cardiac imaging, in patients<br />

with known extra-cardiac atherosclerosis. Radiological<br />

screening for asymptomatic CAD may improve survival in<br />

these patients. Preliminary results indicate that significant<br />

coronary atherosclerosis is prevalent in patient with known<br />

extracoronary atherosclerosis.<br />

VUMC<br />

PSEUDO-CONTINUOUS ARTERIAL SPIN<br />

LABELING AT 3T IN ALZHEIMER’S DISEASE -<br />

INITIAL EXPERIENCE IN A MEMORY CLINIC<br />

M.A.A. Binnewijzend, J.P.A. Kuijer, M.R. Benedictus,<br />

P.J. Visser, W.M. van der Flier, M.P. Wattjes, P. Scheltens,<br />

F.A. Barkhof<br />

3D pseudo-continuous arterial spin labeling (PCASL) is a<br />

non-invasive scan technique that measures cerebral blood<br />

flow (CBF). We aimed to compare CBF of subjects with<br />

Alzheimer’s disease (AD), mild cognitive impairment (MCI)<br />

and subjective memory complaints (SMC).<br />

MRI scans, including MPRAGE and 3D-PCASL (post-label<br />

delay 2.0s, 3D-FSE, TR=4.8s, TE=4.7ms, spiral readout 8<br />

arms x 512 samples; 36x5.0mm axial slices; total scan time<br />

4min) were acquired on a 3T GE HDxt scanner in 76 consecutive<br />

subjects (33 AD, 15 MCI, 28 SMC) that visited our<br />

memory clinic. Partial volume estimates were obtained from<br />

MPRAGE images (using the FAST algorithm, part of FSL) to<br />

create CBF maps corrected for partial volume effects. Gray<br />

matter (GM) CBF-values were compared using analyses-ofvariance.<br />

Correlations with cognition (MMSE-scores) and<br />

vascular white matter lesions (WML) were investigated<br />

using linear regression analyses, correcting for age and<br />

gender.<br />

Four subjects (1 AD, 2 MCI, 1 SMC) were excluded from<br />

further analyses because of poor scan quality. Compared<br />

to SMC subjects, GM-CBF was decreased in both MCI<br />

(43±7 vs. 50±8 ml/100g/min; p


RC<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Figure 1: Whole brain CBF map.<br />

Figure 2: Partial volume corrected gray matter CBF map.<br />

Figure 3: Boxplot of gray matter CBF in SMC, MCI and AD.<br />

UMC St Radboud<br />

MR GESTUURDE PROSTAAT INTERVENTIES;<br />

KLAAR VOOR DE PRAKTIJK?<br />

J.J. Fütterer<br />

Next to digital rectal examination and PSA level, biopsy of<br />

the prostate is an essential procedure for determining optimal<br />

treatment. Systematic TRUSBx is the gold standard, but<br />

it fails to detect numerous tumors. This systematic approach<br />

is characterized by low sensitivity (39–52%) and high specificity<br />

(81–82%).<br />

Using diagnostic MRimages during an MR-directed biopsy<br />

procedure improves quality of the biopsy. In open MR scanners,<br />

the prebiopsy MR images often must be registered to<br />

the real-time biopsy images because open MR scanners do<br />

not provide optimal tissue contrast; thus, the patient must<br />

first be examined in a closed MR scanner and then biopsied<br />

in an open scanner. The advantage of open MR over closed<br />

MR is that the physician has easy patient access. Closed<br />

MR scanners can be used for the prebiopsy scan as well as<br />

for the biopsy procedure. Because operating room is limited<br />

within the closed MR scanner, manipulators are used to perform<br />

the biopsy. The MR detection rates after one negative<br />

biopsy round using MR-guided biopsy ranges between 38%<br />

and 55.5%.<br />

The clinical value of MR-guided prostate biopsy lies in<br />

the fact that a high percentage of prostate cancers can be<br />

depicted using an targeted biopsy technique, eliminating<br />

unnecessary systematic prostate biopsies for patients with<br />

elevated PSA levels and repeated tumor-negative TRUSBx.<br />

Extensive clinical studies are still essential to review the<br />

value of MR-guided biopsy. One of the largest challenges<br />

in taking biopsiesof the prostate is the correction for movements<br />

of the prostate tissue during the biopsy procedure.<br />

In conclusion the combination of a diagnostic MR examination<br />

and MR-guided biopsy is a promising tool and may be<br />

used in patients with previous negative TRUSBx.<br />

MUMC<br />

WAIT AND SEE IN RECTAL CANCER<br />

PATIENTS: SELECTION BY IMAGING AND<br />

OUTCOME<br />

M. Maas, R.G.H. Beets-Tan<br />

Locally advanced rectal cancer is treated with neoadjuvant<br />

chemoradiation. In approximately 20% of the patients the<br />

tumor and the involved lymph nodes disappear or become<br />

sterilized due to this chemoradiation: a complete response.<br />

With a combination of T2-weighted MRI, diffusion-weighted<br />

MRI, gadofosveset-enhanced MRI and endoscopy these<br />

patients can be selected for a ‘wait-and-see policy’, in which<br />

surgery is omitted and patients undergo intensive follow-up.<br />

Maastricht University Medical Centre is the only Dutch<br />

centre that currently performs a study to evaluate this waitand-see<br />

policy with MRI-based selection and follow-up. The<br />

preliminary results are very encouraging and for the future<br />

we expect to be able to offer this wait-and-see policy safely<br />

to complete responders after neoadjuvant chemoradiation.<br />

16<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


esearch naam corner sessie<br />

RC<br />

AMC<br />

NEUROTRANSMITTERS IN DE MRI<br />

L. Reneman<br />

Kinderen krijgen steeds vaker medicijnen <strong>voor</strong>geschreven,<br />

terwijl niet duidelijk is òf en hoe dit hun hersenontwikkeling<br />

beïnvloedt. Onderzoek is er nauwelijks. Niet naar de<br />

bijwerkingen en zelfs niet naar de effectiviteit. Toch stijgt het<br />

gebruik fors, want ze kunnen er baat bij hebben. Er is weinig<br />

bekend over bijwerkingen bij kinderen omdat deze medicijnen<br />

altijd zijn getest in volwassen dieren en mensen. Het meerendeel<br />

van de medicijnen dat wordt <strong>voor</strong>geschreven is zelfs<br />

niet geregistreerd <strong>voor</strong> gebruik in kinderen. Ze worden off<br />

label en off license <strong>voor</strong>geschreven. Uit proefdieronderzoek<br />

weten we dat medicijnen de ontwikkeling van het brein langdurig<br />

kunnen beïnvloeden en daardoor een tegenovergesteld<br />

effect kunnen hebben van wat je zou verwachten. Onderzoek<br />

naar eventuele bijwerkingen van medicijnen bij kinderen is<br />

<strong>voor</strong>al belangrijk <strong>voor</strong> geneesmiddelen die hun invloed uitoefenen<br />

op de hersenen, zoals middelen tegen depressie en<br />

ADHD. Want niet alleen wijkt de stofwisseling van kinderen<br />

af van dan die van volwassenen, hun brein is nog in ontwikkeling<br />

tot aan de jong volwassenheid. Medicijnen zouden die<br />

ontwikkeling kunnen verstoren. In Nederland hebben 8.500<br />

kinderen in de leeftijd van 0 t/m 20 jaar in de eerste helft van<br />

2008 een antidepressivum via de apotheek gekregen. Echter,<br />

de sterkste stijging de afgelopen tien jaar zijn medicijnen<br />

<strong>voor</strong> attention deficit hyperactivity disorder (ADHD). Werden<br />

in 2008 ongeveer 500.00 recepten uitgeschreven, was dit<br />

in 1999 nog maar 132.000 keer. De oorzaak van de forse<br />

stijging zijn de verbeterde diagnostiek en de steeds sterkere<br />

behoefte van ouders en artsen aan verlichting van klachten.<br />

De afdeling <strong>Radiologie</strong> van het AMC heeft door de jaren<br />

heen een sterke reputatie opgebouwd in het bestuderen<br />

van effecten van middelen (misbruik) op de hersenen. Zowel<br />

nationaal als internationaal vervult het AMC hierin een<br />

pioniersfunctie en wordt baanbrekend onderzoek verricht.<br />

In een groot multidisciplinair project onderzoeken we nu de<br />

zogeheten neurologische imprinting van geneesmiddelen.<br />

Bij<strong>voor</strong>beeld, rond 2004 kwamen aanwijzingen dat bij<br />

jongvolwassenen het percentage zelfmoordgevallen juist<br />

toenam onder invloed van serotonine heropname remmers<br />

(SSRIs), waardoor dit medicijn een tijdje gecontraindiceerd<br />

is geweest in deze populatie. Wij onderzoeken hoe dat komt<br />

en wat de werking is van andere geneesmiddelen op de<br />

hersenontwikkeling. Kleven er risico’s aan het gebruik op<br />

jonge leeftijd, of misschien juist onverwachte <strong>voor</strong>delen?<br />

We visualiseren de veranderingen die medicijnen kunnen<br />

aanbrengen in de hersenontwikkeling met behulp van farmacologsiche<br />

magnetic resonance imaging (phMRI). Hierbij<br />

kijken we <strong>voor</strong>al naar hersensystemen die werken op basis<br />

van de neurotransmitters serotonine - waarop medicijnen<br />

tegen depressie aangrijpen - en dopamine - <strong>voor</strong> medicijnen<br />

tegen ADHD. Ook kijken we naar het functioneren van de<br />

hersenen met behulp van neuropsychologisch onderzoek.<br />

Wij denken dat hoe jonger kinderen medicijnen krijgen, hoe<br />

meer ze ingrijpen op de normale uitrijping van de hersenen.<br />

Alle artsen willen het beste <strong>voor</strong> kinderen, maar dan moet<br />

wel duidelijk zijn of je meer goed dan kwaad doet. Ons<br />

onderzoek stelt artsen en ouders in staat de eventuele<br />

risico’s van bijwerkingen af te wegen tegen de <strong>voor</strong>delen<br />

van een medicamenteuze behandeling.<br />

UMC Utrecht<br />

MRI-GUIDED HIGH INTENSITY FOCUSED<br />

ULTRASOUND: THE FUTURE OF TUMOR<br />

ABLATION?<br />

M.A.A.J. van den Bosch<br />

MR-HIFU is an innovative, noninvasive tumor ablation technique.<br />

MR-imaging and focused ultrasound is combined allowing<br />

real-time anatomic guidance and temperature mapping<br />

during treatment. Recently, the volumetric ablation approach<br />

has been introduced in order to reduce treatment length and<br />

more homogenous tumor ablation.<br />

A MR-HIFU system has been installed at the department of<br />

Radiology UMC Utrecht in 2009. From the beginning a successful<br />

program for MR-HIFU treatment of uterine fibroids<br />

has been started. Currently one patient a week is treated in<br />

clinical practice, and a phase2 efficacy study is running.<br />

The first step for treatment of malignant tumors with<br />

MR-HIFU has been made in patients with painful bone<br />

metastases. Palliative treatment of painful bone metastases<br />

is applied in clinical practice since the beginning of this<br />

year. It is expected that besides bone, the first breast cancer<br />

patients will be treated in the beginning of 2012.<br />

Several issues need to be further investigated for successful<br />

cancer treatment with MR-HIFU, including patient selection<br />

criteria, definition of treatment margins and optimal<br />

transducer technology. For this we have a multidisciplinary<br />

MR-HIFU team in UMC Utrecht consisting of interventional<br />

radiologists, radiotherapists, physicists, postdocs and PhDstudents.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

17


1 <strong>programma</strong> Abstracts & <strong>abstracts</strong><br />

Sessie 1<br />

Abdominale radiologie 1<br />

Donderdag 29 september, 14.05 - 15.35 uur<br />

O1.1<br />

RESTAGING NODAL STATUS AFTER CHEMO-<br />

RADIATION FOR LOCALLY ADVANCED<br />

RECTAL CANCER: PREDICTIVE FACTORS<br />

M. Maas, D.M.J. Lambregts, M. Berkhof, G.L. Beets,<br />

R.G.H. Beets-Tan<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

Purpose: Restaging N-stage after CRT for rectal cancer is<br />

more accurate than N-stage prediction at primary staging<br />

of rectal cancer. The aim was to identify predictive factors<br />

which can help a radiologist in predicting the yN-stage.<br />

Methods: 39 patients with locally advanced rectal cancer<br />

underwent MRI before and after CRT. All visible nodes in<br />

the mesorectum were measured and recorded before and<br />

after CRT on a 3DT1W GRE-sequence with 1mm3 voxels.<br />

Baseline characteristics were collected and compared between<br />

patients with and without nodal involvement at pathology<br />

with t-tests and χ2. With regression analyses predictive<br />

factors for nodal involvement after CRT were identified.<br />

Based on the regression analyses a predictive model for yNstage<br />

was constructed and ROC curves were constructed for<br />

this predictive model.<br />

Results: 895 nodes were identified, of which 392 (44%)<br />

disappeared after CRT. Patients with ypN+ had larger nodes<br />

than ypN0-patients: mean 6.3 vs 3.6mm before CRT and 4.5<br />

vs 2.3mm after CRT, respectively (both p


Abdominale radiologie 1 1<br />

MRI is used for EMR identification and thus for identification<br />

of patients who need CRT on the obturator areas, patients<br />

can be spared an extensive resection with associated morbidity.<br />

O1.3<br />

GADOFOSVESET-ENHANCED MRI FOR<br />

NODAL STAGING IN RECTAL CANCER:<br />

PREDICTIVE CRITERIA<br />

D.M.J. Lambregts, M. Maas, I.J.G. Rutten, W.H. Backes,<br />

R.G. Riedl, F.C.H. Bakers, V.C. Cappendijk, G.L. Beets,<br />

R.G.H. Beets-Tan<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

Purpose: Recently, we showed that MRI using a new<br />

lymph-node contrast (gadofosveset) can significantly<br />

improve accuracy for staging of rectal cancer nodes. Aim<br />

of the present study was to determine the most accurate<br />

predictive imaging criteria for lymph node assessment using<br />

gadofosveset-MRI.<br />

On gadofosveset-MRI, SI was significantly higher in the<br />

benign nodes (p


1<br />

<strong>programma</strong> Abstracts & <strong>abstracts</strong><br />

in 10 en respectievelijk 8 tumoren. Op MRI 3 tumoren op<br />

niveau omslagplooi: peroperatief 2 rectumtumoren en 1<br />

sigmoïdtumor.<br />

De PS-lijn heeft geen onderscheidend vermogen tussen rectum-<br />

en sigmoïdtumor. Ondanks de matige zichtbaarheid van<br />

de omslagplooi correleert MRI in 18 van de 23 tumoren met<br />

peroperatieve bevindingen. De afstand omslagplooi tot anus<br />

(MRI) benadert het 15cm-criterium (endoscopie).<br />

O1.5<br />

CHRONIC DIVERTICULITIS VERSUS<br />

COLORECTAL CANCER: FINDINGS ON CT<br />

COLONOGRAPHY<br />

S.E.H. Cremers 1 , S. Gryspeerdt 2 , P. Lefere 2 , S. Houterman 3 ,<br />

G. Slooter 3 , M.L. Verhulst 3 , P.T.J. Cremers 3<br />

1<br />

Albert Schweitzer ziekenhuis, Dordrecht<br />

2<br />

Virtual Colonoscopy Teaching Centre (VCTC), Hooglede<br />

3<br />

Máxima Medisch Centrum, Veldhoven<br />

Purpose: In CT colonography chronic diverticulitis (CD) can<br />

mimic colorectal cancer (CRC) masses. In order to distinguish<br />

these two entities several findings were analysed.<br />

Methods: 525 symptomatic patients consecutively underwent<br />

CT colonography between June 2008 and February<br />

2011. All patients with pathologic confirmation of CD (13)<br />

and CRC (30) on surgical specimens were included. The<br />

images were analysed in retrospect by a consensus of<br />

two reviewers. Length of the mass, diverticula included in<br />

the mass, growth pattern, luminal narrowing, presence of<br />

perilesional lymph nodes and mesenteric fat stranding were<br />

evaluated. Statistical analysis was performed using Mann-<br />

Whitney and Chi-Square tests.<br />

Results: There was a significant difference in median<br />

length of the mass between CD and CRC, 100 and 49 mm<br />

respectively ( p


Abdominale radiologie 1 1<br />

Figure 1: A) T1-weighted images (T1W) acquired before, 30 s and 60 s after contrast agent (CA) administration, obtained for a patient with<br />

rectal cancer during primary staging. Red line indicates the tumor boundaries. White arrows indicate different tissue components of the rectum.<br />

T2W tumor image is shown as an image inset (upper left). B) Average signal enhancement-time curves obtained for the tumor (black line), rectal<br />

muscle (red line), mucosa (green line) and mesorectal fat (blue line) in three patients. In patient 3, the delineation of ROIs in rectal muscle and<br />

mucosa was not possible.<br />

O1.7<br />

ASSESSMENT OF A COMPLETE RESPONSE<br />

OF RECTAL CANCER TO PREOPERATIVE<br />

CHEMORADIATION THERAPY: A<br />

COMPARISON BETWEEN MR VOLUMETRY<br />

AND DIFFUSION-WEIGHTED MRI<br />

D.M.J. Lambregts 1 , L. Curvo-Semedo 2 , M. Maas 1 ,<br />

T. Thywissen 1 , G. Lammering 1 , G.L. Beets 1 , F. Caseiro-Alves 2 ,<br />

R.G.H. Beets-Tan 1<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Radiology University Clinic, Coimbra University Hospital,<br />

Coimbra, Portugal<br />

Purpose: To determine the performance of diffusion-weighted<br />

MRI (DWI) in assessing a complete tumor response (CR) after<br />

chemoradiation (CRT) in patients with locally advanced rectal<br />

cancer (LARC) by means of [1] volumetric signal intensity and<br />

[2] apparent diffusion coefficient (ADC) measurements, and to<br />

compare its performance with volumetry on T2W-MRI.<br />

Methods: Fifty LARC patients underwent standard T2W-FSE<br />

and DWI (b0,500,1000) pre- and post-CRT. Two independent<br />

readers retrospectively placed free-hand ROIs in each tumorslice<br />

on both datasets to determine pre-CRT and post-CRT<br />

tumor volumes and the tumor volume reduction (∆volume).<br />

ROIs were copied to an ADC-map to calculate mean tumor<br />

ADCs. Histology (ypT0) was the standard reference. ROCcurves<br />

were generated to compare the performance of T2Wvolumetry,<br />

DWI-volumetry and ADC in assessing a CR. The<br />

intraclass correlation coefficient (ICC) was used to evaluate<br />

interobserver variability and the correlation between T2Wvolumetry<br />

and DWI-volumetry.<br />

Results: Areas under the ROC-curve (AUC) for identification<br />

of a CR based on pre-volume / post-volume / ∆volume were<br />

0.57 / 0.70 / 0.84 for T2W-volumetry versus 0.63 / 0.93 / 0.92<br />

for DWI-volumetry (p=0.15 / 0.02 / 0.42). For ADC, AUCs were<br />

0.55, 0.54 and 0.51. Interobserver agreement was excellent for<br />

all pre-CRT measurements (ICC 0.91-0.96) versus good (0.61-<br />

0.79) post-CRT. The ICC between T2W- and DWI-volumetry<br />

was excellent (0.97) pre-CRT versus fair (0.25) post-CRT.<br />

Conclusion: Post-CRT DWI-volumetry provided a high diagnostic<br />

performance is assessing a CR and was significantly<br />

more accurate than T2W-volumetry. Post-CRT DWI was<br />

equally accurate as ∆volume of both T2W-MRI and DWI. Pretreatment<br />

volumetry and ADC were not reliable.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 21


1<br />

<strong>programma</strong> Abstracts & <strong>abstracts</strong><br />

Figure 1: ROC-curves for assessment of a CR.<br />

O1.8<br />

WHOLE-BODY MRI, INCLUDING DIFFUSION-<br />

WEIGHTED IMAGING, FOR STAGING NEWLY<br />

DIAGNOSED LYMPHOMA: COMPARISON<br />

TO COMPUTED TOMOGRAPHY IN 101<br />

PATIENTS<br />

T.C. Kwee 1 , M.A. Vermoolen 1 , E.M. Akkerman 2 ,<br />

M.J. Kersten 2 , R. Fijnheer 3 , I. Ludwig 1 , F.J. Beek 1 ,<br />

M.S. van Leeuwen 1 , M.B. Bierings 1 , J. Zsiros 2 ,<br />

H.M.E. Quarles van Ufford 1 , J.M.H. de Klerk 3 , J. Adam 2 ,<br />

J. Stoker 2 , C.S.P. Uiterwaal 1 , R.A.J. Nievelstein 1<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Academisch Medisch Centrum, Amsterdam<br />

3<br />

Meander Medisch Centrum, Amersfoort<br />

Purpose: To compare whole-body magnetic resonance<br />

imaging (MRI), including diffusion-weighted imaging (DWI),<br />

to computed tomography (CT) for staging newly diagnosed<br />

lymphoma.<br />

30.7% (31/101), and lower in 4.0% (4/101) of patients, with<br />

correct/incorrect/unresolved overstaging and incorrect/<br />

unresolved understaging relative to CT in 13/12/6 and 3/1<br />

patient(s), respectively. Staging results of whole-body MRI<br />

with DWI were equal to those of CT in 62.5% (60/96),<br />

higher in 32.3% (31/96), and lower in 5.2% (5/96) of<br />

patients, with correct/incorrect/unresolved overstaging and<br />

incorrect/unresolved understaging relative to CT in 18/10/3<br />

and 4/1 patient(s), respectively.<br />

Conclusion: Staging of newly diagnosed lymphoma using<br />

whole-body MRI (without and with DWI) equals staging<br />

using CT in the majority of patients. Disagreements between<br />

whole-body MRI and CT are mostly caused by overstaging of<br />

the former relative to the latter, with the number of correctly<br />

and incorrectly overstaged cases being approximately equal.<br />

The potential advantage of DWI is still unproven.<br />

Materials and methods: One hundred and one consecutive<br />

patients with newly diagnosed lymphoma prospectively<br />

underwent whole-body MRI (T1-weighted and T2-weighted<br />

short inversion time inversion recovery [n=101], and DWI<br />

[n=96]) and CT. Ann Arbor stages were assigned according<br />

to whole-body MRI and CT findings. Disagreements in<br />

staging between whole-body MRI (without and with DWI)<br />

and CT were resolved using bone marrow biopsy, 18F-fluoro-<br />

2-deoxyglucose positron emission tomography (FDG-PET),<br />

and follow-up FDG-PET, CT, and whole-body MRI studies as<br />

reference standard.<br />

Results: Staging results of whole-body MRI without DWI<br />

were equal to those of CT in 65.4% (66/101), higher in<br />

22<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Sessie 2<br />

Abdominale radiologie/<br />

Acute radiologie/Diversen<br />

2<br />

Abdominale radiologie/<br />

Acute radiologie/Diversen<br />

Donderdag 29 september, 14.05 - 15.35 uur<br />

O2.1<br />

DYNAMIC CONTRAST ENHANCED MRI FOR<br />

THE EVALUATION OF PERIANAL FISTULAS<br />

IN PATIENTS WITH CROHN’S DISEASE<br />

M.L.W. Ziech, C. Lavini, C.Y. Ponsioen, M.W.A. Caan,<br />

S. Bipat, A.M. Spijkerboer, P. Stokkers, A.J. Nederveen,<br />

J. Stoker<br />

Academisch Medisch Centrum, Amsterdam<br />

Purpose: To determine if dynamic contrast enhanced MRI<br />

(DCE-MRI) can evaluate disease activity in patients with<br />

perianal fistulizing Crohn’s disease.<br />

Methods and materials: Patients with perianal fistulizing<br />

Crohn’s disease, underwent DCE-MRI. The van Assche<br />

MRI-based score and perianal disease activity index (PDAI)<br />

were determined. Transversal DCE-MRI was performed at 3T<br />

during intravenous contrast injection (TE 2.3, TR 5.1, FA 30,<br />

15 slices, total duration of dynamic scan 5.05 min, 70 scans<br />

per slice, temporal resolution 4.2 sec per volume).<br />

The qualitative parameters Maximum Enhancement (ME),<br />

slope of the enhancement curve (SoE) and curve shape type<br />

(as by Lavini et al), as well as the quantitative parameters<br />

Ktrans, Vep, Kep as in the Tofts model were calculated<br />

(using a measured arterial input function) on a pixel by pixel<br />

basis, and then averaged of over an ROI drawn around the<br />

fistula. Spearman correlations between DCE-MRI parameters<br />

and PDAI and MRI-based score were calculated.<br />

Results: Sixteen patients (7 males) were included, mean<br />

age 37 (range 18-63). PDAI correlated with ME (r=0.669,<br />

p=0.005), SoE (r=0.582, p=0.018), ROI volume (r=0.786,<br />

p


2<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Figure 1<br />

Figure 2<br />

O2.3<br />

MRI FEATURES ASSOCIATED WITH ACUTE<br />

APPENDICITIS<br />

M.M.N. Leeuwenburgh 1 , B.M. Wiarda 2 , A. Spilt 3 ,<br />

P.M.M. Bossuyt 1 , M.A. Boermeester 1 , J. Stoker 1 , OPTIMAP<br />

Studiegroep<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Medisch Centrum Alkmaar, Alkmaar<br />

3<br />

Kennemer Gasthuis, Haarlem<br />

Purpose: To identify MRI features associated with appendicitis.<br />

Methods: Signs expected to be associated with appendicitis<br />

were recorded by two expert radiologists in 223 abdominal<br />

MRI scans of patients with suspected appendicitis<br />

(HASTE, HASTE SPAIR, DWI). The investigated features<br />

were:<br />

(1) Diameter >6mm;<br />

(2) Appendicolith;<br />

(3) Peri-appendiceal fat infiltration;<br />

(4) Peri-appendiceal fluid;<br />

(5) Absence of gas in the appendix;<br />

(6) Destruction of the appendiceal wall structure;<br />

(7) Restricted diffusion of the appendiceal wall;<br />

(8) Restricted diffusion of the appendiceal lumen;<br />

(9) Restricted diffusion of focal fluid collections<br />

An expert panel assigned acute appendicitis as final diagnosis<br />

in 117 of 223 patients based on histopathology and<br />

follow-up after 3 months. Associations between imaging<br />

features and appendicitis were evaluated with multivariable<br />

logistic regression analysis.<br />

Results: In 210 of 223 scans the appendix could be visualised.<br />

All 9 investigated MRI features were significantly<br />

associated with appendicitis in univariate analysis. Presence<br />

of two of these features had a probability of appendicitis<br />

between 85%(95%CI: 78-91%) and 100%(95%CI: 86-100%).<br />

If no features were identified in the MRI appendicitis was<br />

present in 0%(95%CI: 0%-8%) of patients. In multivariable<br />

Table 1<br />

24<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Abdominale radiologie/<br />

Acute radiologie/Diversen<br />

2<br />

analysis only peri-appendiceal fat infiltration and restricted<br />

diffusion of the appendiceal wall had a significant association<br />

with appendicitis. The probability of appendicitis was<br />

96%(95%CI: 90-98%) in presence of both features, and<br />

5%(95%CI: 2-11%) in their absence.<br />

Conclusion: In MRI, peri-appendiceal fat infiltration and<br />

restricted diffusion of the appendiceal wall are strongly<br />

associated with appendicitis. Presence of both features in a<br />

MRI examination leads to a high probability of appendicitis,<br />

whereas their absence almost rules appendicitis out.<br />

O2.4<br />

OPTIMAL STRATEGY IN PATIENTS WITH<br />

SUSPECTED ACUTE APPENDICITIS, CAN MRI<br />

REPLACE CT?<br />

M.M.N. Leeuwenburgh 1 , H.W. van Es 2 , J.W.C. Gratama 3 ,<br />

P.M.M. Bossuyt 1 , M.A. Boermeester 1 , J. Stoker 1 , OPTIMAP<br />

Studiegroep<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

St. Antonius Ziekenhuis, Nieuwegein<br />

3<br />

Gelre ziekenhuizen, Apeldoorn<br />

Purpose: To identify the optimal imaging strategy in adult<br />

patients with suspected appendicitis.<br />

Methods: We included consecutive patients with suspected<br />

appendicitis in six hospitals. Patients underwent initial<br />

US, followed by CT in case of non-diagnostic US results.<br />

Additionally, all patients underwent MRI (HASTE, HASTE<br />

SPAIR, DWI), with the MRI reader blinded for the results of<br />

the other imaging methods. An expert panel assigned a final<br />

diagnosis based on histopathology and clinical follow up<br />

after 3 months. We evaluated the sensitivity and specificity<br />

of the following scenarios: (1) US only;(2) US in all patients<br />

followed by CT after a non-diagnostic US;(3) US followed by<br />

MRI after a non-diagnostic US;(4) MRI only.<br />

Results: We performed 229 US, 126 CT and 223 MRI examinations<br />

in 230 patients (mean age 38 years, 41% male).<br />

Acute appendicitis was assigned as final diagnosis in 118<br />

patients (51%). Sensitivity of US only was 0.76(95%CI:<br />

0.68-0.83); specificity 0.94(95%CI: 0.88-0.97). Conditional<br />

imaging strategies with CT or MR after a non-diagnostic US<br />

resulted in a significantly increased sensitivity (p


2<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O2.5<br />

IS TRAUMA SIMULATIE NUTTIG BIJ<br />

TRAINING VAN RADIOLOGEN IN<br />

OPLEIDING?<br />

M.M.A.C. van Doorn, L.F.M. Beenen<br />

Academisch Medisch Centrum, Amsterdam<br />

Doelstelling: Evalueren van het effect van simulatie van<br />

polytrauma Total Body CT scans.<br />

Achtergrond: In grote traumacentra kan het <strong>voor</strong>komen dat<br />

er meerdere traumata tegelijk moeten worden opgevangen.<br />

Van al deze patiënten wordt beeldvorming verricht, waarbij<br />

er steeds vaker een Total Body CT scan (TBCT) wordt uitgevoerd.<br />

Dit genereert een grote druk bij arts-assistenten,<br />

die in korte tijd uit >1000 beelden per patiënt, allereerst de<br />

klinisch meest relevante afwijkingen moeten vaststellen.<br />

Beschrijving: In een prospectieve setting zijn 3 simulaties<br />

uitgevoerd. Per simulatie werd een groot ongeval aangekondigd<br />

met betrokkenheid van 5 slachtoffers, waarbij om de<br />

10 minuten een TBCT scan werd vervaardigd. Elke arts-assistent<br />

kreeg de uitdrukkelijke opdracht binnen 10 minuten de<br />

levensbedreigende letsels op te sporen. De dataset betrof<br />

alleen axiale coupes, reconstructies konden naar eigen<br />

inzicht worden uitgevoerd op het PACS-station. De simulatie<br />

is 3 maal herhaald, met enkele maanden tussenpoos.<br />

Bij de eerste simulatie werd een blanco invulformulier<br />

gebruikt, bij de tweede en derde simulatie een checklist.<br />

Een Likert-scale van 5 werd gebruikt als confidence-score.<br />

Een webbased-enquête werd opgesteld om achteraf de<br />

ervaringen te evalueren.<br />

Resultaten: 19 van de 31 arts-assistenten hebben minimaal<br />

2 simulaties meegedaan.<br />

Het merendeel van de arts-assistenten vindt de simulatie<br />

reëel met betrekking tot tijdsdruk (20/23) en pathologie<br />

(23/23), en goede <strong>voor</strong>bereiding op een ramp(21/22). Bij<br />

8/19 van de arts-assistenten is er een toename van de<br />

confidence-score.<br />

Conclusie: Simulatie is een eenvoudige methode, die het<br />

vertrouwen van arts-assistenten zowel objectief als subjectief<br />

vergroot.<br />

Met behulp van een checklist verloopt de beoordeling meer<br />

gestructureerd.<br />

O2.6<br />

SIMULTANE INTRODUCTIE VAN EEN<br />

NIEUWE PREVENTIE RICHTLIJN VOOR<br />

CONTRASTNEFROPATHIE IN COMBINATIE<br />

MET EEN AANGEPAST RADIOLOGISCH<br />

AANVRAAGFORMULIER: 1 JAAR ERVARING<br />

H.M. Dekker<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

Doel: De evaluatie van de toepassing van een aangepast<br />

radiologisch aanvraagformulier.<br />

Methoden: Ziekenhuisbreed is een nieuwe richtlijn<br />

geïntroduceerd om contrastnefropathie(CN) te <strong>voor</strong>komen.<br />

Deze richtlijn adviseert om bij alle patiënten de<br />

serumcreatinineconcentratie te bepalen en de eGFR te<br />

schatten met de MDRD formule en om patiënten met hoog<br />

risico te identificeren en <strong>voor</strong>zorgsmaatregelen te nemen.<br />

Hoog-risicopatiënten zijn gedefinieerd als eGFR1 risicofactor (risicofactoren: hartfalen, perifeer<br />

vaatlijden, dehydratie, >75 jaar, anemie, symptomatische<br />

hypotensie, >150 ml contrastmiddel, nefrotoxische<br />

medicatie) of ziekte van Kahler/Waldenström met lichte<br />

ketens in de urine. Op het aangepaste aanvraagformulier<br />

dienen de MDRD en risicofactoren verplicht te worden aangegeven.<br />

Hoog-risicopatiënten werden verwezen naar een<br />

CN-polikliniek. Gedurende 1 jaar werden gegevens<br />

verzameld van alle poliklinisch geplande urologische patiënten<br />

van ≥18 jaar, gepland <strong>voor</strong> CT met iv contrast.<br />

Resultaten: Er waren 622 patiënten, met een gemiddelde<br />

leeftijd van 56 jaar. Bij 99% was een serumcreatinineconcentratie<br />

bekend. In 23% was de eGFR


Abdominale radiologie/<br />

Acute radiologie/Diversen<br />

2<br />

O2.7<br />

MR EVALUATION OF URETHRAL<br />

DIVERTICULA AND DIFFERENTIAL<br />

DIAGNOSIS IN SYMPTOMATIC FEMALE<br />

PATIENTS<br />

S.I. Verschuuren, R.S. Dwarkasing, W. Dinkelaar, W.C.J. Hop,<br />

G.R. Dohle, G.P. Krestin<br />

Erasmus Medisch Centrum, Rotterdam<br />

Objective: The purpose of this study was to evaluate the<br />

role of MRI in the diagnosis and differential diagnosis of<br />

urethral diverticula (UD) in symptomatic female patients.<br />

Materials and methods: Female patients referred for MRI<br />

at a single institution with suspicion of UD were included<br />

retrospectively. All MRI examinations were independently<br />

evaluated by two radiologists and compared with patients’<br />

follow-up data. Sensitivity and specificity of MRI for UD was<br />

calculated using surgery and clinical confirmation as the<br />

reference standard. Image quality of the urethra and<br />

periurethral region performed with the endoluminal coil was<br />

compared with the pelvic phased array coil.<br />

Results: From a study group of 60 patients (mean age, 44<br />

years), 20 patients (33 %) had UD, 28 (47 %) had an alternative<br />

diagnosis, of which 13 (46 %) were demonstrated with<br />

MRI. In the remaining 12 patients (20 %) no abnormalities<br />

were found. For UD, MRI had a sensitivity and specificity of<br />

both 100 %. Twenty patients had a total of 27 diverticula;<br />

these were mostly locally round (n=12) with sharp margins<br />

(n=25) and high (n=19), homogeneous (n=16) signal intensity<br />

on T2- weighted sequences. The ostium of UD was identified<br />

in 23 (85 %) diverticula by both readers. Agreement was<br />

93 % with a kappa value of 0.72. Endoluminal coil in the<br />

vagina demonstrated the best image quality of the urethra<br />

and periurethral region.<br />

Conclusion: Dedicated MRI is an excellent imaging<br />

modality for UD, furthermore, MRI will show the alternative<br />

diagnosis in almost half of the remaining patients.<br />

O2.8<br />

WAARDE VAN METOCLOPRAMIDE BIJ MRI<br />

ENTEROGRAFIE<br />

U.C. Lalji<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

Vraagstelling: Is metoclopramide nuttig bij MR-enterografie <strong>voor</strong><br />

het diagnostiseren van Crohn met betrekking tot darmdistentie.<br />

maag of beoordeelbaarheid van het onderzoek.<br />

Metoclopramide interfereerde niet met de acquisitie van de beelden<br />

na toediening van buscopan.<br />

Discussie: Metoclopramide lijkt geen toegevoegde waarde te<br />

hebben bij MR-enterografie.<br />

Methode: In de periode van 1 mei 2010 tot 30 juni 2010<br />

werden 24 patienten geincludeerd met de vraagstelling Crohn.<br />

Hier<strong>voor</strong> ondergingen ze een MRI van de dunne darm volgens<br />

ons MR-enterografie protocol waarbij er 1 liter water met hierin<br />

opgelost metamucil 1 uur <strong>voor</strong> het onderzoek moest worden<br />

gedronken. Van deze 24 patienten kregen 10 patiënten 3 uur <strong>voor</strong><br />

aanvang van het onderzoek 10 mg metoclopramide per os. Ook<br />

moesten zij een vragenlijst invullen m.b.t. bijwerkingen en vragen<br />

over het onderzoek zelf.<br />

De overige 14 patiënten kregen geen metoclopramide maar volgden<br />

wel de rest van het protocol.<br />

2 abdominale radiologen scoorden de onderzoeken op de volgende<br />

punten:<br />

Distentie proximale dunne darm, distentie distale dunne darm,<br />

distensie terminale ilium, maagresidu en beoordeelbaarheid<br />

onderzoek.<br />

De radiologen waren hierbij niet op de hoogte welke patiënten<br />

metoclopramide hadden gekregen.<br />

Resultaten: De onderzoeken waren over het algemeen goed te<br />

beoordelen. Vergeleken met de groep zonder metoclopramide liet<br />

de groep met metoclopramide geen significante verschillen zien in<br />

mate van distentie van de delen van de dunne darm, residu in de<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

27


3 <strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Sessie 3<br />

Cardiovasculaire radiologie<br />

Donderdag 29 september, 14.05 - 15.35 uur<br />

O3.1<br />

DIAGNOSTIC ACCURACY OF COMPUTED<br />

TOMOGRAPHY CORONARY ANGIOGRAPHY<br />

(CTCA) IN WOMEN WITH LOW,<br />

INTERMEDIATE AND HIGH RISK FOR<br />

CORONARY ARTERY DISEASE (CAD)<br />

A.S. Dharampal, A. Rossi, A.C. Weustink, L. Neefjes,<br />

K. Nieman, N.R.A. Mollet, E.H. Boersma, G.P. Krestin,<br />

P.J. de Feyter<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To determine the diagnostic accuracy of CTCA<br />

in women with low, intermediate and high risk of having<br />

significant CAD.<br />

Materials and methods: Retrospective study including<br />

symptomatic women without prior history of coronary<br />

revascularization who underwent both CTCA and invasive<br />

coronary angiography between 2004 and 2009. The pre-test<br />

probability for significant CAD was estimated using the<br />

Duke Clinical Score and were grouped in low (≤20%), intermediate<br />

(21-80%), and high risk (≥81% probability) groups.<br />

The diagnostic accuracy of CTCA to detect significant CAD<br />

(≥50% lumen diameter narrowing) was assessed in the dif<br />

ferent risk groups on a per patient level.<br />

Results: Two-hundred-and-seventy-five women were included<br />

and stratified in low (n=50), intermediate (n=183) and<br />

high (n=42) risk group. The pre-test probability in the low,<br />

intermediate and high risk groups were 12%, 49% and 89%<br />

with a prevalence of 38%, 66%, and 83%, respectively.<br />

In the low risk group the sensitivity, specificity, PPV and NPV<br />

were 100%(95%CI: 83-100%), 74%(57-86%), 70%(52-84%)<br />

and 100%(85-100%).<br />

In the intermediate risk group the sensitivity, specificity, PPV<br />

and NPV were 98%(94-100%), 78%(66-86%), 89%(83-94%)<br />

and 96%(87-99%).<br />

In the high risk group the sensitivity, specificity, PPV and<br />

NPV were 100%(90-100%), 57%(25-84%), 92%(81-97%)<br />

and 100%(51-100%).<br />

Conclusion: The prevalence of CAD in women is underestimated<br />

in low and intermediate risk groups.<br />

CTCA can accurately rule out significant CAD in women with<br />

all risk groups.<br />

The post-test probability for detecting significant CAD is not<br />

depended on the pre-test probability of disease.<br />

O3.2<br />

ANALYSIS OF AORTIC VALVE ANNULUS<br />

PULSATILE DISTENSION IN PATIENTS<br />

WITHOUT AORTIC VALVE DISEASE BY<br />

ECG-GATED MULTISLICE COMPUTED<br />

TOMOGRAPHY (MSCT)<br />

L.M. de Heer, L.W. Bartels, L.A. van Herwerden,<br />

W.P.Th.M. Mali, K.L. Vincken, J. van Prehn, J. Kluin,<br />

R.P.J. Budde<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Objective: A key element of successful transcatheter<br />

aortic valve (AV) implantation is adequate prosthesis sizing.<br />

Cardiac output and aortic compliance result in aortic shape<br />

changes throughout the cardiac cycle. This may result in<br />

inadequate prosthesis sizing. To understand the dynamic<br />

changes in stenotic AV, the healthy aorta has to be studied<br />

first. We assessed the dynamic changes of the AV annulus<br />

using ECG-gated MSCT.<br />

Methods: Fifteen patients without AV disease who had<br />

undergone cardiac MSCT were identified. 3D datasets were<br />

reconstructed at each 10% of the ECG-interval. Per phase a<br />

cross-section in-plane with the AV annulus was reconstructed.<br />

The annulus area was segmented and analysed using<br />

in-home developed software (Dynamix, ISI) (figure). Radius<br />

changes were measured over 360 degrees from the center<br />

of mass per phase and plotted. The complete annulus shape<br />

change in all directions was depicted by fitting an ellipse<br />

over the data obtained in 360 degrees and described by<br />

radius changes over the major and minor axis. The asymmetry<br />

ratio was calculated by dividing the major by the minor<br />

axis. In addition area change was determined.<br />

28<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Cardiovasculaire radiologie 3<br />

Results: In all patients distension of the AV annulus was<br />

asymmetric (ratio 1.3±0.2). Diameter and area changes<br />

were significant in all patients. Mean diameter change was<br />

20±4%. Mean area change was 28±7%.<br />

Conclusions: The healthy AV annulus diameter and area<br />

show over 20% change during the cardiac cycle and these<br />

changes are asymmetrical. Quantification of dynamic morphological<br />

changes may aid prosthesis sizing and it may<br />

have implications for ultimate clinical success.<br />

Figure 1: Aortic segmentation (pink) by thresholding<br />

O3.3<br />

DIAGNOSTIC PERFORMANCE OF 128-<br />

SLICE DUAL SOURCE CT CORONARY<br />

ANGIOGRAPHY IN PATIENTS WITH<br />

VARIOUS HEART RATES USING 3 DIFFERENT<br />

SCAN PROTOCOLS: A RANDOMIZED STUDY<br />

L.A. Neefjes, A. Rossi, A.S. Dharampal, K. Nieman,<br />

A.C. Weustink, P.J. de Feyter, G.P. Krestin, N.R. Mollet<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To compare radiation dose and diagnostic performance<br />

of 3 CT coronary angiography (CTCA) protocols using<br />

a 128-slice Dual Source CT scanner (Siemens): a prospective<br />

high pitch spiral (HPS), a prospective step-and-shoot (SAS),<br />

and a retrospective (RS) scan protocol.<br />

Materials and methods: We prospectively included 459<br />

symptomatic patients with a regular heart rate (HR). Patients<br />

with a pre-scan HR


3<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

on a 64 detector-row scanner. Diastolic and systolic images<br />

were reconstructed with FBP (high and low-dose) and the<br />

IR algorithm (low-dose only). Hypo- and hyperdense artifact<br />

volumes were determined using two threshold filters (≤-50<br />

HU and ≥175 HU, respectively). Image noise was measured.<br />

Results: Mean image noise was 16.3±1.6 HU (high-dose<br />

FBP), 23.2±2.3 HU (low-dose FBP) and 16.5±1.7 (low-dose<br />

IR). Low-dose IR reconstructions had similar image noise<br />

compared to high-dose FBP (16.5±1.7 vs. 16.3±1.6, mean<br />

± SD). Mean hypo- and hyperdense artifact volumes (mm 3 )<br />

were 1235/5346 (high-dose FBP); 2405/6877 (low-dose FBP)<br />

and 1218/5333 (low-dose IR). For all PHV types, hypodense<br />

and hyperdense artifact volumes were similar for the highdose<br />

scans reconstructed with FBP when compared to lowdose<br />

scans reconstructed with IR.<br />

Conclusion: Iterative reconstruction allows ECG-gated PHV<br />

imaging with similar image noise and PHV artifacts at 50%<br />

less dose compared to FBP in an in vitro pulsatile model.<br />

Figure 1<br />

O3.5<br />

RADIATION DOSE AND ARTIFACTS<br />

ARE REDUCED BY PROSPECTIVE ECG-<br />

TRIGGERING RELATIVE TO RETROSPECTIVE<br />

ECG-GATING FOR IMAGING OF PROSTHETIC<br />

HEART VALVES WITH 256-SLICE CTS<br />

P. Symersky 1 , J. Habets 2 , B.A.J.M. de Mol 1 , M. Prokop 3 ,<br />

R.P.J. Budde 2<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Universitair Medisch Centrum, Utrecht<br />

3<br />

Radboud University Nijmegen Medical Center, Nijmegen<br />

Introduction: Multislice CT imaging has complementary<br />

diagnostic value in the evaluation of prosthetic heart valve<br />

(PHV) dysfunction. For PHV imaging, modified coronary protocols<br />

with retrospective ECG-gating have been used at<br />

considerable radiation exposure. We compared image noise,<br />

radiation dose and artifacts with prospective triggering to<br />

retrospective gating for PHV evaluation.<br />

Methods: Two mechanical PHVs (St Jude bileaflet and<br />

Medtronic Hall tilting disc) were scanned using a pulsatile<br />

in vitro model. Image acquisition was performed with a<br />

256-slice scanner with either a retrospectively gated helical<br />

scan (120kV, 600mAs, CTDI vol<br />

39.8mGy) or a prospectively<br />

triggered axial scan (120kV, 200mAs, CTDI vol<br />

13.3mGy), rotation<br />

time 0.27sec. Hypo- and hyperdense artifact volumes<br />

were quantified using thresholds of -45 and 175HU. Image<br />

noise and artifacts were compared between protocols.<br />

Additionally, mean image noise and radiation dose were<br />

compared between 6 patients with mechanical PHVs<br />

scanned with a prospectively triggered protocol and 20<br />

30<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Cardiovasculaire radiologie 3<br />

patients scanned with retrospective gating.<br />

Results: In vitro, prospective triggering reduced valve-induced<br />

hypo- and hyperdense artifacts by 35 and 26%, respectively<br />

(p


3<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

aortic (n=59), mitral (n=17), pulmonary (n=1) and tricuspid<br />

(n=1) position. In addition, seven annuloplasty rings were<br />

present. PHV artifacts prohibiting assessment of at least one<br />

coronary segment were present in 12/70 patients (17%).<br />

Artifacts were located in the RCA, LCX and LAD: in 9/70<br />

patients (13%) (mainly from PHVs in the aortic position), in<br />

7/70 patients (10%) and in 3/70 patients (4%) (both mainly<br />

from PHVs in mitral position), respectively, and never in the<br />

left main coronary artery. Biological PHVs (0/17), annuloplasty<br />

rings (0/7), Carbomedics bileaflet (0/20), ON-X bileaflet<br />

(0/7) and Medtronic Hall tilting disc (1/11) PHVs caused no<br />

artifacts precluding coronary artery assessment. However,<br />

coronary artery assessment was hampered by PHV artifacts<br />

in the Bileaflet Saint Jude (3/11) and Duromedics (1/1) PHVs<br />

as well as Sorin (5/7) and Björk Shiley (4/4) tilting disc PHVs.<br />

Conclusions: MSCT imaging is a suitable technique to<br />

assess coronary artery segments in most patients with<br />

PHVs. Björk-Shiley and Sorin tilting disc PHVs prohibit diagnostic<br />

assessment due to PHV artifacts.<br />

Figure 1: PHV artifact in the RCA.<br />

O3.7<br />

MORE NON-COMPACTED MYOCARDIUM IN<br />

BLACK FOOTBALLERS ON CARDIAC MRI<br />

T. Luijkx 1 , B.K. Velthuis 1 , F.J. van Hellemondt 2 , P.J. Senden 2 ,<br />

N.H.J. Prakken 1 , F.J.G. Backx 1 , W.P.T.M. Mali 1 ,<br />

M.J.M. Cramer 1<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Meander Medisch Centrum, Amersfoort<br />

Purpose: Electro- and echocardiographic (e.g. septal wall<br />

thickness, SWT) characteristics are known to differ between<br />

athletes of black and white ethnic descent. We used cardiac<br />

MRI (CMR) to study differences between elite black and<br />

white football (soccer) players.<br />

Methods: 38 healthy elite male football players aged 19-34<br />

years (mean age 23±4 years) underwent CMR: 28 of white<br />

and 10 of black ethnic descent. Blinded observers used a<br />

reproducible contour tracing protocol to assess ventricular<br />

volumes, function and wall mass. Maximum SWT and the<br />

ratio of non-compacted to compacted (NC/C ratio) myocardium<br />

was determined on a standardized apical-to-mid-ventricular<br />

CMR short axis slice at six positions recommended<br />

by the American Heart Association.<br />

Results: Black athletes showed slightly lower end-diastolic<br />

volumes and higher end-systolic volumes in both ventricles,<br />

resulting in lower ejection fractions. SWT was larger in<br />

black athletes. Myocardial NC was more widely present and<br />

more pronounced in black athletes with both a higher peak<br />

(white/black mean 1.81/2.30, range 1.13-2.42/1.14-3.66) and<br />

average (white/black mean 1.02/1.40, range 0.42-1.66/0.69-<br />

2.08) NC/C ratio.<br />

Conclusions: In this small sample footballers of black ethnicity<br />

show decreased ventricular systolic function at rest,<br />

which may be related to more pronounced myocardial noncompaction.<br />

The NC/C ratio frequently exceeds the clinically<br />

used CMR cut-off value of 2.3.<br />

Table 1<br />

32<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Cardiovasculaire radiologie 3<br />

O3.8<br />

INTRACRANIAL VESSEL WALL IMAGING AT<br />

7.0 TESLA MRI IN ISCHEMIC STROKE AND<br />

TIA PATIENTS<br />

A.G. van der Kolk, J.J.M. Zwanenburg, M. Brundel,<br />

G.J. Biessels, F. Visser, P.R. Luijten, J. Hendrikse<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Background & purpose: Conventional imaging methods<br />

cannot depict the vessel wall of intracranial arteries at<br />

sufficient resolution. This hampers the evaluation of intracranial<br />

arterial disease. The aim of the present study was to<br />

develop a high-resolution MRI method to image intracranial<br />

vessel wall.<br />

Methods: We developed a volumetric (3D) turbo spin<br />

echo (TSE) sequence for intracranial vessel wall imaging<br />

at 7.0 Tesla MRI. Inversion Recovery (IR) was used to null<br />

cerebrospinal fluid to increase contrast with the vessel wall.<br />

Magnetization preparation (MP) was applied prior to inversion<br />

to improve signal-to-noise ratio (SNR). 35 patients<br />

with ischemic stroke or TIA (Transient Ischemic Attack) of<br />

various causes were imaged to test the MPIR-TSE sequence.<br />

Gadolinium-based contrast agent (Gadobutrol, 0.1mL/kg)<br />

was administered to assess possible lesion enhancement in<br />

the patients.<br />

Results: The walls of intracranial arterial vessels could be<br />

visualized in all volunteers and patients with good contrast<br />

between wall, blood and cerebrospinal fluid. The quality of<br />

the vessel wall depiction was independent of the vessel<br />

orientation relative to the plane of acquisition. In 21 of the<br />

35 patients a total number of 52 intracranial vessel wall<br />

lesions were identified. Eleven of the 52 lesions showed<br />

enhancement after contrast administration. Only 14 of the<br />

52 lesions resulted in a stenosis of the arterial lumen.<br />

Conclusions: Intracranial vessel wall and its pathology can<br />

be depicted with the MPIR-TSE sequence at 7.0 Tesla. The<br />

MPIR-TSE sequence will make it possible to study the role<br />

of intracranial arterial wall pathology in ischemic stroke.<br />

Figure 1: Example of wall lesion on 7T MPIR-TSE & TOF-MRA<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

33


4 <strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Sessie 4<br />

Mammadiagnostiek 1<br />

Donderdag 29 september, 14.05 - 15.35 uur<br />

O4.1<br />

VISUELE VERSUS SEMI-AUTOMATISCHE<br />

BEOORDELING VAN MAMMADENSITEIT<br />

IN STANDAARD MAMMOGRAFISCH<br />

ONDERZOEK<br />

M.B.I. Lobbes 1 , J. Cleutjens 1 , V. Lima Passos 2 ,<br />

K. Keymeulen 1 , R.G. Beets-Tan 1 , C. Frotscher 1 , M.J. Lahaye 1 ,<br />

J. Wildberger 1 , C. Boetes †<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Universiteit Maastricht, Maastricht<br />

Doel: BI-RADS richtlijnen adviseren analyse van de klierweefseldensiteit<br />

op mammografisch onderzoek als deel van<br />

de mammografische evaluatie. Over het algemeen wordt<br />

visuele inspectie gebruikt om de densiteit van het klierweefsel<br />

in te schatten. Vergelijking tussen visuele en semi-automatische<br />

beoordeling van de klierdensiteit nog niet eerder<br />

onderzocht met een zogenaamde ‘threshold techniek’.<br />

Methoden: Klierdensiteit werd beoordeeld door een<br />

ervaren en onervaren radioloog in 200 mammografieën.<br />

Klierdensiteit werd ook gemeten met een software<strong>programma</strong><br />

dat gebruik maakt van een zogenaamde ‘threshold<br />

technique’ (figuur 1). Klierdensiteit werd gescoord volgens de<br />

richtlijnen van het BI-RADS classificatiesysteem. De correlatie<br />

tussen klierdensiteit van beide radiologen, alsook de correlatie<br />

tussen hun beoordeling versus de semi-automatische<br />

methode, werd uitgedrukt in de gewogen Kappa-waarde.<br />

Resultaten: Klierdensiteitmetingen van beide mammae en<br />

in beide projectierichtingen waren uitstekend en hoog significant<br />

(intraclass correlation coefficients >0.9, alle p


Mammadiagnostiek 1 4<br />

tly be visualized for evaluation in most patients.<br />

To date, 50 patients are evaluated: 3D-US evaluation of the<br />

breast shows a sensitivity of 88% and specificity of 97%,<br />

compared to MR imaging findings (and histology). In coming<br />

months all 201 patients will be evaluated.<br />

Conclusion: In our study so far, 3D-US shows high sensitivity<br />

and specificity in the detection of suspicious lesions compared<br />

to MRI. Automated breast volume scanning seems a promising<br />

new ultrasound technique in breast evaluation.<br />

O4.3<br />

MEDICOLEGAL CLAIMS FOLLOWING<br />

SCREENING MAMMOGRAPHY IN THE<br />

NETHERLANDS<br />

V. van Breest Smallenburg, W. Setz-Pels, F.H. Jansen,<br />

L.E.M. Duijm<br />

Catharina Ziekenhuis, Eindhoven<br />

Purpose: To determine the type and frequency of medicolegal<br />

claims at a Dutch breast cancer screening programme.<br />

Materials and methods: The study population consisted of<br />

all 80019 women who underwent screening mammography<br />

at a southern breast screening region of the Netherlands<br />

between January 1997 and July 2007 (301139 screens). We<br />

included all medicolegal claims that had been recorded at the<br />

central screening department within 3 years following screening<br />

mammography. During 2-year follow-up, we collected the<br />

biopsy results and surgery reports of all referred women. Two<br />

screening radiologists reviewed the screening mammograms<br />

of all screen detected cancers (SDC) and interval cancers (IC)<br />

and determined whether the cancer had been missed at the<br />

previous screen (in case of SDC) or latest screen (in case of<br />

IC). The radiologists were blinded to each others review; discrepant<br />

readings were followed by consensus reading.<br />

Results: Just 3 medicolegal claims had been reported,<br />

all of them related to financial compensation following a<br />

diagnosis of IC. The verdicts of these cases still have to be<br />

finalized. Excisional biopsy had been performed in 10.7%<br />

(234/2183) of false positive referrals. Review showed that<br />

20.8% (261/1254) of SDC had been missed at the previous<br />

screen and 23.6% (139/588) of IC should have been detected<br />

at the latest screen.<br />

Conclusions: Medicolegal claims were very rare, although<br />

a substantial proportion of false positive referred women<br />

had been confronted with excision biopsy and over 20% of<br />

cancers had been missed at the previous screen or latest<br />

screen, respectively.<br />

O4.4<br />

RADIOFREQUENCY-ASSISTED INTACT<br />

SPECIMEN BIOPSY OF BREAST TUMORS:<br />

AN EVALUATION ACCORDING TO THE<br />

IDEAL GUIDELINES<br />

S.C.E. Diepstraten 1 , H.M. Verkooijen 1 , P.J. van Diest 1 ,<br />

M.A. Fernandez-Gallardo 1 , K.M. Duvivier 1 , A.J. Witkamp 1 ,<br />

T. van Dalen 2 , W.P.Th.M. Mali 1 , M.A.A.J. van den Bosch 1<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Diakonessenhuis, Utrecht<br />

Purpose: Radiofrequency-assisted intact specimen biopsy<br />

(RFIB) has been introduced for percutaneous biopsy or<br />

removal of breast tumors. Using radiofrequency cutting,<br />

the system enables the interventional radiologist to obtain<br />

an intact sample of the target lesion. According to IDEAL<br />

guidelines, we performed a critical evaluation of our initial<br />

experience with RFIB.<br />

Methods: Between June and November of 2010, X-ray guided<br />

RFIB was performed in 19 female patients. All patients<br />

presented with suspicious microcalcifications (BI-RADS<br />

III-V) on mammography. Biopsy specimen integrity, thermal<br />

damage and histological diagnosis were assessed by an<br />

expert breast pathologist. Data on technical success,<br />

diagnostic and therapeutic accuracy and peri-procedural<br />

complications were collected and analyzed according to the<br />

IDEAL guidelines.<br />

Results: Median age was 59 years. Median lesion diameter<br />

on mammography was 8 mm (range 2-76 mm). The procedure<br />

was successful in 17/19 (89%) patients and unsuccessful<br />

in 2/19 (11%) patients (1 nonrepresentative sample,<br />

1 sample with extensive thermal damage). Histological<br />

analysis of the RFIB specimen revealed 12/19 (63%) benign<br />

lesions and 7/19 (37%) malignancies (4 DCIS lesions and 3<br />

invasive ductal carcinomas). In 1 patient a DCIS lesion was<br />

completely removed with RFIB. Overall, 3 peri-procedural<br />

complications occurred (1 wound leakage, 1 arterial hemorrhage<br />

and 1 infection requiring oral antibiotics).<br />

Conclusion: Tissue sampling of suspicious breast lesions<br />

can be performed successfully with RFIB. In 1 patient DCIS<br />

was radically excised with RFIB, which illustrates its potential<br />

as a minimally invasive therapeutic procedure for removal<br />

of small breast tumors. This is an interesting focus for<br />

further research when larger probe sizes become available.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

35


4<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O4.5<br />

CAN COMPUTER-AIDED ANALYSIS OF<br />

BREAST MRI PREDICT THE NOTTINGHAM<br />

PROGNOSTIC INDEX OF PATIENT SURVIVAL?<br />

K.G.A. Gilhuijs 1 , K. Pengel 2 , V. Bruijnes 2 , C. Loo 2<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

NKI-AvL, Amsterdam<br />

Purpose: The aim of this study is to identify imaging biomarkers<br />

from contrast-enhanced breast MRI that predict the<br />

Nottingham prognostic index (NPI) prior to surgery.<br />

Methods: Patients with invasive breast cancer and eligible<br />

for breast-conserving therapy on the basis of conventional<br />

breast imaging and clinical examination received additional<br />

preoperative breast MRI in a prospective study. Temporal and<br />

morphological features of contrast uptake were automatically<br />

analyzed by a custom-build workstation. The size and grade<br />

of the tumor as well as the number of positive lymph nodes<br />

were assessed at histopathology. From their combination, the<br />

NPI was calculated. Based on NPI, patients were stratified in<br />

subgroups with expected 5-year survival rates larger or equal<br />

to 93% and subgroups with lower survival rates. Multivariate<br />

analyses were performed to identify correlations between<br />

computer-extracted MRI features and NPI. Bonferroni correction<br />

and receiver-operating characteristics were employed.<br />

Results: Five-hundred-and-forty-nine patients were included<br />

between 2000 and 2007. The mean patient age was 57<br />

years, the mean tumor size was 1.6 cm. A total of 224/549<br />

patients had one or more positive lymph nodes. The mean<br />

NPI was 3.1 (range 1.2 - 36.2), 304 patients were at or<br />

above the expected 93% 5-year survival threshold, 245 were<br />

below. From 20 computer-extracted features, the largest<br />

diameter of the washout in the enhancing lesion was most<br />

predictive to discriminate between the two groups, yielding<br />

an area under the curve of 0.74.<br />

Discussion and conclusion: Computer-aided analysis<br />

of breast MRI shows potential to estimate the NPI prior to<br />

surgery, and may thus ultimately provide complementary<br />

information to select neoadjuvant or minimally invasive<br />

treatment strategies.<br />

O4.6<br />

MRI RESPONSE MONITORING IN<br />

NEOADJUVANTLY TREATED<br />

MAMMACARCINOMA: ADVANTAGE OF<br />

TWO- AND THREE-DIMENSIONAL OVER<br />

ONE DIMENSIONAL MEASUREMENTS?<br />

M.H.M. Volmerink, A.L.T. Imholz, R.A.J.M. van Dijk<br />

Deventer Ziekenhuis, Deventer<br />

Aim: to investigate the associations of (changes in) MRI<br />

tumoursize in one, two and three dimensions with specimen<br />

pathology of neoadjuvantly treated mammacarcinoma.<br />

Methods: In this retrospective study, in 35 patients dynamic<br />

contrast-enhanced MRI was performed before, during and<br />

after chemotherapy. Tumoursize was measured by RECIST,<br />

cross-section area (2D), volume (3D; all at early (70s) and<br />

late (450s) enhancement) and by RECIST washout<br />

. Change in<br />

tumoursize from MRI 1 to 2, and tumoursize at MRI3 were<br />

correlated with pathology by logistic regression.<br />

Results: decrease in tumoursize measured by 2D late<br />

(ß=4,1<br />

p=0,03), RECIST early<br />

(ß=2,5 p=0,01) and RECIST washout<br />

(ß=3,4<br />

p


Interventieradiologie/<br />

Cardiovasculaire radiologie<br />

Sessie 5<br />

5<br />

Interventieradiologie/<br />

Cardiovasculaire radiologie<br />

Donderdag 29 september, 14.05 - 15.35 uur<br />

O5.1<br />

CRURAL PTA FOR CRITICAL LIMB ISCHEMIA;<br />

TECHNICAL AND CLINICAL LONG-TERM<br />

RESULTS<br />

A.S. van den Berg 1 , H. Odink 1 , B. Winkens 2<br />

1<br />

Atrium Medisch Centrum, Heerlen<br />

2<br />

Universiteit Maastricht, Maastricht<br />

Purpose: To evaluate the technical and clinical long-term<br />

effectiveness of angioplasty of the crural arteries to preserve<br />

the leg.<br />

Materials and methods: In a 5½ year period a retrospective<br />

study was performed with 109 crural PTA’s of consecutive<br />

patients (47 men and 62 women; median age 79 years; SD<br />

= 9) with critical limb ischemia. Analysis of the clinical longterm<br />

effectiveness of angioplasty of the lower leg arteries<br />

in time (limb salvage rate = LSR), was performed using the<br />

Kaplan-Meier life-table analysis.<br />

Results: PTA included 29 stenoses (mean grade of stenosis<br />

= 90%; SD = 6%, mean length = 5 cm; SD = 12 cm) and 80<br />

occlusions (mean length = 15 cm; SD = 10 cm). Total technical<br />

failures were 16 (TF = 15%) and 93 procedures were<br />

successful (TS = 85%). The procedure-related mortality rate<br />

was 4%.<br />

Of 109 limbs 90 procedures were a PTA of a de novo lesion<br />

(83%). In the group of de novo lesions the LSR after 3 years<br />

was 78% (SD = 4.8). For the 80 technically successful procedures<br />

only the LSR after 3 years was 87% (SD = 4.1).<br />

Conclusion: PTA of the crural arteries appears to be an<br />

effective treatment for patients suffering from critical limb<br />

ischemia.<br />

Figure 1: Kaplan-Meier survival curves of PTA .<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

37


5<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O5.2<br />

CLINICAL PERFORMANCE OF A NOVEL<br />

BIOACTIVE COMPOSITE IN THE TREATMENT<br />

OF VERTEBRAL COMPRESSION FRACTURES<br />

R. Schepers-Bok 1 , M. Geerdes 1 , M.E. Havinga 1 , R. Aquarius 2 ,<br />

P.J.W. Wensing 1<br />

1<br />

Ziekenhuisgroep Twente, Hengelo<br />

2<br />

Radboud University Nijmegen Medical Centre, Nijmegen<br />

Objective: To analyse the outcome of percutaneous vertebroplasty<br />

with CortossTM in patients with vertebral compression<br />

fractures.<br />

Methods: Between 2005 and 2010, 221 vertebral compression<br />

fractures were treated with percutaneous vertebroplasty<br />

in 132 patients. Inclusion criteria were: compression fractures<br />

due to osteoporosis, trauma or malignancy, invalidating<br />

back pain due to compression fracture, no improvement<br />

to standard conservative therapy for minimal 6 weeks,<br />

Numerical Rating Scale (NRS) score of at least 7 and bone<br />

marrow edema on MRI scan.<br />

NRS score was obtained before, and two and six weeks<br />

after vertebroplasty. Primary outcome was pain reduction<br />

measured by NRS score. Clinically significant pain relief<br />

was defined as a decrease in NRS score of at least 3 points.<br />

Secondary outcome were new vertebral fractures, injected<br />

volume and complications.<br />

Results: Two weeks after vertebroplasty, 84,7% of the<br />

patients showed a decrease of at least three points on NRS<br />

score. This increased to 86,8% after six weeks. 34 new fractures<br />

occurred in 22 patients (17,4%).No embolisms occurred.<br />

Mean injected volume of Cortoss was 1,54 mL.<br />

Conclusion: In a group of patients with vertebral compression<br />

fractures percutaneous vertebroplasty with Cortoss is<br />

an effective and safe treatment option. PVP leads to a significant,<br />

rapid decrease in pain. Our results are comparable<br />

to results of other studies which used PMMA. These good<br />

clinical results, together with advantages of Cortoss, such<br />

as the low cement volume needed, and the mix-on-demand<br />

delivery system, make it a strong candidate to be a standard<br />

material in vertebral augmentation.<br />

Figure 1: Distribution of Cortoss: trabecular pattern.<br />

Table 1: Patient characteristics.<br />

38<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Interventieradiologie/<br />

Cardiovasculaire radiologie<br />

5<br />

Table 2: Mean NRS before and after vertebroplasty.<br />

O5.3<br />

INTERVENTIES BIJ PATIËNTEN MET KRITIEKE<br />

ISCHEMIE EN KWALITEIT VAN LEVEN<br />

F.A. Frans, R. Met, S. Bipat, M.J.W. Koelemay,<br />

D.A. Legemate, J.A. Reekers<br />

Academisch Medisch Centrum, Amsterdam<br />

De keuze van de behandeling bij patiënten met kritieke<br />

ischemie (CLI) van het onderbeen is maatwerk. Behoud van<br />

het been en Kwaliteit van Leven (Qol) zijn belangrijke uitkomstmaten<br />

bij de behandeling. Doel van dit onderzoek was<br />

het inventariseren van de behandelingen en het vervolgen<br />

van de Qol bij patiënten met CLI.<br />

In deze prospectieve cohort studie werden alle opeenvolgende<br />

patiënten met CLI die zich presenteerden in ons<br />

ziekenhuis geïncludeerd. De ziektespecifieke VascuQol<br />

vragenlijst werd ingevuld bij presentatie (baseline) en na<br />

6 maanden. Verschillen in scores werden getoetst met de<br />

Wilcoxon-Signed Ranks test.<br />

Van mei 2007 t/m mei 2010 presenteerden zich 218 patiënten<br />

met CLI. Hiervan konden 150 patiënten worden geïncludeerd<br />

in de studie. De uiteindelijke studiepopulatie bestond na 6<br />

maanden uit 127 patiënten. Primaire behandeling was een<br />

PTA (79;62%), chirurgisch (32;25%), conservatief (12;10%) of<br />

een amputatie (4;3%). Bij 43 patiënten (34%) was binnen 6<br />

maanden opnieuw een interventie nodig. De hele groep liet<br />

een toename zien in Qol na 6 maanden in de somscore en op<br />

alle individuele domeinen van de VascuQol (p


5<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Methods: five patients with liver metastases were treated<br />

with 166 Ho-radioembolization. In order to assess microsphere<br />

biodistribution, pre and post treatment multi-gradient echo<br />

T 2<br />

*-weighted MR images and post treatment SPECT images<br />

were acquired. R 2<br />

* (R 2<br />

*=1/ T 2<br />

*) maps were constructed,<br />

since increases in R 2<br />

* are known to linearly relate to the<br />

166<br />

Ho-MS concentration. R 2<br />

*-maps were compared with<br />

SPECT images. Couinaud’s liver segments and up to 5 index<br />

lesions per patient were selected in volumes of interest<br />

(VOI) using anatomical MR images. VOIs were projected<br />

over the SPECT images and R 2<br />

*-maps and the intensity per<br />

VOI was expressed in percentage of total liver intensity.<br />

From the 5 patients a total of 61 VOIs from R 2<br />

*-maps and<br />

SPECT were compared.<br />

Results: Presence of 166 Ho-MS in the human liver was clearly<br />

visible with both modalities. In certain cases, the higher<br />

resolution of MR-acquired R2*-maps provided additional<br />

information to the SPECT images with regard to the microsphere<br />

biodistribution within a tumor. Biodistribution measurements<br />

showed a high correlation between SPECT and MRI<br />

for liver segments (r 2 0.92) and index lesions (r 2 0.83).<br />

Conclusion: The intrahepatic biodistribution of 166 Ho-<br />

MS can be clearly visualized with both SPECT and MRI.<br />

Biodistribution measurements based on MRI and based on<br />

SPECT show a very good correlation.<br />

Figure 2: Percentage of total liver intensity in each VOI.<br />

Figure 1: 166Ho microspheres visualised on<br />

R2*-map and SPECT.<br />

O5.5<br />

COMPARISON OF SELF REPORTED WALKING<br />

DISTANCE, TREADMILL TEST PERFORMANCE<br />

AND WALKING ABILITY IN PATIENTS WITH<br />

INTERMITTENT CLAUDICATION<br />

M.B. Zagers, F.A. Frans, S. Bipat, J.A. Reekers, S. Jens,<br />

M.J.W. Koelemay<br />

Academisch Medisch Centrum, Amsterdam<br />

Objectives: Decisions regarding treatment of patients with<br />

intermittent claudication (IC) are guided by the patient’s perceived<br />

disability due to limited pain free (PWD) and<br />

maximum walking distance (MWD), and objective assessment<br />

of PWD and MWD on a treadmill. There are few data<br />

on the relationship between treadmill test, daily life and<br />

patient reporting regarding the outcomes, PWD and MWD.<br />

Our objective was to determine correlations between these<br />

assessments.<br />

Methods: All consecutive outpatients with IC who gave<br />

informed consent were included in this prospective study.<br />

Assessments included PWD and MWD during a standardized<br />

treadmill test (3,0 km/h, 8% incline), and on a walking<br />

track on the corridor at the patient’s own pace. All patients<br />

40<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Interventieradiologie/<br />

Cardiovasculaire radiologie<br />

5<br />

also estimated their Subjective (S)PWD and (S)MWD.<br />

Differences and correlations between the assessments<br />

were determined with the Wilcoxon-Signed Ranks test and<br />

Spearman’s rank test, respectively.<br />

Results: 35 patients (71% men, mean age 64 years) were<br />

included. Mean PWD and MWD at corridor were significantly<br />

higher (115 and 265 meters) compared to the distances<br />

on the treadmill (62 and 128 meters) (P


5<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Figure 2: Opname na thrombectomie (C) zonder thrombolytica.<br />

O5.7<br />

CAROTID ATHEROSCLEROTIC PLAQUE<br />

PROGRESSION AND CHANGE IN PLAQUE<br />

COMPOSITION OVER TIME; A PROSPECTIVE<br />

IN VIVO SERIAL CT ANGIOGRAPHY STUDY<br />

M.J. van Gils, D. Vukadinovic, D.W.J. Dippel, W.J. Niessen,<br />

A. van der Lugt<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: Serial in vivo imaging would improve our understanding<br />

of atherosclerotic plaque progression and would be<br />

useful in assessing cardiovascular risk and monitoring treatment<br />

efficacy. Purpose of this prospective study is to quantify<br />

changes in atherosclerotic carotid plaque volume and<br />

plaque composition over time with CT angiography (CTA).<br />

Results: Thirty out of 222 arteries were excluded (local<br />

treatment, occlusion or poor image quality). Mean follow-up<br />

was 63±8 months. Intra-observer reproducibility of all volume<br />

measurements was good (ICC=0.90-1.00), except for lipid<br />

(ICC=0.79). Wall volume decreased in 30% and increased<br />

in 70% of vessels (range -6.8-10.9%/year). Baseline lumen<br />

volume was 1479±632 mm 3 , wall volume was 1089±461<br />

mm 3 . On average, volumes of vessel, lumen and wall increased<br />

0.6%, 0.5% and 1.2% per year (p≤0.001, oneway<br />

t-test). Plaque composition changed significantly from<br />

baseline (fibrous 66.3%, lipid 29.0%, calcifications 4.7%):<br />

fibrous tissue decreased with 1.1% (p


Interventieradiologie/<br />

Cardiovasculaire radiologie<br />

5<br />

O5.8<br />

1 JAAR NA EVAR BESTAAT NOG ONGEVEER<br />

EENDERDE DEEL VAN DE ANEURYSMAZAK<br />

UIT ONGEORGANISEERDE THROMBUS<br />

BIJ PATIENTEN MET EN ZONDER<br />

AANTOONBAAR ENDOLEAK<br />

S.A.P. Cornelissen 1 , E.P.A. Vonken 1 , H.J. Verhagen 2 ,<br />

F.L. Moll 1 , L.W. Bartels 3<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Erasmus Medisch Centrum, Rotterdam<br />

3<br />

Image Sciences Institute, Universitair Medisch Centrum<br />

Utrecht, Utrecht<br />

Doel: Doel van dit onderzoek was om de veranderende<br />

organisatiegraad van de aneurysmazak gedurende het eerste<br />

jaar na EVAR af te beelden met MRI.<br />

Methoden: In deze METC-goedgekeurde studie ondergingen<br />

30 patiënten MRI-onderzoeken pre-operatief, < 6 weken<br />

postoperatief, 6 maanden en 1 jaar na EVAR. Er werden<br />

pre-contrast T1- en T2- en postcontrast T1-gewogen beelden<br />

gemaakt. De aneurysmazak werd met speciaal hier<strong>voor</strong> ontwikkelde<br />

software door een ervaren radioloog uitgesplitst<br />

in gebieden met endoleak, ongeorganiseerde en georganiseerde<br />

thrombus aan de hand van de signaalintensiteit op<br />

de verschillende beelden.<br />

Resultaten: Het gemiddelde ongeorganiseerde thrombusvolume<br />

pre-operatief was 23 ml(95%CI 16-30ml), postoperatief<br />

51 ml(95%CI 41-61 ml), na 6 maanden 39 ml(95%CI<br />

29-48ml), na 1 jaar 32 ml(23-41ml), zie figuur 1. Er was een<br />

significante toename in ongeorganiseerde thrombusvolume<br />

postoperatief t.o.v. pre-operatief (gepaarde t-test, p


6<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Sessie 6<br />

Abdominale radiologie 2<br />

Vrijdag 30 september, 10.45 - 12.15 uur<br />

O6.1<br />

EVALUATION OF A STANDARDIZED CT<br />

COLONOGRAPHY TRAINING PROGRAM IN<br />

NOVICE READER<br />

M.H. Liedenbaum 1 , S. Bipat 1 , P.M.M. Bossuyt 1 ,<br />

R.S. Dwarkasing 2 , M.C. de Haan 1 , R.J. Jansen 1 ,<br />

D. Kauffman 1 , C. van der Leij 1 , M.S. de Lijster 1 , C.C. Lute 1 ,<br />

M.P. van der Paardt 1 , M.G. Thomeer 2 , I.J.A. Zijlstra 1 ,<br />

J. Stoker 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To determine how many CT colonography (CTC) training<br />

examinations have to be evaluated by novice readers to<br />

obtain an adequate level of competence in polyp detection.<br />

Methods: Informed consent was obtained from all participants.<br />

Six physicians (one radiologist, three radiology<br />

residents, two researchers) and three technicians completed<br />

a CTC training program. 200 CTC’s with colonoscopic verification<br />

were selected from a research database, with 100<br />

CTC’s with at least one polyp ≥6mm. After a lecture session<br />

and an individual hands-on training, CTC reading was done<br />

individually with immediate feedback of the colonoscopy<br />

outcome. The increase in per-polyp sensitivity was calculated<br />

for four sets of 50 CTC’s for lesions ≥6mm. Using logistic<br />

regression analyses, the number of CTC’s to reach 90%<br />

sensitivity for lesions ≥6mm was estimated. Reading times<br />

were registered.<br />

Results: The average per-polyp sensitivity for lesions<br />

≥6mm was 76% (207/270) in the first set of 50 CTC’s,<br />

77% (262/342) in the second set (p=0.96 vs. first set), 80%<br />

(310/387) in the third set (p=0.67 vs. first set) and 91%<br />

(261/288) in the fourth set (p=0.018). The estimated number<br />

of CTC’s to be evaluated to reach a sufficient sensitivity for<br />

lesions ≥6mm was 164. Six of the nine readers reached<br />

this level of competence within 175 CTC’s. Reading times<br />

decreased significantly from the first 50 CTC’s to the second<br />

50 CTC’s for 6 readers.<br />

Conclusions: Novice CT colonography readers obtained a<br />

sensitivity equal to that of experienced readers after practicing<br />

on average 164 CTC studies.<br />

O6.2<br />

THE FEASIBILITY OF TRAINING<br />

RADIOLOGIC TECHNOLOGISTS IN<br />

TRIAGING CT-COLONOGRAPHY FOR<br />

EXTRACOLONIC FINDINGS<br />

T.N. Boellaard, C.Y. Nio, P.M. Bossuyt, J. Stoker<br />

Academisch Medisch Centrum, Amsterdam<br />

Purpose: Cost-effectiveness is important for the implementation<br />

of CT-colonography as a screening tool for colorectal<br />

cancer. Radiologists’ reading time contributes substantially<br />

to CT-colonography costs. Therefore we evaluate the<br />

feasibility of radiologic technologists in triaging screening<br />

CT-colonography for extracolonic findings.<br />

Method and materials: Eight technologists participated in<br />

a training program and subsequently reported extracolonic<br />

findings in 280 CT-colonography exams. The dataset<br />

contained 86 possibly (E3) and 30 probably important (E4)<br />

findings (C-RADS). The first and last 40 cases were identical<br />

examination cases. Feedback was given after each case<br />

from reference standard (the consensus read by two radiologists),<br />

except for the examination cases. Technologists<br />

reported lesion location and characteristics, C-RADS classification,<br />

need for a radiologist’s read and reading time.<br />

We constructed learning curves for correct scan and lesion<br />

triaging using a moving average technique.<br />

Results: For the final exam 70% of scans with E3 or E4<br />

findings were correctly triaged, while 30.5% of scans<br />

without E3 or E4 findings were incorrectly triaged. For the<br />

final exam technologists correctly identified and classified<br />

64.4%(67/104) of E3 and 67.5%(27/40) of E4 findings.<br />

This is an improvement, compared to the first exam, of<br />

33.6%(p0.05). The learning curve for<br />

E3 and E4 findings combined did not reach a plateau after<br />

280 cases. The technologists’ average reading time decreased<br />

from 11:51 to 4:13 minutes(p


Abdominale radiologie 2<br />

6<br />

Conclusion: A training program for radiologic technologists<br />

leads to an increased capability of triaging extracolonic findings<br />

at CT-colonography. The number of cases was too low<br />

to reach a sufficient competence.<br />

O6.3<br />

A RANDOMIZED CONTROLLED TRIAL<br />

COMPARING PARTICIPATION AND<br />

DIAGNOSTIC YIELD IN COLONOSCOPY AND<br />

CT-COLONOGRAPHY FOR POPULATION<br />

BASED COLORECTAL CANCER SCREENING<br />

(COCOS TRIAL)<br />

M.C. de Haan 1 , E. Stoop 2 , T.R. de Wijkerslooth 1 , P.M. Bossuyt 1 ,<br />

M. van Ballegooijen 2 , Y. Nio 1 , M.J. van de Vijver 1 , K. Biermann 2 ,<br />

M. Thomeer 2 , M.E. van Leerdam 2 , P. Fockens 1 , J. Stoker 1 ,<br />

E.J. Kuipers 2 , E. Dekker 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To compare participation rate and diagnostic yield<br />

of colonoscopy and CT-colonography screening in a RCT trial.<br />

Methods: A random selection of the Dutch population, aged<br />

50-75 years, was 2:1 randomized to colonoscopy or CTC<br />

for primary CRC screening. Participation rate was defined<br />

as number of invitees undergoing the examination divided<br />

by the total number of invitees. Colonoscopy was positive<br />

when advanced neoplasia (adenomas with a diameter ≥10<br />

mm, a ≥25% villous component, or high grade dysplasia or<br />

CRC) was detected; CTC when a lesion >5mm was found.<br />

Individuals with ≥1 lesions 6-9mm at CTC were offered<br />

surveillance CTC and colonoscopy was offered for lesions<br />

≥10mm. Diagnostic yield was calculated as number of<br />

advanced neoplasia per 100 invitees.<br />

Results: 1,276 of 5,923 colonoscopy invitees participated<br />

(22%) compared to 982 of 2,919 CTC invitees (34%)<br />

(p


6<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O6.5<br />

MR-COLONOGRAPHY WITH IODINE-<br />

TAGGED LIMITED BOWEL PREPARATION<br />

AND AUTOMATED CARBON DIOXIDE<br />

INSUFFLATION FOR COLONIC DISTENSION<br />

M.P. van der Paardt, F.M. Zijta, T.N. Boellaard, S. Bipat,<br />

A.J. Nederveen, J. Stoker<br />

Academisch Medisch Centrum, Amsterdam<br />

Introduction: To prospectively evaluate image quality and<br />

diagnostic accuracy of 3.0Tesla MR-colonography using<br />

iodine-tagged preparation and CO2 for bowel distension.<br />

Methods: 40 patients at increased risk for colorectal carcinoma<br />

underwent 3.0Tesla MR-colonography using iodinetagged<br />

bowel preparation and automated CO2 insufflation.<br />

Coronal FS 3D-T1-weighted SPGR were acquired in supine<br />

and prone position, 2D-T2-weighted SSFSE in supine<br />

position. Five parameters (Table) were assessed by two<br />

observers for 6 colon segments (240 segments/observer,<br />

480 segments/sequence). Wilcoxon-signed-rank test was<br />

used for comparison. MR-colonography results were compared<br />

with colonoscopy and sensitivity/specificity were<br />

assessed.<br />

Results: The amount of fecal residue was rated ‘0-25%<br />

of lumen filled’ in 66.9%(321/480) of the images. Overall,<br />

the consistency of the residue was scored ‘liquid’;<br />

93.3%(448/480).<br />

Supine distension was ‘adequate’ to ‘optimal’ in<br />

89.2%(428/480) segments on T1-weighted images<br />

and 90.4%(427/472; 8 missing values) on T2-weighted<br />

series. In the T1-weighted series distension was better in<br />

supine compared to prone position: 89.2%(428/480) versus<br />

74.1%(347/468; 12 missing values), p


Abdominale radiologie 2 6<br />

cases, Gd-EOB-DTPA (Primovist®) can be used, which is<br />

taken up by hepatocytes, if they are connected to biliary<br />

ducts, leading to hyperintensity in the hepatobiliary phase.<br />

However, thus far specific enhancement patterns of FNH<br />

have not been reported.<br />

Material and Methods: Retrospective evaluation was<br />

performed of 29 FNH lesions, imaged with MRI precontrast<br />

and after Gd-EOB-DTPA. MR examination consisted<br />

of precontrast T1 sequences, in and out of phase T1<br />

sequences, T1-weighted dynamic sequences after<br />

Gd-EOB-DTPA injection, T2-weighted sequences, Diffusion<br />

weighted imaging and T1 hepatobiliary phase after 10<br />

and 20 minutes.<br />

Results: Evaluation of 29 FNH lesions during the hepatobiliary<br />

phase yielded four types of enhancement: homogenous<br />

hyperintense 12/29 (41,4%), heterogeneous 3/29 (10,3%),<br />

hypointense with peripheral rim enhancement 5/29 (17,3%)<br />

and isointens to liver parenchyma 9/29 (31,0%). In all cases,<br />

enhancement patterns observed at 5 minutes persisted<br />

during 10 and 20 minutes post injection. Pathological examination<br />

demonstrated correlation of observed enhancement<br />

patterns with specific vascular and biliary duct distribution.<br />

Conclusion: In the hepatobiliary phase of the Gd-EOB-DTPA<br />

four different enhancement patterns were recognized in<br />

FNH. Pathological correlation suggests specific subtypes of<br />

FNH lesions.<br />

Figure 1: Four different enhancement patterns FNH.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

47


6<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O6.7<br />

MAGNETIC RESONANCE IMAGING<br />

FINDINGS CORRELATES WITH<br />

PATHOLOGICAL SUBTYPE CLASSIFICATION<br />

OF HEPATOCELLULAR ADENOMAS<br />

S.M. van Aalten, M.G.J. Thomeer, T. Terkivatan,<br />

R.S. Dwarkasing, J. Verheij, R.A. de Man, J.N.M. IJzermans<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To investigate the correlation between magnetic<br />

resonance imaging (MRI) findings and pathological subtype<br />

classification of hepatocellular adenoma (HCA) and to propose<br />

guidelines for follow-up and management.<br />

Methods: This retrospective study was approved by the<br />

institutional review board and the requirement for informed<br />

consent was waived. Seventy-one resected tumours previously<br />

diagnosed as HCA were classified based on pathological<br />

findings and immunohistochemical analysis: liver-fatty<br />

acid binding protein (L-FABP) negative HCA, inflammatory<br />

HCA, β-catenin positive HCA and unclassified HCA. The<br />

available MRI scans of 61 lesions (48 patients, median age<br />

36 years) were independently reviewed by two radiologists,<br />

thereafter consensus was obtained. Chi-square and Fishers’<br />

exact tests were performed for statistical analysis.<br />

Results: MRI signs of diffuse intratumoral fat deposition<br />

were present in 7 of 9 L-FABP-negative HCA compared to<br />

5 of 29 inflammatory HCA (P = 0.001). Steatosis within the<br />

non-tumoral liver was present in 11 of 29 inflammatory<br />

HCA compared to none L-FABP-negative HCA (P = 0.038). A<br />

characteristic ‘atoll’ sign was only seen in the inflammatory<br />

group (P = 0.027). Presence of a typical vaguely defined type<br />

of scar was seen in 5 of 7 β-catenin positive HCA<br />

(P = 0.003). No specific MRI features were identified for the<br />

unclassified cases.<br />

Conclusions: L-FABP-negative HCA, inflammatory HCA and<br />

β-catenin positive HCA were related to MRI signs of diffuse<br />

intratumoral fat deposition, an ‘atoll’ sign, and a typical<br />

vagely defined scar, respectively. Since β-catenin positive<br />

HCA are considered premalignant, closer follow-up with<br />

MRI or resection may be preferred.<br />

O6.8<br />

MAGNETIC RESONACE IMAGING FOR<br />

PREDICTING RESIDUAL DISEASE AFTER<br />

RADIOTHERAPY IN LOCALLY ADVANCED<br />

CERVICAL CANCER<br />

J.E. Mongula 1 , D. Lambregts 1 , R. Kruitwagen 2 , T. van Gorp 2 ,<br />

A .Kruse 2 , L. Lutgens 3 , R. Lalisang 2 , R. Vliegen 4 ,<br />

B.F. Slangen 2 , R. Beets-Tan 1<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

GROW, School for Oncology and Developmental Biology,<br />

Maastricht<br />

3<br />

Maastro clinic, Maastricht<br />

4<br />

Atrium Medisch Centrum, Heerlen<br />

Objective: To assess whether MRI is valuable for evaluating<br />

the presence of residual tumor after RT and which<br />

imaging criteria are the best predictors of response.<br />

Methods: 40 patients with histologically proven primary<br />

cervical cancer FIGO ≥1b were retrospective included, to<br />

date 20 out of 40 have been analyzed. Patients underwent<br />

MRI (standard T2-weighted FSE in 3 planes at 1.5T) before<br />

and 2-3 months after RT. An experienced gynaecologic radiologist<br />

scored the likelihood of residual tumor on post-RT MRI<br />

using a 5-point confidence level score based on assessment<br />

of isointens residual mass, hypointens fibrotic mass, border<br />

irregularity and nodular shape. The standard reference<br />

consisted of gynecological examination with biopsy and/or<br />

clinical follow-up. ROC curve analyses were performed to<br />

determine the performance for assessing residual tumor. The<br />

value of each imaging criterion was assessed.<br />

Results: 3/20 patients had residual disease. AUC for identification<br />

of residual tumor based on visual interpretation<br />

was 0,94; sensitivity 100%, specificity 88%. The individual<br />

imaging criteria resulted in AUCs of 0,94 (isointense mass),<br />

0,50 (hypointense mass), 0,67 (irregular border) and 0,70<br />

(nodular shape). The combination of an isointens nodular<br />

mass resulted in a AUC of 0,98, sensitivity 100%, specificity<br />

88%. Adding an irregular border in AUC of 1,00, sensitivity<br />

100%, specificity 100%<br />

Discussion: MRI can provide high accuracy for the assessment<br />

of residual tumor after RT in patients with locally<br />

advanced cervical carcinoma. The best imaging criteria to<br />

predict residual disease are the presence of an isointense<br />

residual mass with nodular shape and irregular borders.<br />

Use of these criteria could benefit the MR assessment of<br />

residual disease in daily clinical practice.<br />

48<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Sessie 7<br />

Kinderradiologie/Diversen 7<br />

Kinderradiologie/Diversen<br />

Vrijdag 30 september, 10.45 - 12.15 uur<br />

O7.1<br />

THE ROLE OF DYNAMIC CONTRAST<br />

ENHANCED MR ENTEROGRAPHY AS<br />

COMPARED TO ABDOMINAL ULTRASOUND<br />

IN DIAGNOSING INFLAMMATORY BOWEL<br />

DISEASE IN CHILDREN<br />

M.L.W. Ziech, T.Z. Hummel, A.M. Smets, C. Lavini,<br />

A. Kindermann, S. Bipat, A.J. Nederveen, M.W.A. Caan,<br />

J. Stoker<br />

Academisch Medisch Centrum, Amsterdam<br />

Purpose: Our purpose was to assess if dynamic contrast<br />

enhanced magnetic resonance imaging is useful as compared<br />

to ultrasound in diagnosing inflammatory bowel disease<br />

(IBD) in children.<br />

Method and materials: Consecutive consenting pediatric<br />

patients with suspected IBD were included. All patients<br />

underwent diagnostic work-up including ileo-colonoscopy<br />

and esophagogastroduodenoscopy under general anesthesia,<br />

MR enterography (800 ml sorbitol ingested in 3 hours<br />

as an small bowel and colonic intraluminal contrast agent,<br />

3T coronal dynamic contrast enhanced 3D T1-weighted<br />

sequence, temporal resolution 0.8 seconds) and<br />

abdominal ultrasound (including Doppler measurements of<br />

the superior and inferior mesenteric artery). At MRI maximum<br />

enhancement (ME) was calculated in a region of interest<br />

representing the terminal ileum, ascending, transverse<br />

and descending colon. Statistical analysis was performed<br />

with the Kruskall-Wallis test.<br />

Results: Eighteen paediatric patients were included (9<br />

males, 50%; mean age 14, range 10-18 years). Seven were<br />

diagnosed with ulcerative colitis (39%) and eight with<br />

Crohn’s disease (44%). Three patients had no IBD (17%).<br />

Fifteen patients underwent all modalities, three did not<br />

undergo ultrasound. Patients with Crohn’s disease had significantly<br />

larger wall thickness of the terminal ileum (p=0.037)<br />

measured with abdominal ultrasound. There were no differences<br />

between groups for all other segments and flow<br />

velocities. Mean ME at DCE-MRI did not differ significantly<br />

between the three groups (p=0.202).<br />

Conclusion: Wall thickness of the terminal ileum on abdominal<br />

ultrasound can be used for the diagnosing Crohn’s<br />

disease, but not for ulcerative colitis. There seems to be no<br />

role for DCE-MRI in children with suspected IBD.<br />

O7.2<br />

MINIMALLY INVASIVE MRI BY OMITTING<br />

INTRAVENOUS CONTRAST INJECTION;<br />

DOES IT CHANGE THE RADIOLOGIC<br />

ASSESSMENT OF KNEE JOINT PATHOLOGIES<br />

IN JIA?<br />

R. Hemke, M.A.J. van Rossum, M. van Veenendaal,<br />

T.W. Kuijpers, M. Maas<br />

Academisch Medisch Centrum, Amsterdam<br />

Purpose: MRI is the most preferred imaging modality in<br />

detecting joint pathologies in Juvenile Idiopathic Arthritis<br />

(JIA), despite practical limitations. Gadolinium (Gd) contrast<br />

use prolongs examination time, increases invasiveness and<br />

patient discomfort, and thereby reduces feasibility of MRI<br />

in JIA patients. Therefore, our objective is to evaluate if JIA<br />

joint pathologies can be reliably assessed by MRI<br />

without Gd injection compared with Gd-enhanced MRI as<br />

the reference.<br />

Methods: Data-sets (open-bore, 1.0T) of 46 JIA patients<br />

(mean age 12 years [range 4-18]) were prospectively scored<br />

twice by two experienced readers for the presence of knee<br />

joint pathologies. MRI features were evaluated using a<br />

literature-based assessment score, comprising synovial<br />

hypertrophy, bone marrow edema (BME), cartilage lesions<br />

and bone erosions. The first reading included unenhanced<br />

images (-Gd), whereas complete image sets were available<br />

for the second reading (+Gd).<br />

Results: Using +Gd MRI as the reference, sensitivity and<br />

specificity of -Gd MRI in the detection of BME (89%, 99%),<br />

cartilage lesions (73%, 100%) and erosions (100%, 99%)<br />

were high. Good -Gd and +Gd interreader agreements (ICC)<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

49


7<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

were found regarding BME (0.87, 0.88), cartilage lesion<br />

(1.00, 0.97) and bone erosion scores (0.90, 0.93). Regarding<br />

synovial hypertrophy scores, the specificity of -Gd MRI was<br />

98%, though the sensitivity was 60%. ICC for +Gd MRI was<br />

0.88, however omitting post-Gd acquisitions increased interreader<br />

variation (ICC=0.76).<br />

Conclusion: Omitting intravenous contrast is unimportant<br />

in the assessment of bone marrow edema, cartilage lesion<br />

and bone erosion scores in knees of JIA patients, but decreases<br />

the reliability of synovial hypertrophy scores.<br />

O7.3<br />

ULTRASOUND TO PREDICT SIGNIFICANT<br />

HEPATIC STEATOSIS IN OBESE<br />

ADOLESCENTS: POOR POST-TEST<br />

PROBABILITY DESPITE ACCEPTABLE<br />

SENSITIVITY AND SPECIFICITY<br />

A.E. Bohté 1 , B.G. Koot 1 , A.J. Nederveen 1 ,<br />

O.H. van der Baan-Slootweg 2 , S. Bipat 1 , T.H. Pels Rijcken 3 ,<br />

P.L.M. Jansen 1 , M.A. Benninga 1 , J. Stoker 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Heideheuvel Kliniek, Hilversum<br />

3<br />

Tergooiziekenhuizen, Hilversum<br />

Purpose: to evaluate the post-test probability of ultrasound<br />

(US) for the prediction of hepatic steatosis (HS) in a severely<br />

obese adolescent population with 1 H-MRS as reference<br />

standard.<br />

Methods: HS was prospectively evaluated in 113 obese<br />

adolescents with US and 1 H-MRS. For US, HS was<br />

graded semi-quantitatively as 0:none, 1:mild, 2:moderate,<br />

3:severe). 1 H-MR spectra were acquired with a PRESS<br />

sequence in a voxel of 8cm3 at 3T. The fat fraction (FF) was<br />

calculated as: total fat peak area/reference water peak area.<br />

HS was defined as a FF>1.8% and US score ≥1. Moderate/<br />

severe HS as a FF>7.7% and US score ≥2. Sensitivity and<br />

specificity for both thresholds were calculated. Based on<br />

these values the negative and positive post-test probabilities<br />

were determined and plotted against the prevalence of HS.<br />

Results: Mean age was 14.1y; mean BMI was 38.3 kg/m2.<br />

The overall prevalence of HS was 0.45 (95%CI:0.36-0.54)<br />

with a sensitivity of 0.84 (0.78-0.91) and a specificity of 0.55<br />

(0.46-0.64) for US grade ≥1. The prevalence of moderate/<br />

severe HS was 0.14 (0.08-0.21) with a sensitivity of 0.75<br />

(0.67-0.83) and a specificity of 0.87(0.80-0.93) for US grade<br />

≥2. The positive and negative post-test probabilities are<br />

plotted in fig.1 for both threshold values. The positive posttest<br />

probabilities were low: 0.61 for US grade ≥1 and 0.48<br />

for grade ≥2. Negative post-test probabilities (1-NPV) were<br />

adequate: 0.19 and 0.05 respectively.<br />

Discussion: The positive post-test probability of US for HS<br />

was poor. This implies that the applicability of US to predict<br />

HS in the individual obese adolescent is limited.<br />

Figure 1<br />

50<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Kinderradiologie/Diversen 7<br />

O7.4<br />

RESPIRATORY DISEASE IN PAEDIATRIC<br />

ALLOGENEIC HEMATOPOIETIC STEM<br />

CELL TRANSPLANT (HSCT) RECIPIENTS:<br />

COULD A HIGH-RESOLUTION COMPUTED<br />

TOMOGRAPHY (HRCT) SCORE AID IN<br />

DIAGNOSIS?<br />

P.A. de Jong, A.B. Versluys, J.J. Boelens, F.J.A. Beek<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Background: HSCT can be complicated by a variety of<br />

live-threatening infectious and non-infectious pulmonary<br />

complications, but much overlap appears to be present in<br />

HRCT features of these complications.<br />

Aims: To assess observer agreement of a HRCT-score for<br />

typical post-HSCT abnormalities and to determine whether<br />

this HRCT-score can differentiate between infectious and<br />

non-infectious diseases.<br />

Methods: Following protocol paediatric HSCT-recipients<br />

undergo HRCT when respiratory symptoms occur or when<br />

infection is suspected for which chest radiography demonstrates<br />

no obvious cause. Forty-five consecutive disease<br />

episodes in 45 children were studied. HRCT were scored for<br />

severity per lobe (maximum score 18) by two blinded independent<br />

radiologists for various airway and parenchyma/<br />

interstitial abnormalities. Clinical diagnosis was established<br />

by an expert HSCT-physician based on all available information<br />

including follow-up. Possible diagnoses were; pulmonary<br />

infection, early alloimmune lung disease (0.80)<br />

for consolidation and composite<br />

HRCT-score and moderate (intraclass-correlation 0.60-0.79)<br />

for bronchiectasis, tree-in-bud, nodules, ground glass and<br />

expiratory air trapping. The prevalence of abnormalities<br />

largely overlapped between infectious and non-infectious<br />

complications, but alloimmune lung disease was associated<br />

with significantly higher composite HRCT-score (both early<br />

and late), ground glass HRCT-score (early) and air trapping<br />

HRCT-score (late, Figure 1) when compared to infectious<br />

disease.<br />

Conclusion: Our data suggest that the severity of certain<br />

HRCT abnormalities aids in the differentiation between<br />

infectious and non-infectious complications in pediatric<br />

HSCT recipients. The role of the HRCT-score in HSCTrecipients<br />

needs confirmation in an independent study.<br />

Figure 1: Two patients with alloimmune lung disease.<br />

O7.5<br />

OVERCONSUMPTIE VAN RÖNTGEN-<br />

DIAGNOSTIEK BIJ KINDEREN NA<br />

POLSTRAUMA; DE NOODZAAK VAN EEN<br />

KLINISCHE BESLISREGEL<br />

A. Slaar 1 , A. Bentohami 1 , M.W. Walenkamp 1 ,<br />

B.A. van Dijkman 2 , T.S. Bijlsma 3 , M. Maas 1 , J.C.H. Wilde 1 ,<br />

N.W.L. Schep 1 , J.C. Goslings 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Flevoziekenhuis, Almere<br />

3<br />

Spaarne Ziekenhuis, Hoofddorp<br />

Acuut polsletsel bij kinderen is een van de meest <strong>voor</strong>komende<br />

redenen van een bezoek aan de spoedeisende hulp.<br />

In de meeste ziekenhuizen wordt routinematig een<br />

Röntgenfoto gemaakt van de pols. Echter, een groot aantal<br />

van de Röntgenfoto’s laat geen afwijkingen zien.<br />

Doel: onderzoeken welk percentage van de aangevraagde<br />

röntgenfoto’s met de vraagstelling fractuur ook daadwerkelijk<br />

een fractuur liet zien bij kinderen met polsletsel.<br />

Gegevens van de kinderen (3 tot en met 16 jaar oud) die zich<br />

van 1 september 2009 tot 1 september 2010 presenteerden<br />

op de spoedeisende hulp van een ziekenhuis, waarvan een<br />

röntgenfoto van de pols werd gemaakt met de vraagstelling<br />

polsfractuur, werden geanalyseerd. Van deze patiënten werden<br />

de demografische gegevens, het traumamechanisme,<br />

aanwezigheid van een fractuur en fractuurtype verzameld.<br />

309 patiënten konden worden geanalyseerd. De gemiddelde<br />

leeftijd bedroeg 11.20 (SD=3.1); 153 waren jongens. 77%<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

51


7<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

van de patiënten was gevallen, 33% van de kinderen waren<br />

gevallen tijdens spelen.<br />

Slechts 50 % van de röntgenfoto’s liet een polsfractuur zien.<br />

Bij 34% van deze patiënten bedroeg het een torus fractuur,<br />

17% een radius fractuur, 13% een greenstick fractuur, 15%<br />

een antebrachii fractuur, bij 19% een Salter Harris type 2<br />

fractuur, resterende fracturen 2%.<br />

Conclusie: De helft van de röntgenfoto’s van kinderen na<br />

een polstrauma liet geen fractuur gezien. Deze overconsumptie<br />

van röntgendiagnostiek leidt tot onnodige wachttijden,<br />

onnodige stralenbelasting bij kinderen, en onnodige<br />

kosten.<br />

Derhalve is er behoefte aan een klinische beslisregel analoog<br />

aan de Ottowa Ankle rules. Deze Amsterdam Wrist<br />

Rules zijn op dit moment in ontwikkeling.<br />

O7.6<br />

STRALING DOOR CT SCANS BIJ KINDEREN<br />

EN HET RISICO OP KANKER: EEN<br />

EPIDEMIOLOGISCHE STUDIE<br />

M. Hauptmann 1 , A.M. Smets 2 , M. van Herk 1 ,<br />

R.A.J. Nievelstein 3 , J.S. Laméris 2 , C.M. Ronckers 2,4<br />

1<br />

Nederlands Kanker Instituut, Amsterdam<br />

2<br />

Academisch Medisch Centrum, Amsterdam<br />

3<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

4<br />

Stichting Kinderoncologie Nederland, Den Haag<br />

Computer tomografie (CT) scans gaan gepaard met hogere<br />

stralingsdoses dan conventionele beeldvormende technieken.<br />

Omdat het gebruik van CT gestaag stijgt is het van<br />

belang ongewenste neveneffecten goed in kaart te brengen,<br />

in het bijzonder het ontstaan van kanker. Kinderen vormen<br />

een extra kwetsbare groep omdat zij gevoeliger zijn dan<br />

volwassenen <strong>voor</strong> de schadelijke gevolgen van ioniserende<br />

straling en omdat zij een lange levensverwachting hebben<br />

waardoor er een grotere kans is dat negatieve bijwerkingen<br />

tot uiting kunnen komen. Er is op dit moment echter geen<br />

direct empirisch bewijs <strong>voor</strong> een verband tussen CT scans<br />

en kanker.<br />

Wij beschrijven de opzet van een Nederlands retrospectief<br />

cohortonderzoek als onderdeel van een groot multinationaal<br />

samenwerkingsverband. Het onderzoek heeft als doel om<br />

(1) het gebruik van CT scans bij kinderen in Nederland te<br />

beschrijven en (2) het verband tussen CTgerelateerde stralingsdosis<br />

en het risico op kanker (<strong>voor</strong>namelijk leukemie) te<br />

kwantificeren. De methoden van dataverzameling zijn getest<br />

in een pilot-studie en geoptimaliseerd. De beoogde studie<br />

betreft circa 100.000 mensen die in de periode 1999-2010<br />

op kinderleeftijd (0-17 jaar) één of meerdere CT scans hebben<br />

gehad in Nederland. De cohortleden worden geïdentificeerd<br />

en de dosis zal worden geschat op basis van elektronische<br />

archieven (RIS, PACS) van de afdelingen (kinder)<br />

radiologie van deelnemende ziekenhuizen. Follow-up <strong>voor</strong><br />

incidente gevallen van kanker zal via de <strong>Nederlandse</strong> Kanker<br />

Registratie (NKR) gaan. Voorbereidingen <strong>voor</strong> de dataverzameling<br />

zijn dit <strong>voor</strong>jaar van start gegaan, in nauwe samenwerking<br />

met de <strong>Nederlandse</strong> <strong>Vereniging</strong> <strong>voor</strong> <strong>Radiologie</strong> en<br />

de radiologie afdelingen van <strong>Nederlandse</strong> ziekenhuizen.<br />

O7.7<br />

LONGITUDINAL IN VIVO IMAGING OF<br />

GD-LABELED MSCS AND OPTIMIZATION OF<br />

LABELING STRATEGY<br />

J. Guenoun, G.A. Koning, P.A. Wielopolski, G. Doeswijk,<br />

G.P. Krestin, M.R. Bernsen<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: Optimizing the labeling of mesenchymal stem<br />

cells with Gd-liposomes for sensitive, longitudinal cell tracking<br />

in vivo.<br />

Materials and methods: Gd-DTPA was incorporated<br />

in liposomes. Rat mesenchymal stem cells were labeled<br />

with liposomes containing various Gd-dosages, for various<br />

labeling times. Cellular Gd load, cellular toxicity, cell proliferation<br />

rate and cell differentiation were then determined<br />

for the different conditions. Intracellular retention of Gd<br />

was assessed (20d). Intracellular fate of Gd-liposomes was<br />

imaged with confocal microscopy, using intraliposomal fluorescent<br />

dyes. MRI of MSCs was performed on a 1.5T<br />

and 3.0T clinical scanner. Cells were transplanted in rat<br />

skeletal muscle and imaged for 3 weeks in vivo. At several<br />

time-points histology was performed to correlate to MRI<br />

findings. Statistical tests: one-way ANOVA, with Bonferroni<br />

post-hoc test.<br />

Results: Labeling for 4h with 125 µM lipid is most<br />

preferred, combining time-efficiency with sufficient cellular<br />

Gd uptake (30±2.5 pg Gd cell-1), lacking significant<br />

effects on cell viability, proliferation and differentiation.<br />

Gd-liposomes were well retained intracellularly in endosomes.<br />

Gd-liposome labeled MSCs were visualized at 1.5T and<br />

3.0T both in vitro and in vivo. At least 10.000 Gd-MSCs were<br />

detected. Histology showed cellular incorporated liposomes<br />

at the site of injection. Prolonged in vivo imaging of 500,000<br />

Gd-labeled cells was possible for at least two weeks (3.0T).<br />

Conclusion: Gd-loaded liposomes are suitable for cell<br />

labeling, without detrimental effects on cell viability, proliferation<br />

and differentiation allowing sensitive and longitudinal<br />

visualization by MRI.<br />

52<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Kinderradiologie/Diversen 7<br />

Figure 1<br />

O7.8<br />

CELLULAR IMAGING: IN VIVO ASSESSMENT<br />

OF GD- OR SPIO-LABELED CELL GRAFT<br />

VIABILITY, COMBINING MRI AND<br />

BIOLUMINESCENCE IMAGING<br />

J. Guenoun, A.R. Ruggiero, G. Doeswijk, G.A. Koning,<br />

G.P. Krestin, M.R. Bernsen<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: Using MRI mapping techniques to determine<br />

possible differences in R1, R2 or R2* relaxation rate of<br />

viable and non-viable transplanted rMSCs, labeled with Gd<br />

or SPIO .<br />

Using bioluminescence imaging to link changes in R1, R2 or<br />

R2* to cell viability.<br />

Materials and methods: Study type: experimental longitudinal<br />

follow up.<br />

Gd-DTPA was intraliposomal incorporated. Rat mesenchymal<br />

stem cells (rMSCs), expressing firefly luciferase, were labeled<br />

with SPIO or Gd-liposomes. Cells were divided in a viable<br />

and non-viable fraction (non-viable cells were acquired<br />

by repeated freeze-thawing). For in vivo studies, 5x105<br />

viable or non viable rMSCs were injected intramuscular and<br />

imaged with MRI and BLI at days 2, 5, 10, 15. T1, T2 and<br />

T2* mapping was performed on 3T. At end-point animals<br />

were sacrificed for immunofluorescent staining.<br />

Results: Irrelevant MRI signal from non-viable Gd-MSCs<br />

disappeared quickly (


7<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Figure 1<br />

54<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Sessie 8<br />

Mammadiagnostiek 2 8<br />

Mammadiagnostiek 2<br />

Vrijdag 30 september, 10.45 - 12.15 uur<br />

O8.1<br />

EVALUATIE IN TIJD EN ACCURATESSE<br />

VAN CORONALE BEOORDELING VERSUS<br />

CORONALE, SAGITTALE EN AXIALE<br />

VLAKKEN BIJ AUTOMATED BREAST<br />

VOLUME SCANNING<br />

M.D.F. de Jong, G.J. Jager, I.J.M. Dubelaar, T.A. Fassaert,<br />

M.J.C.M. Rutten<br />

Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

Doel: Borstkankerscreening middels mammografie is een<br />

effectieve manier van screenen om de sterfte aan boorstkanker<br />

te verlagen. Echter de sensitiviteit wordt lager naarmate<br />

densiteit van het borstweefsel toeneemt. Automated breast<br />

volume scanning (ABVS) kan worden ingezet als toegevoegde<br />

screeningsmodaliteit. Voorafgaand hieraan zullen de testeigenschappen<br />

(hoge sensitiviteit en laag aantal fout negatieven)<br />

geëvalueerd moeten worden. Voordat implementatie in<br />

een screenings<strong>programma</strong> mogelijk is, zal ook het gebruiksgemak<br />

en beoordelingstijd geëvalueerd moeten worden.<br />

Materiaal & methode: Van 50 ABVS scans werden eerst<br />

de coronale reconstructies beoordeeld volgens de BI-RADS<br />

criteria. Ieder onderzoek betrof 3 a 5 scans per borst. Aantal<br />

en locatie van elke laesie en beoordelingstijd werd genoteerd.<br />

Daarna werden de drie richting scans beoordeeld en<br />

vergeleken met de coronale.<br />

Resultaten: Als proof of principal werden 9 patiënten<br />

beoordeeld tot nu, resulterend in 59 scans van 17 borsten.<br />

Er was geen verschil in BI-RADS classificatie en de<br />

drie vlakken beoordeling detecteerde vier extra cysten.<br />

Beoordelingstijd bedroeg bij de coronale evaluatie 28,1<br />

seconden in vergelijking met 96,0 seconden met drie vlakken,<br />

hetgeen een factor 3,4 bedraagt.<br />

Conclusie: Voorlopige resultaten tonen een goede overeenkomst<br />

tussen de twee manieren van beoordelen, waarbij er<br />

aanzienlijke tijdwinst te behalen valt met de coronale scan<br />

beoordeling. Dit kan belangrijk zijn als ABVS als screeningsmodaliteit<br />

ingezet gaat worden.<br />

O8.2<br />

OPBRENGST VAN HERHAALDE VERWIJZING<br />

NA EEN EERDERE FOUT POSITIEVE<br />

SCREENINGSMAMMOGRAFIE<br />

W. Setz-Pels 1 , L.E. Duijm 1 , A.C. Voogd 2<br />

1<br />

Catharina Ziekenhuis, Eindhoven<br />

2<br />

Universiteit Maastricht, Maastricht<br />

Doel: Bepaling van de screeningsuitkomsten van vrouwen<br />

die opnieuw zijn verwezen <strong>voor</strong> een laesie welke na een<br />

eerdere verwijzing als fout positief is afgegeven.<br />

Methoden: We includeerden alle 424703 screeningsonderzoeken,<br />

welke van 1995 t/m 2009 bij 2 screeningseenheden<br />

waren gemaakt. Van alle 5676 verwijzingen werd na 1 jaar,<br />

middels de verslagen van radiologische, chirurgische en<br />

PA-bevindingen in het natraject, vastgesteld of er al dan niet<br />

sprake was van borstkanker. Bij 61 van de 147 vrouwen, die<br />

na een eerdere fout-positieve verwijzing <strong>voor</strong> een tweede<br />

keer waren verwezen, werd middels de screeningsfoto’s<br />

en notities van de screeningsradiologen vastgesteld dat de<br />

reden <strong>voor</strong> herhaalde verwijzing dezelfde laesie betrof.<br />

Resultaten: Bij 2180 verwezen vrouwen was sprake van<br />

borstkanker (5,1 borstkankers per 1000 screens, positief<br />

<strong>voor</strong>spellende waarde van verwijzing (PVW): 38,4%, 95%<br />

betrouwbaarheids-interval 37,1%-39,7%). Bij 22 van de<br />

61 vrouwen, opnieuw verwezen <strong>voor</strong> dezelfde laesie<br />

na een eerdere fout positieve screen, werd borstkanker<br />

vastgesteld (PVW 36,1%, 95% betrouwbaarheids-interval<br />

23,7%-48,5%). Bij 4 van deze 22 borstkankers betrof het<br />

een advanced cancer (invasief carcinoom >20 mm en/of<br />

lymfkliermetastasen). De vertraging in borstkanker diagnose<br />

varieerde van 21 tot 92 maanden (gemiddeld 42,5 maanden)<br />

en 9 vrouwen (40.9%) waren tenminste 1 keer gescreend<br />

(en niet verwezen) tussen de eerste, ten onrechte fout positieve<br />

verwijzing, en de tweede verwijzing.<br />

Discussie: Bij een belangrijk percentage vrouwen die<br />

opnieuw wordt verwezen <strong>voor</strong> dezelfde laesie, is sprake<br />

van borstkanker. Verder onderzoek is vereist om te bepalen<br />

welke factoren in het natraject en in de screening leiden tot<br />

een vertraging in de diagnose borstkanker.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

55


8<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O8.3<br />

RESPONSE EVALUATION OF NEOADJUVANT<br />

CHEMOTHERAPY IN MAMMACARCINOMA:<br />

ASSOCIATION OF CHANGES IN MRI<br />

DYNAMIC GADOLINEUM ENHANCEMENT<br />

AND DIFFUSION WEIGHTED IMAGING (DWI)<br />

V.H.P. Tran, M.H.M. Volmerink, A.L.T. Imholz,<br />

R.A.J.M. van Dijk<br />

Deventer Ziekenhuis, Deventer<br />

Background: Monitoring tumour response in neoadjuvant<br />

chemotherapy in mammacarcinoma is based on MRI dynamic<br />

gadolineum enhancement. However, the role of DWI in<br />

tumour response monitoring remains to be established.<br />

Methods: In this retrospective study, (changes in) apparent<br />

diffusion coefficient (ADC) after three cycles of neoadjuvant<br />

chemotherapy in 29 consecutive patients treated in our hospital<br />

between 2006 and 2010 were compared to changes<br />

in tumour size measured by RECIST, cross sectional area of<br />

tumour (both early enhancement), and diameter of gadolineum<br />

washout.<br />

Results: Following chemotherapy, ADC increased from<br />

1,44*10 -3 mm 2 /sec (SD0,37*10 -3 ) to 1,69*10 -3 mm 2 /sec<br />

(SD0,40*10 -3 ; Student’s t-test p


Mammadiagnostiek 2 8<br />

MRI was performed on a 7T whole-body scanner (Philips<br />

Health Care, Cleveland, USA) using a two-channel doubletuned<br />

unilateral RF breast coil. The protocol included a dynamic<br />

series consisting of 7 consecutive 3D T1-weighted Turbo<br />

Field Echo scans with fat suppression by means of selective<br />

water excitation [TR/TE 5.0/2.0ms, binominal FA 20˚, FOV<br />

160x160x160mm 3 , acquired resolution<br />

1mm isotropic, temporal resolution of 63seconds]; and a<br />

high resolution T1-weighted 3D Fast Field Echo Spectral<br />

Selection Attenuated Inversion Recovery sequence [acquired<br />

resolution 0.45x0.57x0.45mm 3 ]. After the 1st dynamic scan<br />

0.1mmol/kg Gadobutrol was injected.<br />

Lesions were assessed according to ACR BI-RADS-MRI criteria.<br />

Results were compared to histopathology.<br />

Results: The exams were technically successful. Lipid suppressed<br />

sequences showed good lesion-and-fibroglandulartissue<br />

to fat contrast. All lesions were masses of irregular<br />

shape. Margins were spiculated in 4 and irregular in 1.<br />

Enhancement was heterogeneous in 3, homogeneous in<br />

1 and rim type in 1. In 4 lesions the kinetic curve showed<br />

rapid-rise, followed by wash-out: type-3 curve. 1 lesion showed<br />

rapid-rise followed by a plateau-phase: type-2 curve.<br />

All lesions were categorized BI-RADS V. Histopathology<br />

showed 3 ductulolobular and 2 ductal carcinomas.<br />

Conclusion: CE Breast MRI at 7T is technically feasible.<br />

The exams were amenable to BI-RADS-MRI conform analysis,<br />

allowing for future intra-individual comparison between<br />

7T and 3T.<br />

Figure 1: X-ray mammography and 7T CE-MRI results<br />

obtained from a 62 year old patient.<br />

a) X-ray mammography (Cranio-Caudal view, rotated to correspond<br />

to the MRI orientation), showed a BI-RADS V lesion (circle).<br />

b) Pre-contract T1 weighted MRI (voxel size 1x1x2mm3) showed a<br />

irregular mass.<br />

c) After administration of contrast agent the mass showed heterogeneous<br />

enhancement (T1w imaging, voxel size 1x1x2mm3)<br />

d) High resolution T1w SPAIR (voxel size 0.45x0.45x0.57mm3) showed<br />

good fat suppression and fine morphological details.<br />

e) The most malignant curve (squares) shoed a rapid initial rise, followed<br />

by a plateau in the delayed phase. The average curve showed<br />

a similar “tpe-2” pattern (triangles).<br />

O8.6<br />

DE INVLOED VAN MRI OP HET BELEID EN<br />

DE UITKOMST VAN PATIËNTEN MET EEN<br />

INVASIEF LOBULAIR MAMMACARCINOOM<br />

J.P. Pennings, R. Storm, R. Rozendaal, R.H.C. Bisschops<br />

Albert Schweitzer ziekenhuis, Dordrecht<br />

Doel: Preoperatieve MRI is een onderdeel van de<br />

EU-richtlijnen bij het beleid van het invasieve lobulaire carcinoom<br />

(ILC), vanwege de permeatieve groei, frequent gerapporteerd<br />

multifocaal en multicentrisch <strong>voor</strong>komen (32%) en<br />

contralaterale laesies (7%). In deze retrospectieve studie<br />

is gekeken of er verschil is in de chirurgische behandeling<br />

sinds het invoeren van een preoperatieve MRI.<br />

Methode: Tussen januari 2007 en maart 2011 werden 117<br />

patiënten met een histologisch bewezen ILC geïncludeerd.<br />

49 (42%) patiënten onderging sinds het invoeren van de<br />

richtlijn in 2008 een MRI, van wie 5 postoperatief. Alle<br />

patiënten werden behandeld conform de geldende richtlijnen.<br />

De volgende primaire uitkomstmaten werden vergeleken:<br />

contralaterale bevindingen, chirurgische behandeling,<br />

irradicaliteit en heroperaties.<br />

Resultaten: Tussen de patiënten met (n= 49) en zonder<br />

(n=68) een MR mammografie zijn geen significant verschillen<br />

in patiëntkarakteristieken, bevindingen op X-mammagram<br />

of echografie. In beide groepen werd één contralaterale<br />

tumor gevonden, echter geen ILC maar een ductaal adeno-<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

57


8<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

carcinoom. In de MRI groep toonde 14 (28%) patiënten een<br />

multifocale of een multicentrische laesie. Bij acht patiënten<br />

werd een additionele benigne contralaterale laesie gevonden<br />

met de MRI. Er is geen significant verschil in chirurgische<br />

behandeling tussen de twee groepen, 19 (39%) patiënten<br />

met MRI en 18 (27%) patiënten zonder MRI ondergingen<br />

een lumpectomie. Er zijn ook geen significante verschillen<br />

tussen de MRI groep en de niet-MRI groep in irradicaliteit<br />

(18% vs. 12%) en het aantal heroperaties (14% vs. 4%).<br />

Discussie: Er werd geen contralaterale ILC gevonden.<br />

Preoperatieve MRI liet geen significant verschil zien in chirurgische<br />

behandeling in de door ons onderzochte populatie.<br />

O8.7<br />

MOLECULAR OPTICAL IMAGING USING<br />

AN ORGANIC FLUOROPHORE AND A<br />

CLINICAL FLUORESCENCE DIFFUSE OPTICAL<br />

TOMOGRAPHY SYSTEM - EXTENSIVE<br />

PHANTOM EXPERIMENTS<br />

A. Adams 1 , J.E.M. Mourik 2 , M. van der Voort 3 ,<br />

W.P.Th.M. Mali 1 , S.G. Elias 1<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Leids Universitair Medisch Centrum, Leiden<br />

3<br />

Philips Research, Eindhoven<br />

Purpose: Fluorescence Diffuse Optical Tomography (FDOT)<br />

is an emerging clinical breast imaging modality. To estimate<br />

Limits of Detection (LOD) of a clinical FDOT breast system<br />

(Philips, The Netherlands), phantoms filled with the clinical<br />

grade available near-infrared organic fluorophore IRDye800CW<br />

(Licor, Lincoln, NE) were scanned in various situations.<br />

Methods: Phantoms (0.9cm 3 , 2.1cm 3 ) were filled with<br />

IRDye800CW and suspended in optical matching fluid (with<br />

optical properties of average breast tissue) at a center and<br />

an edge position in a medium sized breast cup (±500cm 3 ).<br />

Relative (1-120:0, 1-6:1) and absolute (2-20nM) phantom-tobackground<br />

concentration differences were assessed. Threedimensional<br />

fluorescence images (excitation: 730nm; filters:<br />

>750nm) were obtained twice on different days. Average<br />

signal intensities were determined on reconstructed images<br />

for volumes matching the sizes and locations of the phantoms.<br />

Regression lines were fitted and LOD were estimated<br />

(LOD=(s B<br />

/β)*k n<br />

; s B<br />

: standard deviation of measurements of<br />

blanks; β: slope of regression line; kn: coverage factor (3.13<br />

for duplicate measurements and five measurements of<br />

blanks to reach a type-1 error of 1%)). Pearson’s correlationcoefficients<br />

and between-day reproducibility were calculated.<br />

Results: The LOD ranged from 0.1nM to 2.3nM for the different<br />

situations. The fluorescent signal was very well linearly<br />

correlated with concentration differences (R 2 : 0.95-1.00); between-day<br />

reproducibility was excellent (intraclass-correlation:<br />

0.93-0.99). Differences in regression line slopes were observed<br />

for the two phantoms and locations but did not affect the LOD.<br />

Conclusion: Limits of Detection of the Fluorescence Diffuse<br />

Optical Tomography system for IRDye800CW are in the lownanomolar<br />

range for relevant situations. Upcoming clinical<br />

studies with this system and this fluorophore are feasible.<br />

This research was supported by the Center for Translational<br />

Molecular Medicine (MAMMOTH).<br />

Figure 1: The clinical Fluorescence Diffuse Optical Tomography<br />

(FDOT) breast imaging system. (Philips, The Netherlands)<br />

Table 1<br />

58<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Mammadiagnostiek 2 8<br />

Figure 2<br />

O8.8<br />

CORRELATIE VAN GEBIOPTEERDE<br />

MICROCALCIFICATIES IN DE MAMMAE MET<br />

DE INITIËLE BI-RADS CODERING; ANALYSE<br />

EN HERBEOORDELING VAN BI-RADS 3<br />

CALCIFICATIES<br />

K.J. Kraal, J.J. Hensen, A.C. Sikkenk, J. Nijman, R.A. Niezen,<br />

D. Vroegindeweij<br />

Maasstad Ziekenhuis, Rotterdam<br />

Doel: evaluatie en justificatie van stereotactisch gebiopteerde<br />

microcalcificaties in de mammae en vergelijking van<br />

de initiële en gereviseerde BI-RADS codering.<br />

Methode: retrospectieve analyse van de in de periode<br />

2007-2009 stereotactisch gebiopteerde microcalcificaties.<br />

Per mammabiopt werd de oorspronkelijke BI-RADS codering<br />

vergeleken met de PA-uitslag.<br />

De BI-RADS 3 groep (42 biopten) werd <strong>voor</strong> herbeoordeling<br />

<strong>voor</strong>gelegd aan een ervaren mammaradioloog (A) en een<br />

ouderejaars assistent (B), zonder kennis van de oorspronkelijke<br />

codering maar met kennis van de oorspronkelijke klinische<br />

informatie en ondergane stereotaxie. Maligne werd<br />

gedefinieerd als BIRADS 4 en 5.<br />

Bij herevaluatie van de oorspronkelijke BI-RADS 3 codering,<br />

ivm te hoog percentage maligniteit, ontstond een spreiding<br />

naar andere coderingen waarbij 44% een BI-RADS code 2<br />

of 3 en 56% code 4 of 5 kregen. Beoordelaar A en B bereikten<br />

een sensitiviteit van 86%, resp. 57 % en een positief<br />

<strong>voor</strong>spellende waarde van 25%, resp. 17 % <strong>voor</strong> de maligne<br />

microcalcificaties.<br />

Conclusie: van de stereotactische biopten in verband met<br />

microcalcificaties bleek 26% maligne. De oorspronkelijke<br />

codering laat een te hoog percentage maligne microcalcificaties<br />

met oorspronkelijke BI-RADS 3 codering zien.<br />

Bij herbeoordeling ontstaat een significante verschuiving van<br />

code 3 naar een hogere codering en een betere correlatie<br />

met de PA.<br />

De meest ervaren beoordelaar haalt bij herbeoordeling de<br />

hoogste sensitiviteit en PVW <strong>voor</strong> maligne microcalcificaties.<br />

Resultaten: van 236 biopten bleek 74% benigne en 26%<br />

maligne. Respectievelijk 0% van de BI-RADS 2-, 16% van de<br />

BI-RADS 3-, 26% van de BI-RADS 4- en 88% van de BIRADS<br />

5 gecodeerde microcalcificaties waren maligne.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

59


8<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O8.9<br />

TRENDS IN INCIDENCE AND DETECTION<br />

OF ADVANCED BREAST CANCERS AT<br />

BIENNIAL SCREENING MAMMOGRAPHY:<br />

A POPULATION BASED COHORT STUDY<br />

J. Nederend, F.H. Jansen, L.E.M. Duijm<br />

Catharina Ziekenhuis, Eindhoven<br />

Purpose: To determine trends in incidence of advanced<br />

breast cancer (ABC) at screening mammography and determine<br />

the potential of reducing ABC at screening.<br />

Methods and Materials: We included all 351,009 biennial<br />

screening mammograms obtained in a Dutch breast<br />

cancer screening region between 1997-2009. Two screening<br />

radiologists reviewed screening mammograms of all advanced<br />

screen detected cancers (SDCs) and advanced interval<br />

cancers (ICs) and determined whether the ABC (defined as<br />

>T2-tumour and/or axillary lymph node positive tumour) had<br />

been visible at the previous screen (SDC) or latest screen<br />

(IC). Outcome measures were the proportions of ABCs<br />

among SDCs and ICs through the years and the potential of<br />

detecting SDCs and ICs at an earlier stage.<br />

Results: The incidence of ABC did not decline through the<br />

years and fluctuated annually from 28.7% to 35.4% (mean<br />

32.2%, 571/1773 among SDCs and from 52.0% to 68.1<br />

% (mean 63.4%, 424/669) among ICs. Of the 571 screen<br />

detected ABCs, 106 (18.6%) were detected at the initial<br />

screen, respectively 266 (46.6%) and 88 (15.4%) were either<br />

not visible or showed a minimal sign at the previous screen<br />

and 111 (19.4%) had been missed at the previous screen.<br />

Advanced ICs were either not visible at the latest screen or<br />

showed a minimal sign in respectively 50.9% (216/424) and<br />

24.3% (103/424) of cases, whereas 25.1% (105/394) had<br />

been missed at screening.<br />

Conclusions: No decline in ABC was observed during 12<br />

years of biennial screening mammography. A majority of<br />

ABCs cannot be prevented through earlier breast cancer<br />

detection at screening.<br />

O8.10<br />

THE VALUE OF BLUE DYE FOR DETECTING<br />

THE SENTINEL LYMPH NODE IN BREAST<br />

CANCER PATIENTS IN ADDITION TO<br />

LYMPHOSCINTIGRAPHY<br />

M.A. Korteweg, J.D. van Amstel, M. Hobbelink,<br />

B.L. Stehouwer, M.A.A.J. van den Bosch, A.J. Witkamp,<br />

P.J. van Diest, W.P.Th.M. Mali, W.B. Veldhuis<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Background: Sentinel lymph node biopsy (SLNB) is<br />

performed for axillary staging of breast cancer patients by<br />

blue dye injection, lymphoscintigraphy or combining both<br />

techniques. This study assesses the added value of blue dye<br />

for sentinel lymph node (SLN) detection in comparison to<br />

lymphoscintigraphy.<br />

Materials & methods: Patients with invasive breast<br />

cancer who underwent a SLNB following both lymphoscintigraphy<br />

(figure1) and blue dye injection between January<br />

2007 and August 2010, were included. The outcome was<br />

recorded. Sensitivity, specificity, positive and negative predictive<br />

value (PPV, NPV) were determined.<br />

Results: 256 SLNs were harvested of 151 patients who<br />

received 153 SLNB procedures. 68 (26%) nodes contained<br />

metastases. Lymphoscintigraphy was unsuccessful in 5 procedures<br />

(3%), of which in 1 case (1/5; 20%) blue dye detected<br />

the SLN (table1). The added overall value of blue dye is<br />

0.7% (1/153). Blue dye was unsuccessful in 55 procedures<br />

(36%), of which lymphoscintigraphy was successful in<br />

51 procedures (51/55; 93%). Of the 4 procedures both techniques<br />

failed, an axillary nodal dissection was performed<br />

in 3 cases and in 1 case the SLN was found by palpability.<br />

Sensitivity, specificity, PPV and NPV for blue dye and for<br />

lymphoscintigraphy were respectively 68%, 50%, 33%,<br />

81% and 97%, 12%, 40%, 92%. Combining both techniques<br />

resulted in values of 99%, 5%, 27% and 90%.<br />

Conclusion: Blue dye injection, as adjunct to lymphoscintigraphy<br />

resulted in 0.7% additional SLN detection. Blue<br />

dye detected the SLN in 20% of failed lymphoscintigraphy<br />

procedures. This implies that blue dye should only be used<br />

when lymphoscintigraphy is unsuccessful.<br />

60<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Mammadiagnostiek 2 8<br />

Figure 1: Anterior(A) and lateral(B) scintigraphic imaging in a 59-year old female patient with breast cancer, two hours after injection of technetium-99<br />

nanocolloid. The largest spot is the injection site of technetium-99-nanocolloid. The nannocolloid was injected peri-tumorally in the<br />

breast. The lateral image also depicts two axillary lymph nodes (arrows) which have taken up the nanocolloid. These nodes are sentinel lymph<br />

nodes as they are assumed to also be the first nodes to accumulate metastases.<br />

# Age Breast Cancer Type Metastatic Node Blue Node<br />

1 69 Ductal None No<br />

2 83 Lobular None No<br />

3 64 Mixed ductal-lobular Macro No<br />

4 73 Mixed ductal-lobular Macro No<br />

5 79 Ductal Macro Yes<br />

Table 1: Patient characteristics of the patients with an unsuccessful lymphoscintigraphy procedure: Patients 1-3 received an axillary lymph node<br />

dissection. Patient number 4 and 5 received a sentinel lymph node biopsy as in patient 4 the node was palpable and in patient 5 the sentinel node<br />

dyed blue.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

61


9 <strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Sessie 9<br />

Neuro- en Hoofdhals radiologie<br />

Vrijdag 30 september, 10.45 - 12.15 uur<br />

O9.1<br />

ARTERIAL CALCIFICATION IN RELATION<br />

TO COGNITION AND STRUCTURAL BRAIN<br />

CHANGES<br />

D. Bos, M.W. Vernooij, S.E. Elias-Smale, G.P. Krestin,<br />

A. Hofman, W.J. Niessen, J.C.M. Witteman, A. van der Lugt,<br />

M.A. Ikram<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: Atherosclerosis plays an important role in the<br />

pathogenesis of cognitive decline and dementia. Calcified<br />

plaque measured with CT is a marker of atherosclerosis.<br />

This study investigates associations between CT-measured<br />

arterial calcifications measured at four locations, with cognition<br />

and macro- and microstructural brain changes.<br />

Method and materials: From the general population, 2437<br />

participants underwent CT of the coronary arteries, aortic<br />

arch, extracranial and intracranial carotid arteries to quantify<br />

calcification volume. Cognitive function was assessed in the<br />

following domains: memory, executive function, information<br />

processing speed and motor speed. In a random subgroup of<br />

844 participants brain MRI was performed to obtain measures<br />

of brain atrophy. Automated quantification of brain MRI<br />

scans yielded tissue-specific brain volumes. Furthermore,<br />

microstructural integrity of white matter was quantified<br />

using diffusion tensor imaging (DTI). Associations between<br />

arterial calcification and cognition, brain tissue volumes and<br />

DTI-measures were assessed with linear regression, adjusted<br />

for relevant confounders.<br />

Results: Larger calcification load was associated with<br />

worse cognitive scores in all domains. Calcification in all<br />

vessel beds was also associated with smaller total brain<br />

volume. Specifically, coronary calcification was associated<br />

with smaller grey matter volume, whilst both extra- and<br />

intracranial carotid artery calcification was associated with<br />

smaller white matter volume. Calcification in all vessel beds<br />

was associated with worse microstructural integrity of white<br />

matter.<br />

Conclusion: Arterial calcification load is associated with<br />

worse cognitive performance. Moreover, larger calcification<br />

load is associated with smaller brain tissue volumes and<br />

with worse white matter microstructural quality, elucidating<br />

possible mechanisms through which atherosclerosis leads to<br />

poorer cognition.<br />

O9.2<br />

TIA AND STROKE PATIENTS WITH CAROTID<br />

STENOSIS: PRESENCE OF COMPLICATED<br />

PLAQUE FEATURES AT MRI IS ASSOCIATED<br />

WITH RECURRENT EVENTS<br />

R.M. Kwee 1 , R.J. van Oostenbrugge 1 , W.H. Mess 1 ,<br />

M.H. Prins 1 , R.J. van der Geest 2 , J.W.M. ter Berg 3 ,<br />

C.L. Franke 4 , A.G.G.C. Korten 5 , B.J. Meems 6 ,<br />

J.M.A. van Engelshoven 1 , J.E. Wildberger 1 , M.E. Kooi 1<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Leids Universitair Medisch Centrum, Leiden<br />

3<br />

Orbis Medisch Centrum, Sittard<br />

4<br />

Atrium Medisch Centrum Parkstad, Heerlen<br />

5<br />

Laurentius Ziekenhuis, Roermond<br />

6<br />

VieCuri Medisch Centrum, Venlo<br />

Purpose: There is a need for improved risk stratification of<br />

TIA and stroke patients with carotid atherosclerosis. The<br />

purpose of the present study was to prospectively investigate<br />

whether certain MRI-based carotid plaque characteristics<br />

are associated with recurrent ischemic events.<br />

Materials and Methods: One hundred TIA/stroke patients<br />

with ipsilateral 30-69% carotid stenosis underwent multisequence<br />

MRI, including contrast-enhanced images, of the<br />

carotid plaque within 32.7±19.9 days after the initial event.<br />

For each plaque, vessel wall volume and volumes of lipidrich<br />

necrotic core (LRNC), calcifications, and fibrous tissue<br />

were assessed. Maximum vessel wall thickness, minimum<br />

lumen area, fibrous cap status, and intraplaque hemorrhage<br />

(IPH) were also assessed. Patients were followed by structured<br />

interviews and chart review to determine the recurrence<br />

of ipsilateral TIA and/or ischemic stroke within one year.<br />

62<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Neuro- en Hoofdhals radiologie 9<br />

Results: Ten of hundred included patients suffered from<br />

recurrent ipsilateral clinical ischemic events (9 TIAs and 1<br />

ischemic stroke). The presence of IPH was associated with<br />

recurrence (Pearson Chi-Square= 7.373, P=0.007). Patients<br />

with recurrent events also had plaques with larger LRNC<br />

volume and larger maximum vessel wall thickness, although<br />

these findings were borderline significant (P=0.032 and<br />

P=0.055, respectively). Other MRI-based parameters were<br />

not related to recurrent ischemic events.<br />

Conclusion: The results of this study indicate that the<br />

presence of IPH, larger LRNC volume, and larger maximum<br />

vessel wall thickness of carotid plaques are associated with<br />

recurrent TIA and ischemic stroke. Assessment of carotid<br />

plaque characteristics by MRI may help identifying high-risk<br />

patients, which could improve patient selection for carotid<br />

endarterectomy or stenting.<br />

O9.3<br />

CAROTID PLAQUE MORPHOLOGY AND<br />

ISCHEMIC VASCULAR BRAIN DISEASE ON<br />

MRI<br />

Q.J.A. van den Bouwhuijsen, M.W. Vernooij, W.J. Niessen,<br />

G.P. Krestin, M.A. Ikram, J.C.M. Witteman, A. van der Lugt<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: Vulnerable plaque components in carotid arteries<br />

can be detected non-invasively with magnetic resonance<br />

imaging (MRI). In asymptomatic persons, the relation between<br />

carotid plaque composition and vascular brain disease<br />

is not well studied. We studied the association between<br />

carotid atherosclerotic plaque characteristics and ischemic<br />

brain disease on MRI.<br />

Methods: From the population-based Rotterdam Study, 952<br />

participants with carotid wall thickening on ultrasound >2.5<br />

mm underwent both carotid MRI and brain MRI. Maximum<br />

carotid wall thickening, degree of stenosis and presence of<br />

intraplaque hemorrhage, lipid core and calcification were<br />

assessed in both carotid arteries. Associations between<br />

plaque characteristics and white matter lesions (WMLs),<br />

lacunar and cortical infarcts were investigated per<br />

participant and additionally per carotid artery. Analysis were<br />

adjusted for cardiovascular risk factors.<br />

Results: Carotid stenosis (OR per 10% stenosis increase<br />

1.2 95% confidence interval (1.0-1.4), maximum carotid<br />

wall thickness (per mm increase 1.3,1.1-1.6) en presence of<br />

intraplaque hemorrhage (1.9,1.1-3.3), were all found to be<br />

significantly associated with presence of cortical infarcts,<br />

both in the participant based analysis and in the carotid<br />

artery based analysis. There were no associations between<br />

any plaque characteristics and presence of lacunar infarcts.<br />

In the subject based analysis maximum plaque thickness,<br />

presence of intraplaque hemorrhage and calcification were<br />

associated with WML-volume. In the artery based analysis<br />

only the association for calcifications remained.<br />

Conclusion: Presence of carotid intraplaque hemorrhage<br />

and measures of carotid plaque size are independently associated<br />

with cortical infarcts, but not with lacunar infarcts.<br />

Plaque calcification, but not vulnerable plaque components,<br />

is related to WML volume.<br />

Clinical relevance: This MRI study gives insight into the<br />

importance of atherosclerotic plaque composition, also in<br />

small plaques, for development of ischemic brain disease.<br />

O9.4<br />

A COMPUTER BASED DIAGNOSTIC<br />

SYSTEM TO FACILITATE THE EARLY AND<br />

DIFFERENTIAL DIAGNOSIS OF DEMENTIA<br />

B. Jasperse, H.A. Vrooman, M. Koek, M.W. Vernooij,<br />

R. de Boer, F. van der Lijn, M.A. Ikram, M. Smits,<br />

W. Niessen, A. van der Lugt<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: Patterns of brain atrophy, hippocampal atrophy and<br />

vascular changes, as visualized on brain-MRI, play an important<br />

role in determining the underlying cause of dementia<br />

syndromes. The visual interpretation of these pathological<br />

changes can be very challenging due to intercurrent agerelated<br />

brain changes.To facilitate the distinction between<br />

abnormal and ‘normal age-related’ brain changes, we<br />

developed an automated system that provides individualspecific<br />

lobar brain volumes, hippocampal volumes and white<br />

matter lesion volume taking into account age- and sex-specific<br />

reference data from a ‘healthy’ aging population.<br />

Methods and Materials: Automated brain tissue segmentation<br />

and atlas-based registration is performed on T1, T2<br />

and FLAIR MR-images, generating lobar brain volumes, hippocampal<br />

volumes and white matter lesion volume. For each<br />

resulting volume, reference curves are used to generate<br />

age- and sex-specific percentile values. The results are then<br />

presented in an on-line viewer to interpret the quality of tissue<br />

and structure segmentation and the quantitative results.<br />

Reference curves are generated from 867 healthy aging<br />

individuals (age-range (years): 61-91, Male/female-ratio (N):<br />

425/422).<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

63


9<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Results/conclusion: An example of segmentation results<br />

and percentile plots (colored lines represent percentile-lines)<br />

for a 69 year old male patient with suspected dementia<br />

is provided in figure 1. Visual inspection suggests parietal<br />

atrophy, which might be attributed to global cortical atrophy.<br />

The automated analysis results show that overall brain<br />

volume is appropriate for age (75th to 95th percentile), with<br />

a strikingly low parietal lobe volume (37th percentile), confirming<br />

the initially suspected parietal lobe atrophy.<br />

A system prototype is currently under evaluation at our<br />

radiology department. Future work aims to incorporate<br />

automated analysis of microbleeds, shape of individual<br />

brain structures and microstructural integrity using diffusionweighted<br />

MRI sequences.<br />

Figure 1: Results for a patient with suspected dementia.<br />

O9.5<br />

MECHANICAL THROMBECTOMY WITH<br />

THE TREVO STENT DEVICE IN PROXIMAL<br />

INTRACRANIAL ARTERIAL OCCLUSIONS<br />

M.M.A.C. van Doorn 1 , R. van den Berg 1 , B. van der Kallen 2 ,<br />

G.J. Lycklama à Nijeholt 2 , W. van Zwam 3 , Y.B. Roos 1 , P.J.<br />

Nederkoorn 1 , M.E. Sprengers 1 , J. Bot 1 , J. Boiten 3 , R. van<br />

Oostenbrugge 3 , A. van der Lugt 4 , D. Beumer 4 , P.S. Fransen 4 ,<br />

D.W.J. Dippel 4 , C.B.L.M. Majoie 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Medisch Centrum Haaglanden, Den Haag<br />

3<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

4<br />

Erasmus Medisch Centrum, Rotterdam<br />

Background and Purpose: To evaluate the safety and<br />

effectiveness of a self-expanding and fully retrievable stent<br />

(Trevo; Concentric Medical Inc, Mountain View, CA, USA) in<br />

revascularization of patients with acute ischemic stroke.<br />

Methods: Prospective multicenter case series of 22 patients<br />

with an acute ischemic stroke caused by a proximal intracranial<br />

arterial occlusion treated with a fully retrievable stent<br />

within the first 8 hours from symptom onset (median NIHSS<br />

21 [range 13-28]). Thrombectomy was used as rescue therapy<br />

in patients who were refractory to, had contraindications<br />

for or were to late for IV rtPA. The occlusion site was the<br />

middle cerebral artery in 7, terminus internal carotid artery<br />

in 2, cervical internal carotid artery/middle cerebral artery in<br />

4 and basilar artery in 9 patients. Complications related to<br />

the procedure and outcome at 3-6 months were assessed.<br />

Results: Stent placement was feasible in all procedures<br />

and successful recanalization defined as thrombosis in cerebral<br />

ischemia (TICI) grade 2b or 3 was achieved in 18 of 22<br />

treated vessels (82%). The mean number of passes for maximal<br />

recanalization was 2 (range 1-5). The median time from<br />

groin puncture to recanalization was 110 minutes (range<br />

26 – 199). One significant procedural event occurred (carotid<br />

artery occlusion after stent removal). 33% of all patients had<br />

a good outcome (mRS 0-2), 0% moderate outcome (mRS 3),<br />

67% poor outcome (mRS 4-6).<br />

Conclusions: These results suggest that with the Trevo<br />

device, clots can be safely and effectively removed from<br />

intracranial large vessel occlusions in acute ischemic stroke.<br />

64<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Neuro- en Hoofdhals radiologie 9<br />

O9.6<br />

RESTING-STATE FUNCTIONAL MRI CHANGES<br />

IN ALZHEIMER’S DISEASE AND MILD<br />

COGNITIVE IMPAIRMENT<br />

M.A.A. Binnewijzend 1 , M.M. Schoonheim 1 , E. Sanz-Arigita 2 ,<br />

A.M. Wink 1 , W.M. van der Flier 1 , N. Tolboom 1 ,<br />

J.S. Damoiseaux 3 , S.M. Adriaanse 1 , P. Scheltens 1 ,<br />

B.N.M. van Berckel 1 , F.A. Barkhof 1<br />

1<br />

VU medisch centrum, Amsterdam<br />

2<br />

Foundation CITA-AD, San Sebastian, Spain<br />

3<br />

Stanford University School of Medicine, Palo Alto, Cal, USA<br />

Alzheimer’s disease (AD) features distinct structural and functional<br />

brain changes. With the prospect of disease-modifying<br />

therapies it is desirable to detect signs of neurodegeneration<br />

before it is detectable on structural MRI as atrophy. In this<br />

study we used resting-state functional MRI (rs-fMRI) to<br />

compare regional functional connectivity of patients with AD,<br />

mild cognitive impairment (MCI) and healthy elderly controls<br />

(HC). MRI scans and neuropsychological assessments were<br />

acquired of 39 AD patients, 23 MCI patients and 43 HC. After<br />

a mean follow-up of 2.8±1.9 years seven MCI patients<br />

converted to AD, while 14 patients remained cognitively stable.<br />

Rs-fMRI scans were non-linearly registered to standard<br />

space and analyzed using independent component analysis<br />

(ICA), followed by a “dual-regression”technique to create<br />

and compare subject-specific maps of each spatio-temporal<br />

independent component, correcting for age, gender and additionally<br />

for gray matter atrophy. AD patients displayed decreased<br />

functional connectivity within the default-mode network<br />

(DMN) in the precuneus and posterior cingulate cortex compared<br />

to HC, which survived correction for gray matter atrophy.<br />

Within these regions, decreased functional connectivity was<br />

found in converting MCI as well, while no differences were<br />

found between stable MCI patients and HC. Correlation with<br />

cognitive dysfunctions demonstrated the clinical relevance of<br />

functional connectivity changes within the DMN. In conclusion,<br />

a clinically relevant decrease in functional connectivity<br />

was observed within the DMN in AD, independent of cortical<br />

atrophy. Similar decreases were present in MCI patients<br />

before conversion to AD. Rs-fMRI is a promising technique<br />

that can identify functional impairment in early AD.<br />

Figure 1: Differences in DMN FC between HC and AD patients.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

65


9 <strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Figure 2: Boxplots of regional FC mean z-values.<br />

O9.7<br />

COMPUTER-AIDED DIAGNOSIS OF<br />

CORTICAL LESIONS IN EPILEPSY PATIENTS<br />

M.C. Hoeberigs 1 , L.M.H. Geelen 1 , P.A.M. Hofman 2<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Kempenhaeghe Epilepsiecentrum, Heeze<br />

About 30% of epilepsy patients with partial seizures have<br />

intractable epilepsy. MRI detection of an epileptogenic lesion<br />

is of clinical importance because focal resection may be the<br />

only viable therapeutic option. In up to 74% of patients with<br />

partial seizures, MRI shows no abnormalities, although it is<br />

assumed that the majority of these patients have a small cortical<br />

dysplasia. In some of these cases the lesion is visible on<br />

the MRI study, but not detected by the neuroradiologist.<br />

We investigated the additional value of a computer-aided<br />

diagnostic technique, by retrospectively analyzing all scans<br />

from patients with partial seizures acquired between<br />

December 2008 and December 2009. The scan protocol on<br />

a 3T scanner included a 3D-T1 weighted scan, which was<br />

used for the post-processing. The other sequences were<br />

axial TSE-T2, FFE-T2 and FLAIR, coronal FLAIR and IR.<br />

MRI post-processing was a fully-automated voxel-based 3D<br />

MRI analysis within SPM5 (normalization, segmentation,<br />

results compared to normal database): feature maps of cortical<br />

thickness, gray-white junction and gray matter extension<br />

were generated. These maps were visually evaluated and<br />

correlated with the full exam. Only when the detected<br />

cortical lesion was also visible on the original scans it was<br />

considered a true cortical lesion.<br />

A total of 289 MRIs were evaluated. Based on visual<br />

assessment, a cortical lesion was described in 45/289. In<br />

28/45 positive scans and in 5 out of the initially negative<br />

244 patients a cortical lesion was detected by computeraided<br />

technique.<br />

Computer-aided postprocessing can increase the diagnostic<br />

yield, but not replace visual assessment.<br />

66<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Neuro- en Hoofdhals radiologie 9<br />

O9.8<br />

COMPLICATIONS OF PARTICLE<br />

EMBOLIZATION OF MENINGIOMAS:<br />

FREQUENCY, RISK FACTORS, AND<br />

OUTCOME<br />

D.F.M. Carli, M.S. Sluzewski, G.N. Beute, W.J.J. van Rooij<br />

St. Elisabeth Ziekenhuis, Tilburg<br />

Purpose: We assessed the frequency and outcome of<br />

complications of embolization of meningiomas and tried to<br />

identify risk factors.<br />

Methods: Between 1994 and 2009, a total of 198 patients<br />

with 201 meningiomas underwent embolization. Indication<br />

for embolization was preoperative in 165 meningiomas<br />

and adjunctive to radiosurgery in 8. In the remaining 28<br />

meningiomas, embolization was initially offered as a sole<br />

therapy. There were 128 women and 70 men with a mean<br />

age of 54.4 years (median age, 54 years; range, 15-90<br />

years). Complications were defined as any neurologic deficit<br />

or death that occurred during or after embolization. Logistic<br />

regression was used to identify the following possible risk<br />

factors: age above median, female sex, tumor size above<br />

median, meningioma location in 5 categories, use of small<br />

particle size (45-150 microm), the presence of major peritumoral<br />

edema, and arterial supply in 3 categories.<br />

Results: Complications occurred in 11 patients (5.6%; 95%<br />

confidence interval [CI], 3.0%-9.8%). Ten complications<br />

were hemorrhagic, and 1 was ischemic. Six of 10 patients<br />

with hemorrhagic complications underwent emergency<br />

surgery with removal of the hematoma and meningioma.<br />

Complications of embolization resulted in death in 2 and<br />

dependency in 5 patients (7/198, 3.5%; 95% CI, 1.6%-2.0%).<br />

The use of small particles (45-150 mum) was the only risk<br />

factor for complications (odds ratio [OR], 10.21; CI, 1.3-80.7;<br />

P = .028).<br />

Conclusions: In this series, particle embolization of meningiomas<br />

had a complication rate of 5.6%. We believe that<br />

the use of small polyvinyl alcohol (PVA) particles (45-150<br />

microm) should be discouraged.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

67


10<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Sessie 10<br />

MSK/Thorax/Diversen<br />

Vrijdag 30 september, 10.45 - 12.15 uur<br />

O10.1<br />

REPRODUCIBILITY OF 3D DELAYED<br />

GADOLINIUM ENHANCED MRI OF<br />

CARTILAGE OF THE KNEE AT 3.0 TESLA<br />

IN PATIENTS WITH EARLY-STAGE<br />

OSTEOARTHRITIS<br />

J. van Tiel, G. Kotek, H. Smit, E. Bron, S. Klein, G.P. Krestin,<br />

H. Weinans, E.H.G. Oei<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To assess the reproducibility of 3D delayed<br />

Gadolinium Enhanced MRI of Cartilage (dGEMRIC) of the<br />

knee at 3.0Tesla in patients with early-stage osteoarthritis<br />

(OA).<br />

Methods: In three early-stage knee OA patients (Kellgren<br />

and Lawrence grade I or II) dGEMRIC was performed twice<br />

with an interval of seven days using a 3.0Tesla MRI-scanner<br />

and a custom-made open design knee coil. This coil was<br />

specifically developed to enable imaging of OA patients who<br />

would not fit in the commercially available knee coil. The<br />

new coil has a higher signal-to-noise ratio in the weightbearing<br />

cartilage compared to the regular knee<br />

coil. The dGEMRIC consisted of an Inversion Recovery Fast<br />

Spoiled Gradient Echo sequence with five different inversion<br />

times. Using Matlab, three regions of interest (ROIs) in the<br />

medial and lateral cartilage (weight-bearing condyle and<br />

plateau and non weight-bearing condyle) were drawn on<br />

three consecutive slices. Mean T1GD relaxation time per<br />

ROI per slice was calculated and compared between the<br />

two dGEMRIC scans using a paired t-test and an intraclass<br />

correlation coefficient (ICC) to assess reproducibility of the<br />

measurements.<br />

Results: In all ROIs of all slices mean T1GD relaxation<br />

time was not significantly different between the two<br />

examinations (p=0.1-0.5). The ICCs of mean T1GD relaxation<br />

times of all ROIs were good to excellent (ICC:0.64-<br />

0.99;p=0.004-0.0001).<br />

Conclusions: These preliminary results suggest that 3D<br />

dGEMRIC of the knee at 3.0Tesla is a reproducible measure<br />

of cartilage quality in early-stage OA patients. Therefore,<br />

it is a valuable tool to assess cartilage quality over time in<br />

longitudinal studies.<br />

Figure 1<br />

68<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


MSK/Thorax/Diversen 10<br />

O10.2<br />

CT-ARTHROGRAPHY TO MEASURE<br />

CARTILAGE QUALITY: INFLUENCE OF<br />

SULPHATED GLYCOSAMINOGLYCAN<br />

CONTENT AND STRUCTURAL<br />

COMPOSITION OF EXTRACELLULAR<br />

MATRIX ON CONTRAST AGENT DIFFUSION<br />

INTO CARTILAGE<br />

J. van Tiel, M. Siebelt, J.H. Waarsing, M. van Straten,<br />

G.P. Krestin, H. Weinans, E.H.G. Oei<br />

Erasmus Medisch Centrum, Rotterdam<br />

Purpose: To assess the potential of CT-arthrography to<br />

evaluate cartilage quality in terms of sulphated glycosaminoglycan<br />

content (sGAG) and structural composition of the<br />

extra-cellular matrix (ECM).<br />

Methods: Eleven human cadaveric knee joints were<br />

scanned on a second generation dual source spiral CT scanner<br />

before and after intra-articular injection of a negatively<br />

charged contrast agent. Mean X-ray attenuation values of<br />

both scans were calculated in seven regions of interest<br />

(ROIs) of the cartilage (weight-bearing condyles and plateaus,<br />

non weight-bearing condyles and patella). Next, all<br />

ROIs were rescanned with contrast-enhanced<br />

micro-CT (μCT), which served as reference standard because<br />

it accurately measures sGAG content and hence quality<br />

of cartilage. Correlation between mean X-ray attenuation<br />

values of CT-arthrography and μCT was analyzed with linear<br />

regression. Additionally, residual values from the linear fit<br />

between unenhanced CT and μCT were used as a covariate<br />

measure to identify the influence of structural composition<br />

of cartilage ECM, i.e. without influence of sGAG, on contrast<br />

diffusion into cartilage.<br />

Results: Mean X-ray attenuation of cartilage was<br />

significantly higher for CT-arthrography compared to<br />

unenhanced CT in all ROIs. Furthermore, CT-arthrography<br />

attenuation values correlated excellently with reference<br />

μCT values representing sGAG content of cartilage<br />

(R=0.86;R2=0.73;p


10<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O10.3<br />

FRACTUREN VAN DE THORACALE EN<br />

LUMBALE WERVELKOLOM IN HET CENTRUM<br />

VOOR GERIATRISCHE TRAUMATOLOGIE:<br />

VASTSTELLEN VAN SCHADE AAN DE MIDDEL-<br />

STE PIJLER NIET VAN BELANG VOOR BELEID<br />

L.B.M. Weerink, M. Kraai, E.C. Folbert, R.S. Smit,<br />

J.H Hegeman, D. van der Velde<br />

Ziekenhuisgroep Twente, Almelo<br />

Over de behandeling van ouderen met een wervelfractuur<br />

door de middelste pijler is geen consensus. De relevantie<br />

van de CT-scan in de diagnostiek staat hiermee ook ter<br />

discussie. Doel van dit onderzoek is de meerwaarde van de<br />

CT-scan bij ouderen met een wervelfractuur te bepalen.<br />

Voor dit onderzoek werden 106 patiënten in het Centrum<br />

<strong>voor</strong> Geriatrische Traumatologie met een fractuur ter hoogte<br />

van de thocacolumbale wervelkolom geïncludeerd. Er werden<br />

retrospectief gegevens verzameld over radiologische<br />

parameters zoals betrokkenheid van de middelste pijler en<br />

diameter van het spinale kanaal. Algemene patiëntengegevens<br />

en gegevens over het functioneren na 6 weken en<br />

3 maanden werden geregistreerd.<br />

In onze populatie is er geen relatie is tussen betrokkenheid<br />

van de middelste pijler, compressie van het spinale kanaal<br />

en andere radiologische parameters met het functioneel<br />

eindresultaat.<br />

In tegenstelling tot de literatuur werd bij patiënten met een<br />

fractuur door <strong>voor</strong>ste en middelste pijler het beleid in 83,3%<br />

(45 patiënten) gewijzigd naar snelle mobilisatie. Het functioneel<br />

eindresultaat in beide groepen is vergelijkbaar.<br />

Conclusie: In onze studie hebben radiologische kenmerken<br />

van een wervelfractuur geen relatie met het functioneringsniveau<br />

na 6 weken en 3 maanden. De toepassing van snelle<br />

mobilisatie in plaats van strikte bedrust bij een fractuur met<br />

betrokkenheid van de middelste pijler is een veilige optie.<br />

Het vaststellen van de betrokkenheid van de middelste pijler<br />

door middel van een CT-scan lijkt met deze conclusies minder<br />

relevant <strong>voor</strong> het te volgen beleid. De rol van de CT-scan<br />

bij de diagnostiek van ouderen met een wervelfractuur staat<br />

hiermee ter discussie.<br />

O10.4<br />

IMPROVING DEPLOYMENT OF MR-SI IN<br />

PATIENTS SUSPECTED FOR SPONDYLO-<br />

ARTHRITIS IN A LARGE CLINICAL PRACTICE,<br />

USING A TARGETED INTERVENTION<br />

M.H.E. Vossen 1 , A.A. den Broeder 2 , F. Hendriks-Roelofs 2 ,<br />

D.M.F.M. van der Heijde 1 , M. Reijnierse 1<br />

1<br />

Leiden Universitair Medisch Centrum, Leiden<br />

2<br />

Sint Maartenskliniek, Nijmegen<br />

Background: Diagnosing axial spondyloarthritis (SpA) can<br />

be difficult: sacroiliac (SI) joint radiographs are often normal.<br />

Magnetic Resonance (MR) exam of SI joints (MR-SI) may<br />

reduce diagnostic uncertainty. Optimal deployment requires<br />

pretest chance of approximately 50%. Otherwise, increased<br />

numbers of MR-SI requests, false positives, excessive<br />

patient burden and costs will result.<br />

Objective: To examine characteristics of deployment of<br />

MR-SI in patients with suspected SpA before and after<br />

targeted intervention.<br />

An introduction on effect of pretest chance on predictive<br />

value, patient burden, costs was given. Alternative behavioral<br />

strategy was offered through a simple diagnostic<br />

algorithm.<br />

Results: 198 MR-SI (148 females / 50 males; mean age 36<br />

± 9.8yrs) were performed between April 1st, 2004 and April<br />

17th, 2007. 166 MR-SI (84%) were normal, 5 (2.5%) suspicious<br />

and 27 (13.5%) positive.<br />

After intervention, MR-SI number dropped to 58 (41 females<br />

/ 17 males; mean age 35. ± 9.8 years). Corrected for total<br />

number of patients seen (mean increase 12%), this is<br />

decrease of 79% with almost doubling of positive MR-SI: 44<br />

normal (76%), 0 suspicious and 14 (24%) positive.<br />

Conclusion: A simple, three stage feedback intervention<br />

resulted in 79% reduction of MR-SI requests with increase<br />

in number of positive MR-SI. This approach may benefit<br />

future research in areas with diagnostic uncertainty.<br />

Methods: MR-SI from April 1st, 2004 to December 31st,<br />

2010 were retrospectively collected. Inclusion criteria: MR-SI<br />

ordered by rheumatologist, suspicion of axial SpA, complete<br />

patient data. MR-SI reports were graded ‘normal’, ‘suspected<br />

sacroiliitis’ and ‘sacroiliitis’. Descriptive statistics were<br />

mean ± standard deviation (SD) or median (25-p75). In April<br />

2007, an intervention was done to improve deployment.<br />

Review data on requesting behavior, patient characteristics,<br />

outcomes were presented to rheumatologists.<br />

70<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


MSK/Thorax/Diversen 10<br />

Figure 1: Diagnostic algorithm by Rudwaleit, M. et al.<br />

O10.5<br />

IMPACT ON DIAGNOSTIC PERFORMANCE<br />

AND READING TIME OF A COMPUTER<br />

AIDED DETECTION ALGORITHM FOR<br />

THE DETECTION OF ACUTE PE: SECOND<br />

READING VERSUS CONCURRENT READING<br />

R. Wittenberg 1 , J.F. Peters 2 , I.A.H. Van den Berk 3 ,<br />

N.J.M. Freling 3 , R.J. Lely 4 , B. de Hoop 5 , K. Horsthuis 3 ,<br />

C.J. Ravesloot 5 , M. Prokop 6 , C.M. Schaefer-Prokop 7<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Philips Healthcare, Best<br />

3<br />

Academisch Medisch Centrum, Amsterdam<br />

4<br />

VU Medisch Centrum, Amsterdam<br />

5<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

6<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

7<br />

Meander Medisch Centrum, Amersfoort<br />

Purpose: Evaluation of a CTPA study for the detection of<br />

pulmonary embolism (PE) represents a time consuming and<br />

tiring reading process. Computer-aided detection (CAD),<br />

when used as second reader, was found to improve reader<br />

performance for the detection of small emboli but inevitably<br />

at the expense of a substantial increase of reading time. We<br />

hypothesised that CAD may be used more advantageously<br />

when used as concurrent reading tool.<br />

Methods and materials: In this retrospective study, six<br />

observers of varying experience evaluated 157 negative and<br />

39 positive 64-slice consecutively acquired CTPA. With a<br />

time interval of 6 weeks, all cases were read twice in different<br />

order using CAD as second and as concurrent reader,<br />

respectively. Per patient, observers were asked to determine<br />

the presence of PE using a 5 point confidence scale and<br />

to document their reading time with and without CAD.<br />

Sensitivity and specificity were calculated by comparing the<br />

reader data with an independent consensus standard.<br />

Results: Baseline performance without CAD was high with<br />

a mean sensitivity of 91 % and increased further to 95 %<br />

with CAD as second reader and 94 % with CAD as concurrent<br />

reader. Mean specificity decreased with CAD as second<br />

reader (96%, 94 % and 96 %, respectively). The mean<br />

reading time with CAD as concurrent reader significantly<br />

decreased (108 s, 136 s and 91s, respectively).<br />

Conclusions: CAD used as concurrent reader has the<br />

potential to achieve the same high sensitivities without<br />

loss of specificity at the advantage of a significantly shorter<br />

reading time.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

71


10<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

O10.6<br />

DEVELOPMENT AND VALIDATION OF<br />

A DIAGNOSTIC MODEL FOR AIRFLOW<br />

LIMITATION IN HEAVY SMOKERS BY USING<br />

QUANTITATIVE COMPUTED TOMOGRAPHY<br />

O.M. Mets 1 , C.M.F. Buckens 1 , P. Zanen 1 , I. Isgum 1 ,<br />

M. Prokop 2 , P.A. de Jong 1<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

Purpose: To develop a CT based diagnostic model for the<br />

presence of airflow limitation in smokers participating in a<br />

lung cancer screening study.<br />

Materials and methods: In 1173 screening participants,<br />

we analyzed inspiratory and expiratory chest computed<br />

tomography (CT) scans, patient characteristics, smoking history<br />

and prebronchodilator spirometry obtained at the same<br />

day as the CT scan. Scan parameters were: 120kVp (≤80kg)<br />

or 140kVp (>80kg) at 30mAs for inspiratory scans, and 90kVp<br />

(≤80kg) or 120kVp (>80kg) at 20mAs for expiratory scans.<br />

Axial slices of 1mm at 0.7mm increment were reconstructed.<br />

CT emphysema was defined as percentage of voxels


MSK/Thorax/Diversen 10<br />

O10.8<br />

ANALYSE RESULTATEN CYTOLOGISCH EN<br />

HISTOLOGISCHE PUNCTIES;CORRELATIE<br />

AAN PA-DIAGNOSE EN UITVOERDER<br />

Y.F.R. Ypma, J.J. Hensen, D. Vroegindeweij, H. van Beek,<br />

R.A Niezen, H. Beerman<br />

Maasstad Ziekenhuis, Rotterdam<br />

Doel: Evaluatie hoe frequent een CT, echografisch of stereotactisch<br />

geleide cytologische en histologische punctie<br />

resulteerde in een PA diagnose. Tevens werd het verschil<br />

in materiaal opbrengst tussen radioloog en arts-assistent<br />

geanalyseerd.<br />

Methode: Retrospectief werden alle cytologische en histologische<br />

puncties van 2009 en 2010 geincludeerd geanalyseerd.<br />

Het verschil tussen cytologische en histologische<br />

punctie werd geanalyseerd alsmede de methode hoe het PA<br />

materiaal werd verkregen en door wie de punctie werd verricht<br />

(radioloog versus assistent).<br />

Daarnaast werden alle puncties gecorreleerd aan de PA<br />

diagnose.<br />

Resultaten: In 2009 en 2010 werden 814 histologische<br />

biopten en 1260 cytologische puncties verricht.<br />

Radiologen verrichtten in deze periode 1056 puncties,<br />

waarvan 407 histologisch en 649 cytologisch. Assistenten<br />

verrichtten 1018 puncties, waarvan 407 histologisch en 611<br />

cytologisch.<br />

Van alle puncties (cytologisch en histologisch) waren er 67<br />

CT geleid, 1820 echogeleid en 175 stereotactisch.<br />

Cytologische puncties gaven in 88,5% (1116/1260) een<br />

PA diagnose en histologie in 95,3% (776/814). Van deze<br />

histologische biopten resulteerde het stereotactische biopt<br />

in de hoogste opbrengst, 96% (168/175), gevolgd door het<br />

echogeleide biopt, 95% (554/581). De laagste opbrengst gaf<br />

het CT geleide biopt, 93 % (62/67).<br />

Radiologen verkregen in 91,1% (962/1056) van de puncties<br />

representatief materiaal, assistenten in 91,3% (930/1018).<br />

Conclusie: Het stereotactisch geleide histologische biopt<br />

resulteerde in de hoogste PA score. Zowel cytologische<br />

puncties als histologische biopten resulteerden in vrijwel<br />

alle gevallen in een juiste PA diagnose. Er was geen significant<br />

verschil tussen de verschillende uitvoerders van de<br />

puncties.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

73


E <strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

Samenvattingen<br />

‘De educatieve <strong>voor</strong>dracht’<br />

Vrijdag 30 september, 10.45 - 12.15 uur<br />

E01<br />

DE VERGROTE BIJNIER:<br />

ENDOSONOGRAFISCHE FNA VAN DE<br />

INKER BIJNIER<br />

R.J.J. de Ridder 1 , V.C. Cappendijk 2<br />

1<br />

Maag-, darm-, leverziekten, Maastricht Universitair<br />

Medisch Centrum, Maastricht<br />

2<br />

<strong>Radiologie</strong>, Maastricht Universitair Medisch Centrum,<br />

Maastricht<br />

Incidentalomen van de bijnier worden door toenemend<br />

gebruik van beeldvormende technieken vaker gevonden.<br />

Driekwart van deze afwijkingen wordt gevonden bij personen<br />

welke beeldvorming ondergaan <strong>voor</strong> de stadiering van een<br />

maligniteit. Vaak kan door beeldvorming, eventueel aangevuld<br />

met endocrinologisch onderzoek, vastgesteld worden dat het<br />

om een (niet-functioneel) bijnieradenoom gaat. Bij twijfel over<br />

een primaire dan wel secundaire maligniteit, en indien relevant<br />

in de klinische context, is nader onderzoek aangewezen.<br />

Percutane CT- of echo geleide FNA van de bijnier heeft een<br />

sensitiviteit <strong>voor</strong> het aantonen van een maligniteit van 93%. In<br />

studies bedraagt het aantal niet diagnostische puncties echter<br />

19-24% [1,2] Belangrijke complicaties ontstaan in 3-8% van<br />

de patiënten aansluitend aan een percutane punctie.[3,4] De<br />

belangrijkste complicaties zijn pneumothorax, bloeding, hematoom<br />

en het risico op entmetastase.<br />

Referenties:<br />

1. Harisinghani MG, Maher MM, Pinkney PF et al. Predictive value<br />

of benign percutaneous adrenal biopsies in oncology patients.<br />

Clin Radiol 2002;57: 898-901<br />

2. Gilliams A, Roberts CM, Shaw P. et al. The value of CT scanning<br />

and percutaneous fine needle aspiration of adrenal masses in<br />

biopsy-proven lung cancer. Clin Radiol 1992;46: 18-22<br />

3. Mody MK, Kazerooni EA, Korobkin M et al. Pecutaneous CT-guided<br />

biopsy of adrenal masses: immediate and delayed complications.<br />

J Comput Assist Tomogr 1995;19:434-439<br />

4. Welch TJ, Sheedy PF, Stephens DH et al. Pecutaneous adrenal<br />

biopsy: review of 10-year experience. Radiology 1994;193:341-4<br />

5. Dietrich CF, WehrmannT, Hoffmann C et al, Detection of the<br />

adrenal gland by endoscopic or transabdominal ultrasound.<br />

Endoscopy 1997;29:859-864<br />

6. Schuurbiers OCJ, Tournoy KG, Schoppers et al. EUS-FNA for the<br />

detection of left adrenal metastasis in patients with lung cancer;<br />

Lung Cancer, in press<br />

7. DeWitt J, Alsatie M, LeBlanc J et al, Endoscopic ultrasoundguided<br />

fine-needle aspiration of left adrenal gland masses,<br />

Endoscopy 2007;39:65-71<br />

Transgastrische endosonografie (onder sedatie middels midazolam)<br />

is een beproefde methode <strong>voor</strong> afbeelding van met name<br />

de linker bijnier. De linker bijnier kan in 98% van de patiënten<br />

middels EUS in beeld worden gebracht, de rechter in 30% van<br />

de gevallen. Transabdomiale echo kan in 69% van de gevallen<br />

de linker bijnier visualiseren.[5]<br />

De sensitiviteit <strong>voor</strong> het aantonen van een maligniteit middels<br />

EUS met FNA bedraagt 86%. Niet diagnostische puncties<br />

variëren sterk tussen studies van 5.9-24%.[6,7] In de literatuur<br />

is slechts een casus van een post-procudurele bloeding<br />

beschreven na EUS-FNA.<br />

De procedure wordt door patiënten goed getolereerd en duurt<br />

ca. 10 minuten.<br />

EUS-FNA is een veilige en weinig belastende procedure <strong>voor</strong><br />

het verkrijgen van een weefsel diagnose indien er bij een vergrote<br />

linkerbijnier de verdenking bestaat op een maligniteit.<br />

74<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Educatieve <strong>abstracts</strong><br />

E<br />

E02<br />

LONG-TERM FOLLOW-UP FEATURES ON<br />

RECTAL MRI DURING A WAIT-AND-SEE<br />

APPROACH AFTER A CLINICAL COMPLETE<br />

RESPONSE IN RECTAL CANCER PATIENTS<br />

TREATED WITH CHEMORADIOTHERAPY<br />

D.M.J. Lambregts, M. Maas, F.C.H. Bakers, V.C. Cappendijk,<br />

G. Lammering, G.L. Beets, R.G.H. Beets-Tan<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

Background: Surgical resection is the standard treatment<br />

for patients with locally advanced rectal cancer who have<br />

undergone preoperative chemoradiation (CRT). There is now,<br />

however, a trend towards a conservative wait-and-see policy<br />

for patients with a complete tumor regression. It is not clear<br />

how patients should be monitored once they are managed<br />

non-operatively and whether follow-up by MRI has any role.<br />

As part of an observational study, a series of 19 carefully<br />

selected patients with a clinical complete response was<br />

managed with a wait-and-see policy and followed regularly<br />

by rectal MRI.<br />

Purpose: To study the short-term and long-term morphological<br />

MRI-features of rectal cancer patients with a complete<br />

tumor response undergoing a wait-and-see policy with regular<br />

MR follow-up after CRT.<br />

MR-imaging features: Shortly (6-8 weeks) after CRT,<br />

patients with a complete tumor response showed either<br />

a normalised rectal wall (26%) or a hypointense fibrotic<br />

remnant (74%). Three patterns of fibrosis could be classified,<br />

the aspects of which were dependent on the initial tumor<br />

morphology at primary MR staging (figure 1). The aspect of<br />

the normalised wall or fibrosis remained entirely consistent<br />

during long-term follow-up (median 20, range 9-57 months).<br />

During the first months after CRT, varying degrees of postradiation<br />

edema were observed in 26% of patients, which<br />

gradually disappeared during longer follow-up (figure 2).<br />

Conclusion: The morphological MR patterns observed in<br />

these patients may be used as a reference for the follow-up<br />

of rectal cancer patients with a complete tumor response<br />

after CRT, managed with a ‘wait and see policy’.<br />

Figure 1: Patterns of post-CRT fibrosis (d-f) and the corresponding types of primary tumors (a-c). Small polypoid tumors (a) typically resulted in<br />

a minimal fibrotic residue (d). Larger, bulky tumors (b) mostly resulted in a ’full thickness’ fibrosis (e). Spicular tumors (c) resulted in a similarly<br />

spicular fibrosis.<br />

Figure 2: Small primary tumor (a). Six weeks after CRT there is an edematous wall thickening (b), visible as a three layered rectal wall consisting<br />

of an inner mucosa (arrowhead), a hyperintense submucosa (*) and a hypointense outer muscular wall (arrow). During long-term follow-up<br />

the edema gradually decreases untill a normalised two-layered rectal wall (d) becomes visible.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 75


e<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

E03<br />

IMPLEMENTATIE VAN VIRTUELE<br />

COLONOSCOPIE IN DE DAGELIJKSE<br />

RADIOLOGISCHE PRAKTIJK<br />

M.T. de Witte 1,2 , P.C.G. Simons 1<br />

1<br />

VieCuri Medisch Centrum, Venlo<br />

2<br />

UMC St Radboud, Nijmegen<br />

Colorectaal carcinoom is 2 e kankergerelateerde doodsoorzaak<br />

in Nederland en de Westerse landen. De incidentie zal naar<br />

verwachting nog stijgen. De adenomateuze poliep wordt<br />

gezien als <strong>voor</strong>loper van het CRC, de zogenaamde “adenomacarcinoma<br />

sequence”. Het vroegtijdig opsporen en verwijderen<br />

van deze benige <strong>voor</strong>loper <strong>voor</strong>komt het uitgroeien tot CRC(1).<br />

Virtuele colonoscopie werd <strong>voor</strong> het eerst beschreven door<br />

David Vining in 1994 (2). Initieel gestart als 2D techniek,<br />

werd al snel ook de 3D “virtuele endoscopie” ontwikkeld.<br />

De segmentatie van darmsegmenten moest aanvankelijk<br />

handmatig gebeuren, een tijdrovende en arbeidsintensieve<br />

procedure. Inmiddels is Virtuele Colonoscopie volgroeid tot<br />

een volautomatische software tool met snelle segmentatie<br />

van darmsegmenten, panoramische weergave, automatische<br />

poliepdetectie (CAD), en elektronische cleansing.<br />

Officieel geaccepteerde indicaties <strong>voor</strong> Virtuele Colonoscopie<br />

zijn onvolledige optische coloscopie <strong>voor</strong> beoordeling van het<br />

proximale colon, verhoogd complicatie risico door hoge leeftijd<br />

en / of comorbiditeit en patientenweigering (3).<br />

In onze ervaring is deze techniek echter breder toepasbaar.<br />

Uit initieel onderzoek blijkt dat bij goede patientenselectie<br />

optische coloscopie in ruim 85% van de gevallen kan<br />

worden <strong>voor</strong>komen (4). Een recente en interessante ontwikkeling<br />

is korte termijn VC follow-up bij 1-2 kleine poliepen.<br />

Door de zeer accurate anatomische lokalisatie van afwijkingen<br />

middels VC blijkt deze techniek bij uitstek geschikt<br />

<strong>voor</strong> follow up van deze poliepen(5). Dit lijkt een geschikt<br />

alternatief <strong>voor</strong> de huidige richtlijnen waarbij excisie van<br />

poliepen ongeacht de grootte wordt geadviseerd (6). 
Nu<br />

besloten is om in Nederland vanaf 2012 een landelijk screenings<strong>programma</strong><br />

naar CRC middels i-FOBT op te starten, zal<br />

het aantal coloscopieen en dus ook het aantal onvolledige<br />

procedures toenemen. Hierdoor zal de vraag naar VC zeker<br />

toenemen. 

VC is een betrouwbare en robuuste techniek<br />

met een grote toekomst. Deze techniek dient dan ook geimplemeteerd<br />

te worden op elke radiologische afdeling.<br />

Referenties:<br />

1. J. Stoker. CT colografie en bevolkingsonderzoek <strong>voor</strong> colorectaal<br />

carcinoom. Memorad 13 (4), 2008; 13-18.
<br />

2. DJ Vining, DW Gelfand, RE Bechtold et al. Technical feasibility of<br />

colon imaging with helical CT and virtual reality. AJR Am J Roentgenol<br />

1994; 162:Suppl: 104 abstract.<br />

3. EG MacFarland, JG Fletcher, PJ Pickhardt et al. ACR Colon Cancer<br />

Committee White Paper: Status of CT Colonography 2009. J Am<br />

Coll Radiol. 2009; 6: 756-772.
<br />

4. CT-colografie als eerstelijnsdiagnosticum bij patienten met darmklachten.<br />

JS Peulen. MT de Witte, P Friederich et. al. Ned Tijdschr<br />

Geneeskd 2010; 154: A1681.
<br />

5. The natural history of small polyps at CT colonography. PJ Pickhardt,<br />

DH kim et al. Annual meeting for the Soceity of Gastrointestinal<br />

Radiologsts 2008; Rancho Mirage, CA.
<br />

6. Coloncarcinoom. Landelijke richtlijn versie 2.0, 09-01-08, Landelijke<br />

Werkgroep Gastro Intestinale Tumoren.<br />

E04<br />

FUTURE CLINICAL APPLICATIONS OF HIGH<br />

RESOLUTION ANATOMICAL IMAGING OF<br />

THE BRAIN AT 7.0 TESLA MRI<br />

A.G. van der Kolk, J.J.M. Zwanenburg, F. Visser, P.R. Luijten,<br />

J. Hendrikse<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Purpose: To show the clinical potential of anatomically highly<br />

detailed images of the brain obtained with 7.0 Tesla MRI.<br />

Background: Although not widely used clinically, an<br />

increasing number of sites worldwide have the availability<br />

of an MRI scanner with a field strength of 7.0 Tesla. There is<br />

active debate if and when it may become the field strength<br />

of choice for certain clinical applications. Specifically,<br />

high resolution anatomical brain imaging at 7.0 Tesla with<br />

sequences such as FLAIR, T1- and T2*-weighted imaging<br />

and MR angiography may be the potential area where 7.0<br />

Tesla MRI provides additional diagnostic information not<br />

found on lower field strengths.<br />

Materials & Methods: Apart from a review of the current<br />

literature regarding anatomical brain MRI at 7.0 Tesla, the<br />

focus will be on clinical patient examples where 7.0 Tesla<br />

MRI gives additional diagnostic information or a better delineation<br />

of pathology than lower field strengths. Also, normal<br />

findings and anatomical variants not seen on 1.5 or 3.0 Tesla<br />

will be shown. When possible, comparison with 3.0 Tesla or<br />

1.5 Tesla MR images will be given (figure 1) to further illustrate<br />

the additional information which can be gained with<br />

7.0 Tesla scanning compared to lower field strength.<br />

Conclusion: High resolution anatomical brain imaging at<br />

7.0 Tesla MRI can give additional information about pathology<br />

and normal anatomical variations and will be able to<br />

contribute to faster and more accurate diagnosing.<br />

76<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Educatieve <strong>abstracts</strong><br />

e<br />

Figuur 1: White matter lesions at 1.5T as compared to 7.0T.<br />

E05<br />

IS BEELDVORMING VAN ATHEROSCLEROSE<br />

KLAAR VOOR DE DAGELIJKSE PRAKTIJK?<br />

S.C. Gerretsen 1 , V.C. Cappendijk 1 , R.M. Kwee 1 ,<br />

M.B.I. Lobbes 1 , M. Das 1 , T. Leiner 2 , J.M.A. van Engelshoven 1 ,<br />

M.E. Kooi 1 , J.E. Wildberger 1<br />

1<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

2<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Doelstelling: Het bieden van een overzicht van de huidige<br />

mogelijkheden <strong>voor</strong> het detecteren en karakteriseren van<br />

atherosclerotische plaques.<br />

Beschrijving: In deze presentatie wordt een overzicht gegeven<br />

van de routine- en geavanceerde technieken die kunnen<br />

worden gebruikt <strong>voor</strong> beeldvorming van atherosclerose. Er<br />

wordt getoond hoe verschillende stadia van atherosclerose<br />

kunnen worden gedetecteerd, hoe stabiele atherosclerotische<br />

plaques van instabiele plaques onderscheiden kunnen worden<br />

en hoe plaques in symptomatische en asymptomatische<br />

patiënten kunnen verschillen. Tenslotte zal uitgelegd worden<br />

welke studies er nodig zijn om het afbeelden van een atherosclerotische<br />

plaques klinisch toepasbaar te maken.<br />

Conclusie: Niet-invasieve beeldvorming is geschikt <strong>voor</strong> de<br />

detectie en karakterisatie van atherosclerotische plaques.<br />

Deze presentatie beoogt de radioloog bewust te maken van<br />

het belang van detectie en rapportage van atherosclerose.<br />

Dit is een belangrijke stap om beeldvorming van atherosclerose<br />

klinisch toepasbaar te maken.<br />

Achtergrond: Atherosclerose is een chronische aandoening<br />

van de arteriële vaatwand die vaatvernauwingen en<br />

thrombo-emboliën kan veroorzaken hetgeen kan leiden tot<br />

een hersen- of hartinfarct. Ondanks <strong>voor</strong>uitgang in diagnostiek<br />

en behandeling blijft atherosclerose één van de belangrijkste<br />

doodsoorzaken in de westerse wereld. Geavanceerde<br />

technieken hebben aangetoond dat het mogelijk is om op<br />

niet-invasieve wijze de arteriële vaatwand af te beelden.<br />

Hierbij kunnen verschillende stadia van atherosclerose in<br />

beeld gebracht worden en zijn er verschillen waargenomen<br />

in plaques tussen symptomatische en asymptomatische personen.<br />

Echter ook op routine-onderzoeken is veel informatie<br />

over de aanwezigheid en mate van atherosclerose te verkrijgen.<br />

Gezien de mogelijke complicaties van atherosclerose is<br />

vroege detectie en rapportage van atherosclerose belangrijk.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 77


e<br />

<strong>programma</strong> <strong>abstracts</strong> & <strong>abstracts</strong><br />

E06<br />

LUNG PERFUSION DEFECTS ON DUAL-<br />

ENERGY COMPUTED TOMOGRAPHY<br />

(DECT): REVIEW OF MORPHOLOGY AND<br />

DIFFERENTIAL DIAGNOSIS?<br />

A.E. Odink 1 , M. Rossius 1 , R. Booij 1 , C.M. Schaefer-Prokop 2 ,<br />

I.J.C. Hartmann 1<br />

1<br />

Erasmus Medisch Centrum, Rotterdam<br />

2<br />

Meander Medisch Centrum, Amersfoort<br />

Purpose: To present insight on the basic principles of DECT<br />

and provide a pictorial review of the range of morphology<br />

of lung perfusion with diagnostic clues for differentiating<br />

pulmonary embolism from other underlying diseases.<br />

Content organization: The classic presentation on a<br />

DECT perfusion map of acute pulmonary embolism (PE) is a<br />

peripheral, wedge shaped defect. However, other underlying<br />

parenchymal diseases such as emphysema, lung cysts, fibrosis<br />

or pneumonia also cause perfusion defects. Location,<br />

distribution and configuration of perfusion defects together<br />

with findings in lung window settings provide the necessary<br />

information for correct differential diagnosis. Also artifacts<br />

caused by beam hardening or pulsation cause perfusion<br />

inhomogeneities that occur in typical locations and are<br />

mostly easy to dismiss.<br />

The exhibit provides an overview of the spectrum of perfusion<br />

map findings to be encountered in a group of unselected<br />

patients undergoing evaluation for suspected PE and<br />

with known or unknown concomitant lung diseases. Typical<br />

and atypical perfusion defects caused by artifacts, focal or<br />

diffuse lung parenchymal diseases will be presented together<br />

with some guidelines for correct interpretation.<br />

Conclusion: Especially in an unselected group of patients<br />

with accompanying lung disease, knowledge of pitfalls and<br />

artifacts is important for correct interpretation of the spectrum<br />

of lung perfusion defects seen in DECT.<br />

E07<br />

VALUE OF COMPUTED TOMOGRAPHY<br />

CORONARY ANGIOGRAPHY IN<br />

FAILED CONVENTIONAL CORONARY<br />

ANGIOGRAPHY<br />

A.S. Thijssen 1 , R.N. de Visser 2 , G.F.A.J.B van Tilborg 2 ,<br />

A.C. Weustink 1 , G.P. Krestin 1 , N.R.A. Mollet 1<br />

1<br />

Erasmus Medisch Centrum, Rotterdam<br />

2<br />

St. Elisabeth Ziekenhuis, Tilburg<br />

Purpose/aim: If conventional X-ray coronary angiography<br />

(CCA) fails, computed tomography coronary angiography<br />

(CTCA) has the potential to provide the desired diagnostical<br />

information concerning coronary patency but may also<br />

demonstrate the cause of failing CCA exams.<br />

Content organization: CTCA has proved its usefulness in<br />

ruling out significant coronary artery stenosis in patients<br />

with an intermediate risk of having coronary artery disease.<br />

Although CCA is superior for this purpose, the exam cannot<br />

always be successfully completed.<br />

We will present a series of cases in which CCA could not be<br />

successfully completed and where CTCA revealed the cause<br />

of the failed exam. The presentation will feature several<br />

images from CTCA studies (multiplanar reformations and 3D<br />

renderings).<br />

Summary: Although CTCA is primarily reserved for patients<br />

with an intermediate risk of coronary artery disease, it can<br />

be employed to image the coronary tree in cases where CCA<br />

fails. In several instances, CTCA will reveal the cause of<br />

failed CCA. CTCA data may also provide useful information<br />

for planning interventional procedures or surgery in patients<br />

with a failed CCA exam.<br />

Figure 1 Figure 2 Figure 3<br />

78<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Educatieve <strong>abstracts</strong><br />

e<br />

E08<br />

PSEUDOTUMOREN BIJ METAAL OP METAAL<br />

TOTALE HEUP ARTROPLASTIEK<br />

M.F. Boomsma 1 , L. Sijbrandij 1 , B.H. Bosker 2 , H.B. Ettema 2 ,<br />

C.C.C.M. Verreyen 2 , B.J. Kollen 3 , M. Maas 4<br />

1<br />

<strong>Radiologie</strong>, Isala klieken, Zwolle<br />

2<br />

Orthopedie Isala klieken, Zwolle<br />

3<br />

Faculteit Medische wetenschappen, Universitair Medisch<br />

Centrum Groningen, Groningen<br />

4<br />

<strong>Radiologie</strong>, Academisch Medisch Centrum, Amsterdam<br />

Na het ondergaan van een totale heupartroplastiek is<br />

bekend dat er als complicatie pseudotumoren kunnen<br />

optreden. Recente vermoedens van verhoogde incidentie<br />

van klachten, gepaard gaande met pseudotumorvorming bij<br />

metaal op metaal totale heup artroplastiek (MoM THA), hebben<br />

geleid tot veel media-aandacht. Inmiddels zijn meerdere<br />

<strong>Nederlandse</strong> ziekenhuizen overgegaan tot het oproepen van<br />

patiënten die een MoM THA hebben ondergaan.<br />

In een recent uitgevoerd prospectief single center cohort<br />

studie is aangetoond dat de incidentie van pseudotumoren bij<br />

deze groep patiënten 36% is. Dit heeft inmiddels geleid tot<br />

revisie tot een polyethyleen acetabulum component van de<br />

MoM THA in 28% van de patiënten met een pseudotumor.[1]<br />

In deze presentatie zal de beeldvorming van de normale en<br />

postoperatieve heup in het kader van de THA worden besproken.<br />

Tevens wordt een overzicht gegeven van de verschillende<br />

uitingsvormen van pseudotumoren bij de MoM THA.<br />

Ervaringen van auteurs hebben geleid tot een “recall imaging”<br />

strategie, welke zal worden besproken. Een belangrijk<br />

item hieruit is het gebruik van CT bevindingen en de verhouding<br />

hiervan ten opzichte van een gangbare MR classificatie<br />

van pseudotumoren bij MoM THA patiënten.[2]<br />

Referenties:<br />

1. Risk assessment for pseudotumor after metal-on-metal largediameter<br />

femoral head total hip arthroplasty: a prospective cohort<br />

study. Bosker BH, Ettema HB, Boomsma MF, Kollen BJ, Wagemakers<br />

B and Verheyen CCPM. (Submitted)<br />

2. Grading the severity of soft tissue changes associated with metalon-metal<br />

hip replacements: reliability of an MR grading system.<br />

Anderson H, Toms AP Cahir JG, Goodwin RW, Wimhurst J and<br />

Nolan JF. Skeletal Radiol (2011) 40:303–307<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1 79


P<br />

<strong>programma</strong> posterpresentaties & <strong>abstracts</strong><br />

Samenvattingen<br />

Posterpresentaties<br />

P01<br />

FOETALE POSTMORTEM<br />

RADIOLOGIE<br />

W.M. Klein, C. Marcelis, F. Vandenbussche<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

Doel: verbetering radiologie congenitale afwijkingen bij<br />

overleden foetussen.<br />

Achtergrond: Met de komst van de 20-wekenecho neemt<br />

het aantal gevonden congenitale afwijkingen sterk toe, en<br />

hiermee ook het aantal zwangerschapsafbrekingen. Toch<br />

daalt het aantal autopsieen (gouden standaard). Postmortem<br />

MRI en CT kunnen, zonder het kind te beschadigen, aanvullende<br />

informatie geven.<br />

Discussie & conclusie: Postmortem foetale MRI en CT<br />

kunnen belangrijke bevestiging en additionele informatie.<br />

Dit is van grote waarde <strong>voor</strong> de verwerking door ouders en<br />

<strong>voor</strong> genetic counseling ten behoeve van volgende kinderen.<br />

Zeker bij een dalend aantal autopsieen is dit van groot<br />

belang.<br />

Een prospectieve studie in samenwerking met pathologie,<br />

radiologie, klinische genetica en gynaecologie zal de diagnostische<br />

waarde moeten aantonen.<br />

Techniek en casuistiek: Postmortem radiologische diagnostiek<br />

(


posterpresentaties<br />

P<br />

Figuur 2: Thanatofore dysplasie.<br />

Figuur 3: Tubureuze sclerose astrocytoom.<br />

P02<br />

AUTOMATED BREAST VOLUME SCANNER:<br />

3D-ULTRASOUND OF BREAST LESIONS<br />

T.A. Fassaert, M.D.F. de Jong, I.J.M. Dubelaar,<br />

M.C.J.M. Rutten<br />

Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

Purpose: Familiarize the reader with the imaging characteristics<br />

of benign and malignant findings in 3-dimensional<br />

breast ultrasound (3D-US) obtained with an automated<br />

breast volume scanner (ABVS). Emphasis is put on the<br />

added value of the new coronal plane (surgeon view) and<br />

the multiplanar correlation.<br />

Content: From a study of 200 consecutive patients, who<br />

underwent breast MRI and ABVS, we demonstrate 3D-US<br />

findings in a selection of illustrative cases with benign and<br />

malignant breast lesions. The illustrated cases are correlated<br />

with digital mammography, handheld 2D ultrasound,<br />

MRI and histopathological findings.<br />

Summary: ABVS provides high-resolution 3D-US images of<br />

breast lesions. The new coronal view and multiplanar correlation<br />

facilitate the sonographic assessment of benign and<br />

malignant breast lesions.<br />

Figuur 1: 3D-UScorrelation necrotic focus after RFA.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

81


P<br />

<strong>programma</strong> posterpresentaties & <strong>abstracts</strong><br />

Figuur 2: 3D-US correlation of lymph node & vascular bundle.<br />

Figuur 3: 3D-US correlation of a stellate lesion.<br />

82<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


posterpresentaties<br />

P<br />

P03<br />

BRAIN PLASTICITY IN APHASIC PATIENTS<br />

AFTER MELODIC INTONATION THERAPY<br />

ASSESSED WITH FUNCTIONAL MAGNETIC<br />

RESONANCE IMAGING (FMRI)<br />

M.A.H. Bechan 1 , W.M.E. van de Sandt-Koenderman 2 ,<br />

C.P. Mendez 1 , E.G. Visch-Brink 1 , M. Smits 1<br />

1<br />

Erasmus Medisch Centrum, Rotterdam<br />

2<br />

Rijndam revalidatiecentrum, Rotterdam<br />

Purpose: Certain aphasic patients are treated with Melodic<br />

Intonation Therapy (MIT), which uses musical elements of<br />

speech to initiate language production. The purpose of this<br />

study is to visualize neuronal reorganizational processes in<br />

the brain in response to MIT using fMRI.<br />

Methods and materials: Four patients with chronic and<br />

two with acute aphasia (22-67 years; 4 males; 5 righthanded)<br />

were scanned at 3T before and after six weeks of<br />

MIT, which consisted of naming, repeating and spontaneous<br />

speech. To visualize language processing a block design<br />

task, consisting of listening to stories versus reverse speech,<br />

was used. Language performance was measured using the<br />

Sabadel story telling task. Imaging data were analyzed<br />

using Statistical Parametric Mapping 8 (London, UK). After<br />

preprocessing individual statistical t-contrast maps were<br />

calculated for pre- and post-therapy datasets. Lateralization<br />

indices (LI) were calculated using the number of significantly<br />

(p


P<br />

<strong>programma</strong> posterpresentaties & <strong>abstracts</strong><br />

P04<br />

DESMOID-TYPE FIBROMATOSIS:<br />

A COMPREHENSIVE REVIEW OF<br />

MULTIMODALITY IMAGING FINDINGS<br />

IN PRIMARY, RECURRENT AND<br />

DEDIFFERENTIATED DISEASE WITH<br />

HISTOPATHOLOGIC CORRELATION<br />

I.J.M. Dubelaar 1 , U. Flucke 2 , J. Bonenkamp 2 , M. Prokop 2 ,<br />

J.W.J. de Rooy 2<br />

1<br />

Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

2<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

Summary: Desmoid-type fibromatoses are rare, locally<br />

aggressive, non-metastazing soft tissue tumors with high<br />

tendency towards local recurrence.<br />

This exhibition will review:<br />

1. the various types and the multimodality imaging features<br />

of primary, recurrent and dedifferentiated disease with<br />

histopathological correlation<br />

2. The role of imaging in the management of these types of<br />

soft tissue tumors<br />

3. Current treatment options<br />

Content organization:<br />

1. Desmoid-type fibromatosis review; - epidemiology, aetiology,<br />

localization and clinical features of different types<br />

- multimodality imaging features of primary, recurrent/<br />

dedifferentiated disease and post- therapy changes<br />

2. Histopathologic morphology and genetics<br />

3. Treatment options: - local excision - radiotherapy -<br />

systemic therapy<br />

P05<br />

REPEATED PHASE-CONTRAST MAGNETIC<br />

RESONANCE ANGIOGRAPHY TO ASSESS<br />

CEREBROVASCULAR REACTIVITY IN<br />

PATIENTS WITH CAROTID ARTERY STENOSIS<br />

N.S. Hartkamp, J. Hendrikse, H.B. van der Worp,<br />

G.J. de Borst, R.P.H. Bokkers<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

Purpose: To assess the cerebrovascular reactivity in<br />

patients with internal carotid artery (ICA) stenosis and<br />

identify the optimal timing for reactivity measurements with<br />

acetazolamide as vasodilatory challenge medication.<br />

Methods: Twenty-one patients with a symptomatic ICA<br />

stenosis and 18 healthy control subjects underwent twodimensional<br />

phase-contrast magnetic resonance angiography<br />

to repeatedly measure the blood flow (ml/min) in the<br />

ICAs at baseline and in 5 minute intervals for 30 minutes<br />

after intravenous administration of 12 gram acetazolamide<br />

per kilogram body weight.<br />

Results: The blood flow during the exam was significantly<br />

lower in the stenosed ICA of patients (figure 1, indicated<br />

with the star) than in the contralateral ICA (light gray)<br />

and than in the ICAs of healthy controls (white). The<br />

absolute increase of blood flow after 15 minutes was as<br />

well significantly lower in the stenosed ICA than in the<br />

contralateral ICA and than in the healthy ICAs (respectively<br />

74.6±12, 122±18, and 137±15 ml/min), whereas the relative<br />

increase was not (respectively 46.9±6.7%, 56.0±9.4%, and<br />

58.2±7.2%). The vasodilatory effect in the stenosed ICAs<br />

Figure 1: Blood flow after acetazolamide administration.<br />

Figure 2: Time to peak after acetazolamide<br />

administration.<br />

84<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


posterpresentaties<br />

P<br />

was maximal after 15 minutes (figure 2, indicated with the<br />

star) and decreased after 20 minutes (figure 1), which was<br />

significantly later than in the contralateral ICA (light gray)<br />

and healthy ICAs (white).<br />

Conclusion: Patients with ICA stenosis have a reduced<br />

absolute increase in blood flow with preserved relative<br />

increase after a vasodilatory challenge with acetazolamide.<br />

The time to maximum vasodilatation was also longer in<br />

the stenosed ICA of patients. The optimal timing for single<br />

reactivity measurements using acetazolamide is between 15<br />

to 20 minutes after administration.<br />

P06<br />

MIXED CEREBRAL PERFUSION TERRITORIES<br />

IN THE POSTERIOR CIRCULATION<br />

INVESTIGATED USING SUPER-SELECTIVE<br />

ARTERIAL SPIN LABELING MRI<br />

N.S. Hartkamp 1 , M. Helle 2 , R.P.H. Bokkers 1 , J. Hendrikse 1 ,<br />

M.J.P. Van Osch 3<br />

1<br />

Universitair Medisch Centrum Utrecht, Utrecht<br />

2<br />

Institute of Neuroradiology, Christian-Albrechts-Universität,<br />

Kiel, Germany<br />

3<br />

Leiden Universitair Medisch Centrum, Leiden<br />

Purpose: The posterior circulation is supplied with blood by<br />

the vertebral arteries (VA) that fuse into the basilar artery<br />

(BA). We aim to investigate to which extent blood mixes in<br />

the BA before it arrives in cerebral hemispheres.<br />

Methods: Five healthy volunteers were investigated on a 3T<br />

MRI scanner with super-selective pseudo-continuous arterial<br />

spin labeling (ASL) perfusion imaging, which allows separate<br />

labeling of the VAs. The contribution to the perfusion<br />

of each individual VAs was calculated for the left and right<br />

hemisphere of the cerebellum and cerebrum.<br />

Results: The relative amount of ASL-signal from each VA<br />

to either hemisphere of the cerebellum and cerebrum are<br />

summarized in table 1. The posterior circulation of subject 1<br />

was almost exclusively supplied by one VA due to a variant<br />

anatomy. The perfusion images of both the left and right VA<br />

from subject 5 shown in figure 1. Examination of the perfusion<br />

images reveals areas in the cerebellum exclusively supplied<br />

by either the left or the right VA (also shown in figure<br />

1). The perfusion images show increasing overlap in the<br />

cerebrum. Both in the cerebellum and in the cerebrum most<br />

of the ASL-signal is observed ipsilateral from the labeled<br />

VA, although significant signal is also observed contralaterally,<br />

especially in the cerebrum.<br />

Conclusion: The results show that although most ASLsignal<br />

in the posterior flow territory originates from the<br />

ipsilateral VA, a considerable amount of ASL-signal stems<br />

from the contralateral VA, indicating mixing of blood or at<br />

least exchange of magnetization between blood streams in<br />

the BA. Mixing in the BA however does not produce a completely<br />

homogeneous blood supply to the cerebral posterior<br />

circulation in our subjects.<br />

Figure 1: Perfusion images of the left and right VA.<br />

Table 1: Relative contributions of the left and right VA.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

85


P<br />

<strong>programma</strong> posterpresentaties & <strong>abstracts</strong><br />

P07<br />

MALFORMATIE VAN DE VENE<br />

VAN GALENI<br />

I.J.M. Dubelaar 1 , F.A. Meijer 2<br />

1<br />

Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

2<br />

Universitair Medisch Centrum St Radboud, Nijmegen<br />

Purpose: To inform the reader of the rare congenital<br />

aneurysmal malformation of the vein of Galen. To illustrate<br />

the appearance, therapy options and various outcome in a<br />

pictorial review.<br />

Content organization: Aneurysmal malformation of the<br />

vein of Galen is a rare congenital vascular malformation,<br />

resulting in developmental delay, congestive heart failure,<br />

hydrocephalus, brain damage and/or death in childhood.<br />

In a pictorial review, we illustrate the best outcome<br />

(spontaneous thrombosis), the worst outcome (melting<br />

brain) and therapy options (endovascular embolization).<br />

Pathophysiology, clinical presentation and therapy options<br />

will be briefly discussed.<br />

Summary: Vein of Galen malformation and resulting<br />

aneurysm is a rare, often fatal congenital disorder. Various<br />

outcome is illustrated and therapy options discussed.<br />

P08<br />

SUBSEQUENT ISCHEMIC STROKE IN<br />

VASCULAR TERRITORIES AFFECTED BY<br />

INTRACRANIAL ARTERIAL STENOSIS IN<br />

PATIENTS WITH TRANSIENT ISCHEMIC<br />

ATTACK AND ISCHEMIC STROKE<br />

P.J. Homburg, M.J. van Gils, G.J.J. Plas, H.L.J. Tanghe,<br />

D.W.J. Dippel, A. van der Lugt<br />

Erasmus Medisch Centrum, Rotterdam<br />

Background and purpose: Compared to extracranial carotid<br />

artery atherosclerosis, intracranial arterial stenosis (ICAS)<br />

has received little attention as a cause of cortical ischemic<br />

stroke. We evaluated the stroke recurrence risk of ICAS per<br />

arterial territory in a large cohort of patients with a transient<br />

ischemic attack (TIA) or ischemic stroke.<br />

Methods: Consecutive patients (n=786) were prospectively<br />

evaluated for the presence and distribution of ICAS (≥30%<br />

stenosis) using CT angiography. Multivariable Cox<br />

proportional hazards models were used to identify risk<br />

factors associated with subsequent ischemic stroke and to<br />

analyze the stroke recurrence risk for ICAS per territory (left<br />

carotid territory, right carotid territory and posterior territory).<br />

Results: In 178/786 patients (23%), 288 ICAS were<br />

observed. Subsequent ischemic stroke occurred in 49<br />

patients (6%), of which 15/49 (31%) occurred in a territory<br />

affected by ICAS. After adjustment for age, sex, hypertension,<br />

diabetes mellitus and extracranial artery stenosis ≥50%,<br />

ischemic stroke risks in territories affected by ICAS were HR<br />

4.34 (95%CI 1.36-13.87) for the left carotid territory, HR 8.09<br />

(95%CI 2.53-25.92) for the right carotid territory and HR 6.94<br />

(95%CI 1.93-25.04) for the posterior territory.<br />

Conclusions: Ischemic stroke and TIA patients with ICAS<br />

have a particularly high risk of subsequent ischemic stroke<br />

in the affected arterial territory. This finding warrants more<br />

research in the pathophysiology of ICAS and modified treatment<br />

for patients with ICAS.<br />

P09<br />

PROSPECTIVE QUALITATIVE COMPARISON<br />

OF 4D RADIAL ACQUISITION CONTRAST-<br />

ENHANCED MR ANGIOGRAPHY VERSUS<br />

DIGITAL SUBTRACTION ANGIOGRAPHY<br />

IN CHARACTERIZING INTRACRANIAL<br />

ARTERIOVENOUS MALFORMATIONS<br />

M. van der Vlies 1, 2 , R. van den Berg 1 , C.B.L.M. Majoie 1<br />

1<br />

Academisch Medisch Centrum, Amsterdam<br />

2<br />

Onze Lieve Vrouwe Gasthuis, Amsterdam<br />

Introduction: Digital subtraction angiography (DSA) is<br />

the gold-standard procedure for diagnosis and follow-up<br />

of cerebral AVM because of its high temporal and spatial<br />

resolution. However, alternative time-resolved techniques<br />

such as TRICKS (GE Healthcare), TWIST (Siemens) and 4D<br />

TRAK (Philips Healthcare) are now widely available<br />

to allow dynamic MR imaging for the appreciation of<br />

contrast kinetics. We hypothesized that in agreement with<br />

other studies, 4D radial acquisition contrast enhanced<br />

MRA (4D rCE-MRA) compared to DSA, approximates<br />

vascular architecture and flow dynamics of AVMs, furthermore<br />

implying a reduction in risk exposure and in<br />

procedural risks.<br />

Methods: A total of 21 consecutive patients were assessed<br />

prospectively, 7 had AVM, 7 had AV-fistula and 2 had a DVA.<br />

4D rCE-MRA and DSA were performed. The 4D rCE-MRA<br />

images were assessed regarding vascular architecture and<br />

dynamic flow characteristics.<br />

Results: 4D rCE-MRA correctly depicted location, nidal<br />

size, venous drainage pattern and prominent arterial feeders<br />

in almost all cases of AVMs and AV-fistulas. There<br />

86<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


posterpresentaties<br />

P<br />

was good agreement (approximately 90%) between DSA<br />

and 4D rCE-MRA images.<br />

Conclusion: 4D rCE-MRA is a good alternative imaging<br />

modality tool approximating the imaging gold standard of<br />

DSA and furthermore proving to be a reliable minimal invasive<br />

imaging tool that avoids the risks associated with DSA.<br />

Figure 1: 4D MRA arterial phase.<br />

Figure 2: 4D MRA venous phase.<br />

Figure 3: 4D MRA late venous phase, showing cerebellar AVM.<br />

P10<br />

RADIOFREQUENTE ABLATIE VAN OUDERE<br />

PATIENTEN MET T1 MAMMACARCINOOM<br />

DIE NIET IN AANMERKING KOMEN VOOR<br />

CHIRURGIE<br />

M.D.F. de Jong, M.J.C.M. Rutten, D. Kreb, B.G. Looij,<br />

K. Bosscha, M. Ernst, H. van der Linden, G.J. Jager<br />

Jeroen Bosch Ziekenhuis, ‘s-Hertogenbosch<br />

Doel: Radiofrequente ablatie (RFA) kan een alternatieve en<br />

effectieve behandeling vormen bij patiënten met T1 borstkanker,<br />

welke niet geschikt zijn <strong>voor</strong> chirurgisch ingrijpen.<br />

Doel is te bepalen of RFA technisch haalbaar en veilig is<br />

en of lokale tumorcontrole verkregen kan worden. Daarbij<br />

wordt geëvalueerd hoe de behandeling door patiënten wordt<br />

ervaren.<br />

Methode: Patiënten >70 jaar met een oestrogeen positief<br />

mammacarcinoom < 2 cm worden gevraagd deel te nemen<br />

aan deze studie. De respons na de aanvullende RFA therapie<br />

(naast hormonale therapie) zal geëvalueerd worden, middels<br />

mammografie, echografie en MRI na 1, 6 en 12 maanden.<br />

Tevens zal een echogeleid vacuümbiopt volgen van het<br />

RFA-gebied <strong>voor</strong> histologische analyse volgen na een jaar.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

87


P<br />

<strong>programma</strong> posterpresentaties & <strong>abstracts</strong><br />

Ervaringen van patiënten <strong>voor</strong>, tijdens en na de behandeling<br />

worden geëvalueerd.<br />

Resultaten: In totaal hebben vijf patiënten RFA ondergaan,<br />

waarbij er geen aanwijzingen waren op lokaal recidief<br />

of residu weefsel na een jaar follow-up. De geableerde<br />

gebieden vertoonden afname van grootte en ringaankleuring<br />

gedurende follow-up. Bij één patiënte is interval follow-up<br />

niet verricht in verband met een CVA. Patiënten vonden<br />

RFA-behandeling verdraagbaar en er was afname van één<br />

punt op een zeven puntsschaal ter analyse van de kwaliteit<br />

van leven.<br />

Conclusie: RFA kan technisch veilig worden uitgevoerd bij<br />

inoperabele, oudere patiënten met een solitaire borsttumor,<br />

met minimale afname op de kwaliteit van leven.<br />

Figuur 1: bewezen maligne laesie linker mamma.<br />

Figuur 2: controle na 1 maand toont ringaankleuring.<br />

Figuur 3: na 1 jaar afname aankleuring, geen recidief.<br />

88<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


posterpresentaties<br />

P<br />

P12<br />

PROPOSAL FOR AN ADAPTATION OF THE<br />

BERLIN ALGORITHM FOR DIAGNOSING<br />

SPA: RESULTS OF THE SPONDYLOARTHRITIS<br />

CAUGHT EARLY (SPACE)-COHORT<br />

R. van den Berg, M.H.E. Vossen, M. Reijnierse,<br />

T.W.J. Huizinga, D.M.F.M. van der Heijde<br />

Leids Universitair Medisch Centrum, Leiden<br />

Background: The Berlin algorithm assists clinicians in diagnosing<br />

early axial SpA.<br />

Objectives: Validate the Berlin algorithm in the<br />

SPondyloArthritis Caught Early (SPACE)-cohort.<br />

Methods: The SPACE-cohort is set-up in our hospital to<br />

early diagnose and treat (axial) spondyloarthritis (SpA)-<br />

patients. Patients with back pain (>3 months, < 2 years;<br />

onset 80% probability. In patients<br />

(n=65) not diagnosed with axial SpA, 14 (21.5%) patients<br />

fulfilled ASAS axial SpA criteria and 7 (10.8%) had >80%<br />

probability; the majority did not have IBP.<br />

The modified Berlin algorithm, with IBP as additional SpAfeature,<br />

resulted in three entry groups; requirement of ≥4,<br />

2-3, and 0-1 SpA-features. According to this modified algorithm,<br />

57 patients (50%) has axial SpA; 45 (78.9%) fulfilled<br />

ASAS axial SpA criteria and 55 (96.5%) had >80% probability.<br />

Of the 57 patients not diagnosed as SpA, six (10.5%)<br />

fulfilled ASAS axial SpA criteria. 15 additional patients<br />

could now be diagnosed as axial SpA by the modified Berlin<br />

algorithm and no single patient with a probability >80% was<br />

excluded.<br />

Conclusions: We propose a slightly modified Berlin algorithm<br />

excluding IBP as entry criterion that is better in accordance<br />

with the new ASAS axial SpA criteria.<br />

Results: In 4/114 patients no MRI was made and were analyzed<br />

as MRI-. According to the Berlin algorithm 49 patients<br />

Figure 1: The Berlin algorithm.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

89


P<br />

<strong>programma</strong> posterpresentaties & <strong>abstracts</strong><br />

Figure 2: The modified Berlin algorithm.<br />

P13<br />

DIFFERENCE IN CLINICAL PRESENTATION OF<br />

PATIENTS WITH SPONDYLOARTHRITIS WITH<br />

A POSITIVE MRI OF THE SI JOINTS AND/OR<br />

HLA-B27 POSITIVITY<br />

R. van den Berg, M.H.E. Vossen, M. Reijnierse,<br />

T.W.J. Huizinga, D.M.F.M. van der Heijde<br />

Leids Universitair Medisch Centrum, Leiden<br />

Background: The SPondyloArthritis Caught Early (SPACE)-<br />

cohort is set-up in our hospital to early diagnose and treat<br />

(axial) spondyloarthritis (SpA)-patients. The new ASAS axial<br />

and peripheral SpA criteria rely on the presence of active<br />

sacroiliitis on MRI and on HLA-B27 positivity.<br />

Objective: Investigate the difference in presentation of<br />

patients with sacroiliitis vs. non-sacroiliitis on MRI and presence<br />

vs. absence of HLA-B27.<br />

Methods: Patients with back pain (>3 months, < 2 years;<br />

onset


posterpresentaties<br />

P<br />

Table 1: Presence and distribution of SpA-features.<br />

P14<br />

FEASIBILITY OF FUNCTIONAL IMAGING,<br />

INCLUDING DYNAMIC CONSTRAST-<br />

ENHANCED MRI AND PERFUSION CT,<br />

FOR POST-CHEMORADIOTHERAPEUTIC<br />

RESTAGING IN RECTAL CANCER PATIENTS<br />

S.J. Klieverik, E. Kluza, M. Maas, R.G.H. Beets-Tan, G. Beets,<br />

D.M.J. Lambregts<br />

Maastricht Universitair Medisch Centrum, Maastricht<br />

Aim: The aim of this study was to perform a review of the<br />

literature to determine whether 1) the current literature<br />

reports correlations between functional imaging and clinicopathological<br />

markers in rectal cancer patients and 2) if<br />

functional imaging is sensitive to chemoradiotherapy (CRT)-<br />

induced changes in rectal cancer.<br />

Methods: The literature of interest was searched using<br />

Pubmed. Studies were included when correlations between<br />

functional and clinicopathological markers and differences<br />

in functional parameters between pre- and post-CRT were<br />

reported.<br />

Results: Five studies used dynamic constrast-enhanced MRI<br />

(DCE-MRI) and two studies used perfusion CT (p-CT) to<br />

investigate the correlation between functional and clinicopathological<br />

markers. Two studies compared functional parameters<br />

from DCE-MRI in CRT responders vs. non-responders.<br />

Studies correlating DCE-MRI parameters with clinicopathological<br />

markers showed that higher endothelial transfer<br />

coefficient (Ktrans) and perfusion index (PI; a measure of<br />

both perfusion and cappilary permeability surface product)<br />

were significantly correlated with more advanced cancer<br />

stages (e.g. TNM stage) and that these functional parameters<br />

were significantly higher before treatment in patients<br />

with a good response to CRT than in non-responders. Two<br />

studies evaluated the correlation between p-CT parameters<br />

and clinicopathological parameters. Results showed that<br />

significantly higher blood volume, blood flow and mean<br />

transit time were found in groups with poor prognosis (e.g.<br />

high MVD, existence of lympathic metastasis). There were<br />

no studies comparing p-CT parameter in a pre vs. post-CRT<br />

setting.<br />

Conclusion: The reviewed literature shows that functional<br />

imaging parameters, especially Ktrans in DCE-MRI and<br />

BV and BF in p-CT, correlate with clinical and pathological<br />

markers. Therefore, both DCE-MRI and p-CT are of great<br />

potentional as non-invasive therapy-monitoring or therapypredicting<br />

methods in rectal cancer.<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

91


<strong>programma</strong> aantekeningen & <strong>abstracts</strong><br />

92<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


16 E RADIOLOGENDAGEN 2011<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

93


<strong>programma</strong> PLATTEGRONDEn & <strong>abstracts</strong><br />

0-niveau<br />

0.4 0.5<br />

Brussels<br />

Paris<br />

Naar Expo Foyer<br />

Copenhagen<br />

0.3<br />

Lobby<br />

0.6<br />

0.7<br />

0.2<br />

0.9 0.8<br />

Berlin<br />

Athens<br />

Rome<br />

0.1<br />

London<br />

Naar hotel<br />

K1<br />

K2<br />

K3<br />

0.14 0.12<br />

0.13<br />

0.11<br />

94<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


16 E RADIOLOGENDAGEN 2011<br />

1-niveau<br />

Forum Passage<br />

Registratiebalie<br />

Trajectum<br />

Entree<br />

Naar hotel<br />

Expo Foyer<br />

Auditorium 1<br />

Slide preview ><br />

1.3<br />

1.2<br />

Podium<br />

Auditorium 2<br />

1 6 E R A D I O L O G E N D A G E N - 2 9 e n 3 0 S E P T E M B E R 2 0 1 1<br />

95


<strong>programma</strong> PLATTEGRONDen En <strong>programma</strong> & <strong>abstracts</strong><br />

2-niveau<br />

2.7 2.8 2.9 2.10<br />

Promenade<br />

2.11<br />

2.12<br />

2.13<br />

2.6<br />

2.5<br />

Auditorium 1<br />

2.14<br />

2.4<br />

2.3<br />

Podium<br />

2.1<br />

Colorado<br />

Auditorium 2<br />

96<br />

k i j k o o k o p w w w . c o n g r e s s c o m p a n y . c o m<br />

o f w w w . r a d i o l o g e n . n l


Donderdag 29 september 2011<br />

Expofoyer Auditorium 2 Zaal 0.2 Berlin Zaal 0.3 Copenhagen Zaal 0.4 Brussels Zaal 0.5 Paris Zaal 0.8 Rome Zaal 0.9 Athens Zaal 2.1 Colorado<br />

10.00 - 10.45 Ontvangst<br />

10.45 - 12.00 Plenaire sessie: Emeritus <strong>programma</strong><br />

Deze misser maak je (start vanaf 11.20 uur)<br />

maar één keer<br />

12.00 - 13.00 Lunch<br />

12.15 - 12.45 Postersessie<br />

13.00 - 14.00 Plenaire sessie:<br />

Setting standards in<br />

healthcare -<br />

many ways, no return<br />

14.05 - 15.35 Research corner Vervolg Parallelsessie: Parallelsessie: Parallelsessie: Parallelsessie: Parallelsessie:<br />

Emeritus <strong>programma</strong> Interventieradiologie / Cardiovasculaire Abdominale radiologie / Mammadiagnostiek 1 Abdominale<br />

Cardiovasculaire radiologie radiologie Acute radiologie / Diversen radiologie 1<br />

15.35 - 16.00 Theepauze<br />

16.00 - 17.15 Refresher course: Workshop: Vervolg Refresher course: refresher course: Refresher course: refresher course:<br />

Respons monitoring “Interpretatie van radiologisch Emeritus <strong>programma</strong> Chronische thrombo- Neuranatomie Beeldvorming bij groei- What is the best imaging<br />

made sexy wetenschappelijk onderzoek” embolische pulmonale <strong>voor</strong> dummies en puberteitsstoornissen modality for “aseptic/low<br />

hypertensie grade infection/infectious<br />

loosening of joint prostheses?”<br />

17.15 - 17.30 Uitreiking WSS penning<br />

17.30 - 18.45 ALV NVvR & Juniorsectie<br />

18.15 Industrieborrel:<br />

excl. aangeboden door<br />

Vrijdag 30 september 2011<br />

Expofoyer Auditorium 2 Zaal 0.1 London Zaal 0.2 Berlin Zaal 0.4 Brussels Zaal 0.5 Paris Zaal 0.8 Rome Zaal 0.9 Athens Zaal 2.1 Colorado<br />

08.30 - 09.00 Ontvangst<br />

09.00 - 10.15 Workshop/hands-on: Workshop: refresher course: refresher course: Refresher course: refresher course: refresher course:<br />

To make Radlex more familiar. “Interpretatie van Buiktrauma, waar gaat Acute pijn op de borst: De knie: Niet standaard Opleiden anno 2011 Veneuze<br />

Using IHE TCE for radiologisch het nou eigenlijk om Stand van zaken MRI bevindingen en interventies<br />

export of PACS data to wetenschappelijk de postoperatieve knie<br />

an MIRC teaching file onderzoek”<br />

10.15 - 10.45 Koffiepauze<br />

10.45 - 12.15 Parallelsessie: Parallelsessie: Parallelsessie: Parallelsessie: Parallelsessie: Parallelsessie:<br />

De educatieve Abdominale Mammadiagnostiek 2 Kinderradiologie / MSK / Thorax / Neuro-Hoofdhals<br />

<strong>voor</strong>dracht radiologie 2 & Uitreiking Diversen Diversen radiologie<br />

Jan Hendriksprijs<br />

12.15 - 13.15 Lunch<br />

12.30 - 13.00 Postersessie<br />

13.15 - 13.30 Wetenschappelijk beleid<br />

NVvR <strong>voor</strong> academischeen<br />

niet academische centra<br />

13.30 - 14.30 Plenaire sessie:<br />

Pro-con: Setting standards in<br />

healthcare - which way to go?<br />

14.30 - 15.15 Richtlijnen sessie<br />

15.15 - 15.45 Theepauze<br />

15.45 - 16.25 Prijsuitreiking:<br />

Philipsprijs, Posterprijs,<br />

Radiologendagenprijs,<br />

NVvR Travel Grant en<br />

Fellowshipdiploma’s<br />

16.25 - 17.15 Quiz<br />

Vanaf 20.00 Diner & galafeest in Amrâth Grand Hotel De L’Empereur, Maastricht<br />

Het uitgebreide <strong>programma</strong> en de leerdoelen vindt<br />

u <strong>voor</strong>aan in dit <strong>programma</strong>- en abstractboek:<br />

Donderdag 29 september 2011: bladzijde 2 t/m 5<br />

Vrijdag 30 september 2011: bladzijde 5 t/m 7


Hoofdsponsoren radiologendagen 2011<br />

sponsoren en exposanten<br />

Agfa HealthCare<br />

Alliance Medical<br />

Bard Benelux<br />

Bayer Schering Pharma<br />

Biomedic<br />

Bracco Imaging Europe<br />

Covidien Nederland<br />

Esaote Pie Medical<br />

GE Healthcare<br />

Guerbet Nederland<br />

Haga Medical<br />

Helsebemanning<br />

Medtronic Nederland<br />

Melius Pro<br />

Oldelft Benelux<br />

Radiomatix<br />

Toshiba Medical Systems Nederland<br />

Tromp Medical<br />

Vrest Medical

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!